🥚 Hatched from Shells (Super 8-K Filers)
đź“š What is a Super 8-K — aka The Reverse Merger?
When a shell company — one with no real business operations — completes a reverse merger with a private operating company, it must file a special SEC Form 8-K disclosing the transaction under Item 2.01 (Completion of Acquisition or Disposition of Assets). Because this filing must include full company disclosures equivalent to a Form 10 registration, it runs 50–500 pages and is known informally as a Super 8-K. It marks the moment a shell company ceases to exist and a real business takes its place — sometimes overnight. For the company involved, this is a once-in-a-lifetime transformation — often overlooked by retail investors, and can precede significant price movement. The companies listed below have all crossed that threshold.
339 Super 8-K filings identified across our universe since April 2025 — the full history, latest first.
July 2026
52 filings
▲
KULR
AMEX
▲ SUPER 8-K
KULR Technology Group, Inc.
EDGAR Items: 2.01
# Summary of KULR Technology Group 8-K Filing
KULR Technology Group completed the sale of approximately 333 bitcoin between July 9-23, 2026 at a weighted average price of $64,538 per BTC, generating $21.5 million in gross proceeds. The company used the net proceeds to fully repay its $20 million credit facility with Coinbase Credit, eliminating the debt and releasing 565 BTC previously pledged as collateral. This strategic deleveraging strengthens KULR's balance sheet by reducing interest expense and liquidation risk while the company retains approximately 760 BTC and maintains a largely debt-free financial position as it scales its core battery technology business.
CNTN
NASDAQ
▲ SUPER 8-K
Canton Strategic Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# Summary of Canton Strategic Holdings, Inc. Form 8-K Filing
Canton Strategic Holdings, Inc. completed the sale of its wholly-owned subsidiary Gravitas Life Sciences, LLC (a clinical-stage biotech company focused on immunology and inflammation therapeutics) to Gravitas Collective Corp. on July 17, 2026, for $3.5 million in an unsecured promissory note bearing 15% annual interest, compounded semi-annually, with a maturity date of July 17, 2029, plus potential development milestone payments. The transaction involves a related-party element, as the buyer is affiliated with three former company directors (Vincent LoPriore, Sireesh Appajosyula, and Gary Stetz), though a special committee of independent directors reviewed and approved the deal. Canton retained bispecific antibodies development assets through its subsidiary Tharimmune SPV1, mitigating complete divestiture risk.
**Investor Impact**: This disposition reduces Canton's operational biotech pipeline but preserves liquidity through the $3.5 million note receivable; however, investors should monitor note repayment risk given the buyer's affiliation with former insiders and the absence of upfront cash consideration, which may signal valuation concerns or liquidity constraints.
FGMCR
NASDAQ
▲ SUPER 8-K
FG Merger II Corp. Rights
EDGAR Items: 1.01,1.02,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# Summary of Boxabl Inc. Form 8-K Filing
Boxabl Inc. (trading under ticker BXBL on Nasdaq) successfully completed its merger with FG Merger II Corp. (SPAC) on July 17, 2026, with the combined company beginning trading on July 20, 2026. Under the merger agreement, former Boxabl shareholders received approximately 246.5 million shares of common stock and 103.5 million shares of preferred stock, valuing the transaction at $3.5 billion based on a $10.00 per share deemed value. Lock-up agreements restrict insiders from selling shares for 12 months (with 50% of shares able to unlock earlier if the stock reaches $12.00 for 20 trading days within any 30-day period), and all lock-up restrictions automatically terminate if the stock trades at $20.00 or above at any point. The transaction represents a significant capitalization event for the modular housing company, bringing it to public markets with substantial insider ownership restrictions in place to ensure stability during the critical post-merger period.
ZSTK
NASDAQ
▲ SUPER 8-K
ZeroStack Corp. Common Stock
EDGAR Items: 2.01
# ZeroStack Corp. (ZSTK) 8-K Summary
ZeroStack Corp. completed a private cryptocurrency financing transaction on July 20, 2026, acquiring 142.2 million native tokens from the Zero Gravity (0G) blockchain in exchange for issuing 9.1 million new common shares to investors. The transaction was facilitated through a subsidiary structure (Texas Blocker Corp.) and received shareholder approval at the company's annual meeting. Executive Chairman Michael Heinrich's affiliated entity, Zero Gravity Labs Inc., was a significant investor, acquiring approximately 4.6 million shares (50.6% of the financing) and effectively maintaining substantial control of the company post-transaction.
**Investor Impact:** The financing significantly dilutes existing shareholders while concentrating voting power in affiliated parties, and ties the company's value to cryptocurrency assets (0G tokens) rather than traditional operations, increasing volatility and speculative risk. Investors should monitor whether the 0G tokens generate meaningful value and review governance implications of the insider's substantial ownership stake.
KORGW
OTC
▲ SUPER 8-K
KORE Group Holdings, Inc.
EDGAR Items: 1.01,1.02,2.01,2.03,3.01,3.03,5.01,5.02,5.03,5.07,7.01,9.01
# Summary of KORE Group Holdings, Inc. 8-K Filing
KORE Group Holdings, Inc. completed its going-private merger on July 21, 2026, with funds managed by Searchlight Capital Partners and Abry Partners acquiring the company at $9.25 per share in cash. The transaction eliminates KORE's status as a public company, as all outstanding common shares were converted to cash consideration and the company became a wholly-owned subsidiary of the acquiring entities' parent partnership. Simultaneously, the company repaid all outstanding debt, including its credit facility and $5.50% Exchangeable Senior Notes due 2028, and terminated its equity incentive plan. For investors holding common stock, the merger provides liquidity at the agreed valuation, while RSUs and service-based cash awards continue to vest under the same terms, and performance-based cash awards remain eligible to vest based on achievement of original metrics through their performance periods.
STCB
OTC
▲ SUPER 8-K
Starco Brands, Inc.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Summary: Starco Brands, Inc.
Starco Brands, Inc. completed the acquisition of Custom Foods, LLC on July 15, 2026, through its subsidiary Starco Manufacturing, LLC, paying $8.0 million in cash at closing plus up to $2.5 million in earn-out consideration tied to 2027 revenue metrics. To finance this acquisition, the company secured an $11.0 million term loan from Pasadena Private Lending Inc., along with a $3.0 million revolving credit facility and an accordion feature allowing up to $4.0 million in additional borrowing, with all obligations cross-defaulted and cross-collateralized. The debt is personally guaranteed by CEO Ross Sklar and various family trusts, with security interests in substantially all company assets, and requires compliance with financial covenants including a maximum senior debt-to-EBITDA ratio of 3.0x and minimum fixed charge coverage ratio of 2.0x measured quarterly. This acquisition substantially increases Starco's leverage and tightens its financial flexibility through restrictive covenants, while the earnout structure creates upside potential but adds execution risk dependent on Custom Foods' 2027 revenue performance.
RBOTW
OTC
▲ SUPER 8-K
Vicarious Surgical Inc.
EDGAR Items: 1.01,2.01,5.02,5.07,8.01,9.01
# Summary of Vicarious Surgical Inc. 8-K Filing
Vicarious Surgical Inc. is undergoing liquidation through an assignment for the benefit of creditors (not a formal bankruptcy filing), with stockholder and board approval received on July 21, 2026. The company has transferred substantially all of its assets to Vicarious Liquidation, LLC, with creditors receiving priority over stockholders in distributions. The company is simultaneously deregistering its stock by filing Form 15 (suspending SEC reporting obligations effective immediately) and dissolving under Delaware law, with the dissolution expected to be filed on July 22, 2026.
All seven board members have resigned effective upon Form 15 filing, and four key executives—including CEO Stephen From, President Adam Sachs, and CTO Sammy Khalifa—have been terminated, triggering severance payments totaling approximately $2.06 million plus full vesting of their time-based equity awards. For investors, this represents a complete exit event where common stockholders will likely receive minimal or no recovery after creditor claims are satisfied from the assigned assets.
RBOT
OTC
▲ SUPER 8-K
Vicarious Surgical Inc.
EDGAR Items: 1.01,2.01,5.02,5.07,8.01,9.01
# Summary of Vicarious Surgical Inc. Form 8-K Filing
Vicarious Surgical Inc. announced a comprehensive liquidation on July 21, 2026, transferring substantially all company assets to an assignee through an assignment for the benefit of creditors, which was approved by stockholders and authorized by the Board of Directors. The company is simultaneously pursuing voluntary deregistration by filing Form 15 with the SEC (citing fewer than 300 holders of record) and voluntary dissolution under Delaware law, with both actions expected to be finalized by late July/August 2026. All seven board members resigned effective upon Form 15 filing, and key executives—including CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa, and Chief Medical Officer Dr. Barry Greene—were terminated, with severance obligations totaling approximately $2.06 million plus full equity vesting.
**Investor Impact:** This represents a complete wind-down of the company with creditors receiving priority over stockholders in asset distributions, meaning common equity holders face significant dilution risk or total loss. The immediate suspension of SEC reporting obligations upon Form 15 filing and 90-day deregistration timeline signal the end of public company status and trading liquidity for shareholders.
NRDE
OTC
▲ SUPER 8-K
NU RIDE INC.
EDGAR Items: 2.01,5.03,8.01,9.01
# SEC 8-K Summary: Stark Novus Financial Inc.
Stark Novus Financial Inc. (formerly Nu Ride Inc.) completed the acquisition of Affinity Advisory Network, LLC and AAN Wealth Advisors, LLC on July 15, 2026, for $6.72 million in cash, 80,000 shares of Class A common stock, and a 15% equity stake in the acquisition subsidiary, plus up to $1.31 million in contingent earnout payments tied to insurance-writing performance. The company simultaneously rebranded from "Nu Ride Inc." to reflect its new business direction in financial advisory services and announced that its Class A Common Stock will trade on the OTC under the ticker symbol "SNFI." This acquisition represents a significant strategic pivot from the company's previous operations and establishes it as a wealth advisory platform. Investors should note that detailed financial statements and pro forma information for the acquired business will be filed within 71 days.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# Summary of Generation Income Properties, Inc. 8-K Filing
On July 15, 2026, Generation Income Properties, Inc. completed the sale of its net lease property located at 991 Nut Tree Road in Vacaville, California to Taricens Medical Estates LLC for $2,475,000, generating approximately $2,356,757 in net proceeds after closing costs and commissions. The property had been leased to the U.S. Government under a lease agreement dating back to August 2010. This asset disposition represents a reduction in the company's real estate portfolio and will affect future lease income streams from this property. Investors should note this transaction reduces the company's revenue-generating assets and should monitor the impact on dividend sustainability and overall portfolio composition.
GORO
AMEX
▲ SUPER 8-K
Goldgroup Mining Inc.
EDGAR Items: 2.01,3.01,3.03,5.01,5.02,5.03,7.01,9.01
# Summary of Gold Resource Corporation 8-K Filing
Gold Resource Corporation completed its merger with Goldgroup Mining Inc. on July 17, 2026, whereby Gold Resource shareholders received 0.3619 Goldgroup shares per share held (reflecting a four-for-one consolidation). Gold Resource is now a wholly owned subsidiary of Goldgroup, representing a change of control of the company. The company's common stock has been delisted from NYSE American, with trading suspended and a Form 25 notification filed to deregister the securities under Section 12(b) of the Securities Exchange Act; Gold Resource intends to suspend its SEC reporting obligations via Form 15. All outstanding employee awards (options, DSUs, RSUs, and PSUs) were assumed and converted by Goldgroup using the exchange ratio, while the former Board of Directors was replaced in connection with the merger.
ATER
NASDAQ
▲ SUPER 8-K
Aterian, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,3.03,5.01,5.02,5.03,5.07,8.01,9.01
# Aterian, Inc. (ATER) 8-K Summary
Aterian completed a major restructuring on July 17, 2026, selling its core branded assets (Mueller Living, PurSteam, hOmeLabs, Squatty Potty, and others) to Trademark Global for $18.0 million and selling preferred stock to investor David Lazar for $7.0 million, while simultaneously repaying and terminating its existing credit facility with MidCap Funding. The company established a contingent value rights (CVR) structure that will distribute to shareholders any proceeds received from the asset sale, additional reserves, future asset sales, and cash releases—though there is no assurance shareholders will receive any payments. This transaction substantially transforms Aterian from a multi-brand consumer products company into a smaller entity operating only legacy brands like Vremi and Xtava, with investor returns now dependent on uncertain future liquidation proceeds rather than ongoing business operations.
JSPR
NASDAQ
▲ SUPER 8-K
Jasper Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,9.01
# Jasper Therapeutics 8-K Summary
Jasper Therapeutics completed its acquisition of Kira Pharmaceuticals on July 16, 2026, issuing approximately 5.2 million shares of voting common stock and 4.6 million shares of convertible preferred stock (convertible into ~283 million common shares) to Kira shareholders. The merger dramatically dilutes existing Jasper shareholders from ~11.27% to ~6.68% ownership on a fully-diluted basis, while Kira shareholders gain ~49.86% ownership post-financing. The company must seek stockholder approval within 120 days for the preferred stock conversion, board appointments, and an increase in authorized common shares to facilitate the conversion and concurrent PIPE financing. This acquisition represents a significant recapitalization of Jasper, with investors needing to monitor upcoming proxy materials and the subsequent financing details for full impact assessment.
BHR
NYSE
▲ SUPER 8-K
Braemar Hotels & Resorts Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts announced two significant asset disposition transactions totaling approximately $627.5 million. The company completed the sale of three properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel and Spa) for $437.5 million on July 14, 2026, and entered into a binding agreement to sell the Pier House Resort & Spa in Key West, Florida for $190 million, pending customary closing conditions. These large-scale divestitures represent a material shift in the company's portfolio composition and suggest a strategic deleveraging initiative to reduce debt and reposition operations. For investors, the completed sales provide near-term liquidity that may be applied to debt reduction or capital deployment, though the loss of premium resort assets in attractive markets may impact future revenue generation and operational diversification.
QUCY
NASDAQ
▲ SUPER 8-K
Quantum Cyber N.V. Ordinary Shares
EDGAR Items: 2.01,7.01,8.01,9.01
# Summary of Quantum Cyber N.V. Form 8-K Filing
Quantum Cyber N.V. completed the acquisition of real property located at 38 Union Avenue, Bridgeport, Connecticut on July 15, 2026, for $2.3 million through its subsidiary Quantum Drones Corporation. The transaction was finalized following the execution of an Asset Purchase Agreement with Arcade Technology LLC announced on June 26, 2026. Additionally, the company relocated its corporate headquarters from West Palm Beach, Florida to Norwalk, Connecticut on July 16, 2026. These moves suggest the company is consolidating operations and establishing a physical footprint in Connecticut aligned with its drones business strategy, though the filing provides limited detail on the strategic rationale or expected operational impact on shareholders.
SBIGW
OTC
▲ SUPER 8-K
SpringBig Holdings, Inc.
EDGAR Items: 1.01,2.01,5.02,9.01
# SpringBig Holdings, Inc. - 8-K Summary
SpringBig Holdings, Inc. has undergone a significant restructuring in which secured lenders exercised their rights under Delaware law (Section 272(b)) to transfer substantially all of the company's assets, including its operating subsidiary SpringBig, Inc., to Lightbank II, L.P. and LS Round II, LLC. This reorganization transaction eliminated approximately $12.5 million in principal and accrued interest owed under the company's Senior Secured Convertible and Term Promissory Notes, fully releasing the company from those obligations. Following the asset transfer, the parent company (SpringBig Holdings, Inc.) has retained no operating assets and intends to pursue a strategic business combination or, if unsuccessful, will dissolve. The board appointed Andrew Jay Glashow as both director and Chief Executive Officer at a reduced compensation package ($125,000 annual base salary) with a performance bonus contingent on completing a strategic transaction, signaling management's focus on finding an acquisition partner or merger rather than operating the business independently.
**Investor Impact:** Existing equity holders have been substantially diluted or potentially eliminated from control, as the secured lenders have taken ownership of the operating business. Investors should view this as a distressed restructuring with significant execution risk around whether management can identify and complete a viable strategic transaction before the company winds down.
SBIG
OTC
▲ SUPER 8-K
SpringBig Holdings, Inc.
EDGAR Items: 1.01,2.01,5.02,9.01
# SpringBig Holdings, Inc. - 8-K Summary
SpringBig Holdings, Inc. completed a reorganization transaction on July 13, 2026, in which secured lenders transferred the company's collateral (including all equity interests in its operating subsidiary) to Lightbank II, L.P. and LS Round II, LLC, resulting in the company being released from approximately $12.5 million in principal and accrued interest on its Senior Secured Convertible and Term Promissory Notes. As a result of this transaction, substantially all of the company's operating assets are now owned and controlled by the transferee entities, effectively transferring control away from existing equity holders. The company has appointed Andrew Jay Glashow as a new director and Chief Executive Officer with a mandate to identify and consummate a strategic business combination; if unsuccessful, the company intends to wind down and dissolve. This represents a material restructuring that significantly dilutes existing shareholder value, as equity holders have lost control of the operating business to the secured lenders' transferees.
GCTK
NASDAQ
▲ SUPER 8-K
GlucoTrack, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.03,7.01,8.01,9.01
# Summary of GlucoTrack, Inc. 8-K Filing
GlucoTrack, Inc. (NASDAQ: GCTK) completed a reverse merger transaction on July 14, 2026, acquiring Lokahi Therapeutics, Inc., with Lokahi shareholders receiving approximately 90% of GlucoTrack's fully-diluted equity in the form of common stock and Series A convertible preferred stock, while existing GlucoTrack shareholders retained a 10% floor protection. The transaction represents a substantial change in ownership and control, effectively making GlucoTrack a shell company for Lokahi's operations. GlucoTrack must obtain stockholder approval for the issuance of conversion shares and other equity securities under Nasdaq Listing Rules 5635(a), (b), and (d), requiring a proxy filing and stockholder meeting. This reverse merger materially dilutes existing shareholders and requires immediate stockholder action, creating significant investor risk depending on Lokahi's business prospects and the terms of any Bridge or PIPE financing shares that will further dilute the Company Allocation.
LGNYZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary: Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation on July 14, 2026, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) representing future contingent payments. In connection with the transaction, Ligand entered into an Amended and Restated Credit Agreement providing a $125 million revolving credit facility maturing in September 2028, secured by collateral and guaranteed by material domestic subsidiaries. The new credit facility carries interest margins of 1.75%-2.50% for SOFR-based borrowings and includes restrictive covenants requiring maintenance of a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x for material acquisitions) and minimum EBITDA of $100-150 million depending on the period. For investors, this acquisition expands Ligand's royalty portfolio while the new financing structure provides liquidity through 2028, though the leverage and EBITDA maintenance covenants create operational constraints on future financial flexibility.
LGNZZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Summary of Ligand Pharmaceuticals 8-K Filing
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future performance. Simultaneously, Ligand entered into an Amended and Restated Credit Agreement providing a $125 million revolving credit facility maturing in September 2028, secured by company collateral and guaranteed by material domestic subsidiaries. The new credit facility includes financial covenants requiring a consolidated senior secured net leverage ratio of no greater than 2.50x (expandable to 3.00x under certain conditions) and minimum trailing twelve-month EBITDA of $100-150 million depending on the period. This acquisition and refinancing materially expand Ligand's asset base and financial obligations, with investors exposed to leverage risks tied to EBITDA performance and potential covenant violations that could trigger debt acceleration.
FLYX
AMEX
▲ SUPER 8-K
flyExclusive, Inc.
EDGAR Items: 1.01,2.01,9.01
# Summary of flyExclusive, Inc. 8-K Filing (July 13, 2026)
flyExclusive, Inc. completed its merger with Jet.AI SpinCo, Inc. on July 13, 2026, with SpinCo becoming a wholly owned subsidiary of the company. SpinCo shareholders will receive approximately 7.1 million shares of flyExclusive Class A Common Stock at a closing exchange ratio of 3.6253 shares per SpinCo share, with an additional 1.4 million shares (representing 20% of consideration) held in reserve pending final net cash adjustments. Amendment No. 5 to the merger agreement modified the post-closing net cash adjustment mechanism, specifically clarifying that SpinCo's indirect equity investment in Space Exploration Technologies Corporation (SpaceX) will be valued based on actual liquidation proceeds if sold post-closing, or at its estimated value if held. The transaction represents a significant dilution to existing flyExclusive shareholders through substantial new share issuance, with the SpaceX investment stake adding meaningful valuation uncertainty and optionality depending on future liquidity events.
LGNXZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Ligand Pharmaceuticals 8-K Summary
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future XOMA Royalty LLC distributions. In connection with the acquisition, Ligand entered into an amended credit agreement providing a $125 million revolving credit facility maturing September 2028, with interest rates tied to SOFR plus margins of 1.75%-2.50% and financial covenants requiring a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x) and minimum EBITDA of $100-150 million depending on the period. The acquisition expands Ligand's portfolio but increases leverage; investors should monitor the company's ability to maintain required financial covenants and generate sufficient EBITDA to support the enlarged debt obligations.
LGNDZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Ligand Pharmaceuticals 8-K Summary
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future XOMA Royalty LLC distributions. In connection with the acquisition, Ligand entered into an amended $125 million revolving credit facility with Citibank maturing in September 2028, featuring pricing margins of 1.75%-2.50% and financial covenants requiring a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x for material acquisitions) and minimum EBITDA of $100-150 million. The transaction represents a significant expansion of Ligand's portfolio and debt structure, with investors gaining exposure to contingent payments from XOMA's royalty streams but also facing increased financial leverage and restrictive covenants that could limit future operational flexibility.
FSP
AMEX
▲ SUPER 8-K
Franklin Street Properties Corp
EDGAR Items: 2.01,9.01
# Summary of Franklin Street Properties Corp. 8-K Filing
Franklin Street Properties Corp. completed the sale of two office buildings located in Englewood, Colorado (approximately 196,236 square feet) to University of Colorado Health for $19.356 million on July 8, 2026. The company allocated roughly $8.5 million of the proceeds toward debt repayment, with the remaining balance retained for tenant improvements, leasing commissions, and general corporate purposes. This asset disposition represents a strategic deleveraging move for the REIT, reducing its debt burden while maintaining liquidity for operational investments. Investors should monitor the company's updated pro forma financials to assess the impact on leverage ratios and future cash flow generation capacity.
ESPR
NASDAQ
▲ SUPER 8-K
Esperion Therapeutics, Inc.
EDGAR Items: 1.01,1.02,2.01,2.03,3.01,3.03,5.01,5.02,5.03,9.01
# Summary of Esperion Therapeutics 8-K Filing
Esperion Therapeutics, Inc. completed its acquisition by Essence Parent Inc. on July 13, 2026, with Esperion becoming a wholly owned subsidiary of Parent. Shareholders received $3.16 per share in cash, while also receiving Contingent Value Rights (CVRs) that provide eligibility for up to $100 million in additional contingent cash payments upon achievement of specified milestones. The company simultaneously entered into new financing arrangements with BioPharma Credit entities and refinanced its debt obligations, replacing its prior credit agreement with a new loan facility. Convertible note holders have modified conversion rights post-merger, with the ability to receive cash ($1,032.68-$1,232.62 per $1,000 principal depending on conversion timing) plus CVRs upon conversion. For investors, this acquisition concludes Esperion's public company status but creates potential upside through the milestone-contingent CVR payments, though realization of the full $100 million contingent pool depends on achievement of undisclosed operational milestones.
SUIC
OTC
▲ SUPER 8-K
SUIC Worldwide Holdings Ltd.
EDGAR Items: 1.01,2.01,5.01,5.02,9.01
# SUIC Worldwide Holdings Ltd. - 8-K Summary
SUIC Worldwide Holdings Ltd. completed a material acquisition on July 10, 2026, acquiring 51% of Taiwan Vision Renu Corporation in exchange for 30 million shares of SUIC common stock, which will represent approximately 35% of total outstanding shares on a fully-diluted basis. Vision Renu is a medical device manufacturer focused on innovative ophthalmic and neurological treatments, including a Scleral Micro-Ablation Laser System for presbyopia (currently in FDA certification) and a Transcranial Magnetic Stimulation device for depression treatment (already approved and generating orders). The transaction resulted in a complete change of control, with three existing directors and officers resigning and two new executives (Chen King Te as Chairman/CEO and Shan Hua Peng as CFO) appointed from Vision Renu's leadership. **For investors, this represents significant dilution (35% stake going to Vision Renu shareholders) and a strategic pivot toward high-tech medical devices, though execution risks exist given Vision Renu's early commercialization stage and the company's small workforce of just 7 full-time employees.**
NUMD
OTC
▲ SUPER 8-K
Nu-Med Plus, Inc.
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01
# Nu-Med Plus, Inc. Form 8-K Summary
Nu-Med Plus, Inc. completed a share exchange transaction on July 8, 2026, acquiring 100% ownership of Avid Gold Ltd (a UK-formed private company) in exchange for issuing 4.5 million shares of Series A Preferred Stock to Avid Gold shareholders and assuming a $100,000 promissory note. The company also entered into a Registration Rights Agreement obligating it to file a registration statement within 30 days of shareholder approval and maintain effectiveness for three years, with holders receiving piggyback rights for 18 months.
Material changes for investors include a reverse 1-for-27 stock split of common shares, an increase in authorized common stock from 90 million to 500 million shares, and a potential redomiciliation from Utah to Nevada—all requiring shareholder approval through a proxy vote to be held within 50 days of SEC clearance. The transaction involves significant dilution and voting control implications, as existing shareholders (the Voting Shareholders including CEO William Hayde) committed to voting in favor of director elections and other matters designated by Avid Gold shareholder Fred Tejada, who joined the board, effectively transferring governance influence to the transaction sellers.
BDN
NYSE
▲ SUPER 8-K
Brandywine Realty Trust
EDGAR Items: 2.01,9.01
# Summary of Brandywine Realty Trust Form 8-K Filing
On July 9, 2026, Brandywine Realty Trust completed the disposition of a 206,000 square-foot office building and 520-space parking garage in Austin, Texas for $151.0 million in sales proceeds ($146.1 million net). This asset sale represents a material reduction in the company's real estate portfolio and generates significant liquidity that could be deployed toward debt reduction, dividend payments, or strategic reinvestment. The filing includes unaudited pro forma financial statements reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, which investors should review to assess changes to the company's balance sheet, net operating income, and key metrics like FFO and occupancy rates.
DFNS
NASDAQ
▲ SUPER 8-K
T3 Defense Inc. Common Stock
EDGAR Items: 2.01,9.01
# T3 Defense Inc. - 8-K Summary
On July 6, 2026, T3 Defense Inc. completed the acquisition of a 60% equity stake in Project 35, an Israeli defense technology company, for 21,059,871 shares of common stock and a $1.25 million promissory note (12% interest, maturing July 5, 2027), with an additional $2.5 million investment obligation over the next 12 months. Project 35 is a supplier to major Israeli defense contractors (IAI, Rafael, Elbit Systems) specializing in unmanned aerial systems and counter-drone technology, including the recently field-tested HY-380 autonomous aerial interceptor designed to neutralize hostile drones. The significant share issuance (21+ million shares) represents substantial dilution to existing shareholders, while the transaction expands T3 Defense's product portfolio in the strategic defense sector with operationally proven systems.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Marriott Fremont Silicon Valley hotel in Fremont, California on July 1, 2026, for $53.0 million in cash. This asset disposition represents the company's continued portfolio optimization strategy, generating liquidity that could be deployed toward debt reduction or reinvestment in higher-performing properties. The filing includes unaudited pro forma financial information reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, and for the year ended December 31, 2025. For investors, this sale signals management's focus on streamlining operations and improving financial flexibility in the competitive hospitality sector.
SECZ
NYSE
▲ SUPER 8-K
Securitize Corp.
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,9.01
# Securitize Corp. 8-K Summary
Securitize Corp. (formerly Securitize Holdings, Inc.) completed its business combination with Cantor Equity Partners II, Inc. (CEPT) on July 1, 2026, with the combined entity now trading on NYSE under ticker SECZ. In the transaction, CEPT shareholders' Class A and B shares converted into common stock on a 1:1 basis, while Securitize, Inc. shareholders received approximately 4.4439 shares of PubCo common stock per share held, with all preferred stock and convertible instruments (options, warrants, SAFE notes, and convertible notes) similarly adjusted using the exchange ratio. Approximately 28.5% of CEPT Class A shareholders exercised redemption rights, resulting in $72.5 million in cash redemptions at $10.60 per share. The business combination creates a publicly traded fintech platform combining CEPT's capital with Securitize's blockchain-based financial infrastructure, though investors should note the significant dilution from the exchange ratio and redemption activity.
BNZI
NASDAQ
▲ SUPER 8-K
Banzai International, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,7.01,9.01
# Summary of Banzai International, Inc. 8-K Filing
Banzai International, Inc. announced two significant material events on July 7, 2026: (1) execution of a $2.1 million subordinated loan agreement with Agile Capital Funding, LLC, providing $2 million in net proceeds repayable in 32 weekly installments by February 10, 2027 at a 1.44x payment multiplier, and (2) completion of an asset purchase agreement to acquire substantially all assets of ConnectAndSell, Inc., an AI-powered sales enablement software company, for up to $15.2 million in total consideration (including earn-out payments). The ConnectAndSell acquisition consideration comprises $8.45 million in closing payments ($750,000 cash plus $5.9 million in stock representing 9.99% dilution, plus an $1.8 million note), $4.75 million in deferred cash payments, and performance-based earn-out payments contingent on revenue targets. The subordinated debt is secured by substantially all company assets but ranks behind existing senior lenders (CP BF Lending, 3i, LP, and Hudson Global Ventures), and default rates spike 5% above the base rate, creating execution risk if the company cannot generate sufficient cash flow from the ConnectAndSell acquisition to service both debt obligations.
GGRP
NASDAQ
▲ SUPER 8-K
The Glimpse Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of The Glimpse Group, Inc. Form 8-K Filing
The Glimpse Group, Inc. completed the sale of its wholly-owned subsidiary, Glimpse Learning, LLC, to Glimpse Learning, Inc. on June 30, 2026, in exchange for a 19.99% equity stake in the buyer, royalty payments, and assumption of specified liabilities. The transaction involves a related party interest, as former CEO Lyron Bentovim (who owns ~5% of Glimpse Group) owns approximately 50.6% of the buyer company. The company will receive royalty payments of 7% of revenues through December 2027 and 10% thereafter, capped at $1.2 million in aggregate, with a buyout option available to the buyer for $1 million. Investors should note the company incurred $200,000 in upfront working capital adjustment payments and faces additional contractual obligations of $76,000 through March 2027, while the long-term value depends on the buyer's revenue generation and the related-party nature of the transaction warrants close monitoring.
HODO
NASDAQ
▲ SUPER 8-K
House of Doge Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Filing Summary: House of Doge Inc.
House of Doge Inc. (formerly Brag House Holdings, Inc.) completed its merger with House of Doge Inc., a Texas corporation, on June 30, 2026, resulting in a significant ownership shift and leadership transition. The merger converted approximately 329.9 million shares of the target company into 64 million common shares plus preferred shares convertible into 5 billion shares, with former HOD stockholders now owning approximately 90.66% of outstanding Common Stock (83.32% on a fully diluted basis). The company executed a complete management and board overhaul, installing new CEO Marco Margiotta and CFO Charles Park, while transferring the pre-merger Brag House business to a subsidiary under previous management's control. The company also completed a name change to House of Doge Inc. and issued 1.125 million additional consideration shares to former executives. This transaction fundamentally restructures the company from Brag House Holdings into a holding company, resulting in substantial shareholder dilution for existing investors who now control less than 10% on a fully diluted basis.
MGNX
NASDAQ
▲ SUPER 8-K
MacroGenics, Inc.
EDGAR Items: 2.01,7.01,9.01
# MacroGenics, Inc. (MGNX) - 8-K Summary
MacroGenics completed the sale of its GMP manufacturing and CDMO (contract development and manufacturing organization) business operations to Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC for $122.5 million in cash (before transaction fees and expenses and subject to post-closing adjustments) as of June 30, 2026. The divestiture includes the company's Rockville, Maryland manufacturing facility and Frederick, Maryland warehouse operations, while retaining all research and related assets. This strategic asset sale allows MacroGenics to refocus on its core therapeutic development programs and should improve cash flow, though investors should monitor the post-closing financial adjustments and the company's use of proceeds for R&D investments.
OLPX
NASDAQ
▲ SUPER 8-K
Olaplex Holdings, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# Summary of Olaplex Holdings, Inc. 8-K Filing
Olaplex Holdings, Inc. completed its acquisition by Henkel US Operations Corporation on July 7, 2026, with shareholders receiving $2.06 per share in cash. The company paid approximately $357.6 million to fully repay and terminate its credit agreement with no early termination penalties, and the common stock was delisted from Nasdaq effective July 7, 2026. All employee equity awards (options and restricted stock units) were converted into cash payments based on the merger consideration, and security holders' rights in the company ceased upon the merger's completion. The company intends to file Form 15 with the SEC to terminate its public reporting obligations following the delisting process, transitioning from a public to a wholly owned private subsidiary of Henkel.
TBH
NASDAQ
▲ SUPER 8-K
Brag House Holdings, Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Summary: House of Doge Inc. (Formerly Brag House Holdings, Inc.)
On June 30, 2026, House of Doge Inc. completed its merger with House of Doge Inc. (a Texas corporation), with the former Brag House Holdings, Inc. acquiring HOD's business and becoming a holding company renamed House of Doge Inc. The merger resulted in HOD's stockholders obtaining approximately 90.66% ownership of the combined company on a fully diluted basis, representing a significant shift in control. Simultaneously, the company's board was reconstituted with six new directors and new executive leadership, including Marco Margiotta as CEO and Charles Park as CFO, while the previous management team continues to operate the legacy Brag House business as a subsidiary. For existing Brag House shareholders, this transaction substantially dilutes their ownership stake from controlling the company to holding only ~9% post-merger, representing a material negative impact despite receiving merger consideration in the form of Class C preferred shares convertible into 5 million common shares each.
AETN
OTC
▲ SUPER 8-K
AETERNUM HEALTH, INC.
EDGAR Items: 2.01,3.02,5.01,5.02,9.01
# SEC 8-K Filing Summary: Aeternum Health, Inc.
On June 30, 2026, Aeternum Health, Inc. (formerly Shorepower Technologies) completed a merger with Aeternum Health LLC, resulting in a significant change of control and strategic direction. Paul Mann, Manager of Aeternum Health, became President, CEO, and sole board member, replacing former leadership. In exchange for the merger, Mann received 49 million common shares (51% ownership) and 2 million Series B preferred shares with 40 votes each per share.
The company is pivoting away from its previous transportation electrification business to focus on two new areas: mining critical minerals for U.S. government needs and developing longevity/health-related products and services. Aeternum Health contributed minimum assets of $1.5 million (including $300,000 in cash and mineral sourcing expertise/intellectual property) to support this transition.
Following the merger, the company has 96.1 million common shares outstanding and 2 million Series B preferred shares outstanding, with authorized shares increased to 250 million. The stock now trades under ticker AETN on OTC Markets. This represents a substantial dilution to existing shareholders and a complete business transformation with significant execution risk in unfamiliar industries.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,3.02,8.01,9.01
# Summary of Cemtrex, Inc. Form 8-K Filing
Cemtrex, Inc. completed the acquisition of substantially all assets of Plant Engineering Services, Inc. (PES) on July 1, 2026, for $3.5 million in cash, with an additional $1.75 million in contingent earnout payments possible over three years based on gross profit targets. The acquired business has been integrated into the company's Industrial Services Segment through its wholly owned subsidiary AIS Engineering, Inc. Additionally, the company disclosed that since its June 5, 2026 reverse stock split (1-for-10), it has issued approximately 609,000 unregistered common shares in private placements and exempt transactions, bringing total outstanding shares to approximately 1.72 million as of July 2, 2026. Financial statements and pro forma information for the acquisition will be filed by amendment within 71 days, as required by SEC regulations.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hyatt Regency Savannah on June 30, 2026, for $158.0 million in cash to C&C Bay Hotel Owner, LLC. This asset disposition represents a strategic reduction in the company's portfolio, with the sale price subject to customary closing adjustments and pro-rations. The filing includes pro forma financial statements reflecting the impact of this divestiture for the three-month period ended March 31, 2026, and the full year 2025. For investors, this sale reduces the company's asset base and could affect future revenue and earnings, though the proceeds may be used for debt reduction, distribution enhancement, or reinvestment in higher-yielding properties.
CETXP
OTC
▲ SUPER 8-K
CEMTREX INC
EDGAR Items: 2.01,3.02,8.01,9.01
# Summary of Cemtrex, Inc. 8-K Filing
Cemtrex, Inc. (CETX) completed the acquisition of substantially all assets of Plant Engineering Services, Inc. on July 1, 2026, for $3.5 million in cash plus up to $1.75 million in contingent earnout payments over three years based on gross profit targets. The acquisition was executed through the company's subsidiary Advanced Industrial Services and integrates PES's operations into Cemtrex's Industrial Services Segment. Additionally, the company disclosed that since its June 5, 2026 reverse stock split (1-for-10), it has issued approximately 609,000 unregistered shares through private placements, bringing total outstanding shares to approximately 1.72 million as of July 2, 2026. For investors, this acquisition expands the company's industrial services capabilities, though the contingent earnout structure creates uncertainty around total acquisition costs, and the recent equity issuances may have diluted existing shareholders.
LIMN
NASDAQ
▲ SUPER 8-K
Liminatus Pharma, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary: Liminatus Pharma, Inc.
On June 29, 2026, Liminatus Pharma, Inc. entered into an Amended and Restated Merger Agreement with InnocsAI LLC to restructure a previously announced transaction, allowing the deal to close before stockholder approval by issuing merger consideration as a combination of common stock and newly created Series A Non-Voting Convertible Preferred Stock. The company will issue approximately 11.2 million common shares (capped at ~19.99% of outstanding stock under Nasdaq rules) plus ~158,881 shares of Series A Preferred Stock (each convertible into 10,000 common shares) to InnocsAI members, representing 1.6 billion total common shares of consideration. The merger closed on July 2, 2026, and the company has committed to seeking stockholder approval for the conversion of preferred shares and obtained registration rights agreements with the former InnocsAI members. This structure allows the acquisition to proceed immediately while deferring the dilutive impact of the full common stock issuance pending shareholder approval, potentially protecting existing shareholders from immediate voting control dilution but creating significant future conversion risk if approved.
MSS
NASDAQ
▲ SUPER 8-K
Maison Solutions Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# Summary of Maison Solutions Inc. Form 8-K Filing
Maison Solutions Inc. completed the sale of a 91.67% equity stake in its subsidiary, Super HK of El Monte, Inc., to DNL Management Inc. on July 2, 2026, for only $1.00. The buyer acquired the asset "as-is, where-is" and assumed all known and unknown debts and liabilities of the subsidiary, effectively transferring the company's operational and financial obligations. This transaction represents a material disposition of assets for the company, though the nominal purchase price suggests the subsidiary may carry significant liabilities that made it effectively worthless to retain. Investors should note that this divestiture could significantly impact the company's operational scope and financial position, depending on the subsidiary's contribution to overall revenues and the extent of liabilities transferred.
MIDDV
NASDAQ
▲ SUPER 8-K
Middleby Corp. Common Stock Ex-Distribution When Issued
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# Summary of Middleby Corporation 8-K Filing
The Middleby Corporation completed a spin-off of its food processing business as Midera Food Processing, Inc. on July 6, 2026, distributing 100% of Midera's shares to Middleby stockholders on a one-for-one basis; Midera commenced trading on Nasdaq under the symbol "MFP" on July 7, 2026. To facilitate the separation and ongoing relationship, the companies executed five material agreements: a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Matters Agreement, and Transition Services Agreement, which collectively govern tax obligations, employee benefits, IP licensing, and transitional service provisions. Key personnel transitions include two Middleby board members (Robert Nerbonne and Cathy McCarthy) and the Chief Development Officer (Matthew Fuchsen) departing to join Midera's leadership. For Middleby investors, this spin-off represents a strategic narrowing of the company's focus and portfolio, while creating a separate publicly traded entity for shareholders to evaluate independently; the transition agreements ensure operational continuity during the separation period.
EVTV
NASDAQ
▲ SUPER 8-K
Azio AI Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,9.01
# Summary of Envirotech Vehicles, Inc. 8-K Filing
Envirotech Vehicles, Inc. (EVTV) completed its acquisition of Azio AI Corporation on July 2, 2026, through a two-step merger structure, issuing 2,460,351 shares of common stock (capped at 19.9% of pre-merger outstanding shares) and 973,450 shares of Series A Non-Voting Convertible Preferred Stock to Azio AI shareholders, along with assuming $150,000 in convertible notes. The company intends to rebrand as "Azio AI Holdings, Inc." and will seek stockholder approval for converting the Series A Preferred Stock into common shares, adopting a new equity incentive plan, and amending its certificate of incorporation. The merger was approved by EVTV's board without requiring stockholder authorization, though company officers and directors have committed via a support agreement to vote in favor of the transaction proposals at an upcoming stockholder meeting. For investors, this represents a significant strategic pivot toward AI operations, though the exact operational and financial implications depend on Azio AI's business performance and the subsequent stockholder vote on the conversion and corporate name change.
LHAI
NASDAQ
▲ SUPER 8-K
Linkhome Holdings Inc. Common stock
EDGAR Items: 2.01,3.01,7.01,9.01
# Summary of Linkhome Holdings Inc. (LHAI) 8-K Filing
Linkhome Holdings Inc. completed its acquisition of Mortgage One Group on July 1, 2026, issuing 300,000 common shares and offering up to $750,000 in earnout payments to acquire the mortgage services company as a wholly owned subsidiary. However, this positive development is significantly overshadowed by a critical delisting notice from Nasdaq: on June 29, 2026, the company received notification that it has failed to maintain the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The company has 180 calendar days (until December 28, 2026) to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days, or it faces delisting. For investors, this dual development presents a mixed signal—the acquisition may strengthen operations long-term, but the immediate delisting risk poses a serious threat to stock liquidity and market accessibility unless the share price recovers substantially and quickly.
USDE
NASDAQ
▲ SUPER 8-K
StablecoinX Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.03,5.01,5.02,5.03,5.05,5.06,9.01
# StablecoinX Inc. (USDE) - 8-K Summary
StablecoinX Inc. completed its business combination with TLGY Acquisition Corp. on June 25, 2026, whereby StablecoinX became a publicly traded company trading on Nasdaq under ticker USDE and USDEW (warrants). The transaction involved two sequential mergers that integrated TLGY and StablecoinX Assets Inc. into StablecoinX, with 379,721 public shares redeemed at approximately $13.35 per share for $5.1 million. Concurrently, the company entered into lock-up agreements with Legacy SPAC and SC Assets shareholders restricting share transfers for six months post-closing, and granted registration rights to 5.04 million shares held by significant shareholders. For investors, this marks the transition from a SPAC to an operating public company in the stablecoin/cryptocurrency space, with insider lock-ups providing a 6-month trading restriction and registration rights enabling future shareholder liquidity.
MBGL
NYSE
▲ SUPER 8-K
Mobility Global Inc.
EDGAR Items: 1.01,2.01,5.01,5.02,5.03,8.01,9.01
# Summary of Mobility Global Inc. 8-K Filing
Mobility Global Inc. completed its separation from S&P Global Inc. effective July 1, 2026, becoming an independent publicly-traded company with common stock listed on the New York Stock Exchange under ticker "MBGL." S&P Global distributed 100% of Mobility Global shares to its shareholders on a one-for-one basis, with S&P Global retaining no ownership interest following the distribution.
In connection with the separation, Mobility Global entered into four key agreements with S&P Global: a Separation and Distribution Agreement governing the restructuring and asset transfers, a Tax Matters Agreement addressing pre- and post-closing tax responsibilities and preserving tax-free treatment of the separation, a Transition Services Agreement, and an Employee Matters Agreement. The Separation and Distribution Agreement includes uncapped cross-indemnities allocating financial responsibility for the Spin Business to Mobility Global and S&P Global's retained businesses to S&P Global, though certain assets transferred on an "as is, where is" basis may require ongoing cooperation if consents were not obtained.
**Investor Impact:** Mobility Global shareholders now own a standalone company focused on automotive analytics and data solutions, with their investment exposure no longer tied to S&P Global's diversified business portfolio. However, investors should monitor Mobility Global's obligations under the Tax Matters Agreement covenants, which restrict certain corporate actions to preserve the tax-free separation status, and the indemnification obligations that could create contingent liabilities.
APTOF
OTC
▲ SUPER 8-K
Aptose Biosciences Inc.
EDGAR Items: 2.01,3.03,5.01,5.02,8.01,9.01
# Summary of Aptose Biosciences Inc. 8-K Filing
Aptose Biosciences Inc. completed its acquisition by South Korean pharmaceutical company Hanmi Pharmaceuticals on June 30, 2026, pursuant to a statutory plan of arrangement, resulting in a change of control and conversion of all outstanding common shares into C$2.41 per share in cash (approximately USD $3.47 million total consideration). Hanmi acquired 2,043,719 shares not previously owned, and the Company is now a wholly owned subsidiary of Hanmi Purchasers. The common shares will be delisted from the Toronto Stock Exchange (TSX) on or about July 3, 2026, and the Company intends to file a Form 15 to terminate its SEC reporting obligations. All directors resigned effective at the transaction close. Shareholders who held shares outside of Hanmi's prior 19.93% stake received their cash consideration, marking the end of Aptose as an independent public company.
SITC
NYSE
▲ SUPER 8-K
SITE Centers Corp. Common Shares
EDGAR Items: 2.01
# Summary of SITE Centers Corp. 8-K Filing
SITE Centers Corp. completed the sale of its ground leasehold interest and other assets in The Pike Outlets (Long Beach, California) to Pike Long Beach Owner LLC on June 30, 2026, for $50.0 million in cash. The company received net proceeds of approximately $46.5 million after closing costs, representing a $3.5 million reduction from the gross sale price. This divestiture allows the company to monetize a non-core or underperforming property asset and generate liquidity that can be used for debt reduction, capital allocation, or other strategic purposes. The transaction may signal a portfolio optimization strategy as SITE Centers continues to manage its real estate holdings.
MCHX
NASDAQ
▲ SUPER 8-K
Marchex, Inc. Class B
EDGAR Items: 1.01,2.01,2.03,3.02,5.07,9.01
# Summary of Marchex, Inc. 8-K Filing (July 1, 2026)
Marchex, Inc. completed its acquisition of Archenia, Inc. on July 1, 2026, paying $10 million in convertible promissory notes to shareholders including Chairman Russell Horowitz and Vice Chairman Michael Arends. The notes bear 6% interest, are payable in three equal tranches over 24 months, and are convertible into Marchex Class B common stock at $1.80 per share. Additionally, the sellers are eligible to receive up to 2 million shares per year for the first two years if Archenia meets specified revenue, EBITDA, and integration targets. The acquisition, approved by stockholders with 99.9% support, brings Archenia's AI-powered performance marketing technology focused on customer qualification and high-intent consumer identification into Marchex's portfolio. For investors, this deal creates potential upside through earnout provisions tied to Archenia's post-acquisition performance, though the convertible structure and contingent equity issuances could dilute existing shareholders' ownership depending on financial results and conversion activity.
INIS
OTC
▲ SUPER 8-K
RADNOSTIX INC
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# Radnostix, Inc. 8-K Summary
Radnostix completed a $900,000 asset acquisition on June 25, 2026, purchasing the Lara System technology platform and Ellexa Explorer Software from Lucerno Dynamics, LLC, paying $150,000 cash and $750,000 in common stock, with potential earn-out payments up to $750,000 based on regulatory approval and sales milestones. Simultaneously, the company secured $500,000 in financing through a convertible promissory note from a related party (a company owned by Chairman Christopher Grosso) at 5% interest, convertible at $0.07 per share. Additionally, the company amended four historic promissory notes totaling $1.62 million, extending their maturity to March 31, 2031, adding voluntary conversion rights at $0.07 per share, and permanently releasing all security interests on company assets. These transactions significantly increase shareholder dilution through substantial equity issuances and create conversion pressure if the stock reaches $0.12 per share.
June 2026
34 filings
▼
CMRF
OTC
▲ SUPER 8-K
CIM REAL ESTATE FINANCE TRUST, INC.
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,7.01,8.01,9.01
# Summary of CIM Group, Inc. 8-K Filing
On June 23-24, 2026, CIM Real Estate Finance Trust, Inc. (renamed CIM Group, Inc.) completed a transformative merger acquiring Legacy CIM's real assets management business and investment portfolio. The transaction restructured the company into a diversified real estate owner, operator, lender, and developer, with CIM Group Holdings receiving 67.5% economic and voting ownership through 907.4 million Class A LP units and special voting preferred shares, while existing shareholders retained 32.5% ownership. The deal includes earnout provisions that could increase CIM Group Holdings' stake by up to 3.75% based on financial performance through 2028, plus a cash distribution to compensate for foregone distributions during the earnout period.
For investors, this represents a significant shift from a focused real estate finance trust to a broader platform, with mandatory quarterly dividends ranging from $0.06 to $0.095 per share over three years. The company has committed to pursuing a national exchange listing within 24 months (completing within 5 years) or pursuing alternative liquidity events including recapitalization or sale, providing a defined pathway for public shareholders to eventually achieve liquidity. However, existing shareholders face substantial dilution from the majority stake granted to CIM Group Holdings and the structure's contingent earnout obligations.
USDW
OTC
▲ SUPER 8-K
MADE IN USA INC.
EDGAR Items: 2.01,7.01,9.01
# Summary of Made in USA Inc. 8-K Filing
On June 26, 2026, Made in USA Inc. completed an acquisition of intellectual property and technology assets from affiliate Made in USA One LLC, issuing 5 million restricted common shares as sole consideration with no cash paid. The acquired assets comprise a comprehensive "Made in USA" verification and supply-chain transparency platform, including 65 premium domain names, AI-enabled verification tools, blockchain infrastructure (XRPL and Hyperledger frameworks), IoT-integrated ERP systems, and related digital infrastructure. This related-party transaction between commonly controlled entities raises valuation transparency concerns for investors, as no independent appraisal methodology is disclosed and the 5 million shares represent significant potential dilution depending on current share count. The restriction on share resale under Rule 144 limits immediate liquidity for the seller but does not affect the dilutive impact on existing shareholders.
HTCR
NASDAQ
▲ SUPER 8-K
Heartcore Enterprises, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# HeartCore Enterprises 8-K Summary
On June 22, 2026, HeartCore Enterprises divested its 51% majority stake in subsidiary Sigmaways, Inc. to Semaphore Technologies, Inc., completing a strategic exit from the business. The transaction involved selling 229,500 shares and $2.19 million in outstanding debt obligations for up to $650,000 in total consideration—comprising $1,000 at closing plus an earn-out of up to $649,000 based on 10% of Sigmaways' gross revenue exceeding $5.5 million over the next 12 months. Additionally, the company contributed a $350,000 SAFE note from Heart-Tech Health as mutual consideration for releasing claims. This divestiture signals HeartCore's strategic repositioning and eliminates future operational involvement with Sigmaways, though investors should note the highly contingent nature of the earn-out and the relatively modest upfront cash recovery ($1,000) relative to the company's historical investment.
GXAI
NASDAQ
▲ SUPER 8-K
Gaxos.ai Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Summary: Gaxos.ai Inc.
On June 18, 2026, Gaxos.ai Inc. completed the sale of substantially all its gaming assets, including its mobile games portfolio and Gaxos Gaming Lab, to Game Foundry AI in exchange for 2.2 million shares of the buyer's common stock valued at approximately $1.76 million. This asset disposition represents a significant strategic shift, indicating the company is divesting its gaming operations, which were apparently a material part of its business. The transaction was completed on the same day it was entered into, with the buyer's shares issued under Securities Act Section 4(a)(2) exemption. Pro forma financial information has been filed reflecting the impact of this asset sale on the company's financial position as of year-end 2025.
**Investor Impact:** This divestiture likely signals a pivot in business strategy for Gaxos.ai, with the company potentially repositioning itself or facing liquidity considerations given the relatively modest valuation of its gaming operations. Shareholders should monitor upcoming disclosures to understand management's plans for deploying proceeds and the company's future direction, as the sale of "substantially all" gaming assets represents a fundamental change to operations.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hilton Garden Inn Austin Downtown on June 18, 2026, for $26.85 million in cash to JMIR Acquisitions, LLC. This asset disposition represents a continuing strategy of portfolio optimization for the hospitality REIT. The company has provided pro forma financial information reflecting the impact of this divestiture on its financial position as of March 31, 2026, and for the year ended December 31, 2025. For investors, the sale generates liquidity that could be used for debt reduction, distributions, or reinvestment in higher-performing properties, though the significance of this transaction's impact depends on the hotel's historical performance and contribution to overall EBITDA.
KOS
NYSE
▲ SUPER 8-K
Kosmos Energy Ltd.
EDGAR Items: 2.01,9.01
# Kosmos Energy Ltd. - 8-K Summary
Kosmos Energy completed the sale of its participating interests in the Ceiba Field and Okume Complex production assets in Equatorial Guinea to a Panoro Energy subsidiary on June 16, 2026, receiving approximately $127 million in cash consideration. The company is also eligible for up to $39.5 million in contingent payments through 2029, contingent on production performance and oil price thresholds. This significant asset disposition represents a strategic shift in the company's portfolio, reducing its production asset base in the region. Investors should monitor the company's use of the proceeds and track whether contingent payments are realized, as this transaction reflects management's reassessment of asset value and strategic priorities.
ATXG
NASDAQ
▲ SUPER 8-K
Addentax Group Corp. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Summary: Addentax Group Corp.
On June 15, 2026, Addentax Group Corp. completed a share exchange acquisition, with its Hong Kong subsidiary acquiring a 41.67% equity stake in Riches Family Office Limited in exchange for issuing 33,500 shares of common stock to Mr. Wu Rui, the Company's Chief Operating Officer. The transaction involved the transfer of equity interests from Riches FO Holdings Limited (Mr. Wu Rui's holding company) to Addentax's subsidiary, creating a strategic ownership position in the target entity. The shares were issued under Regulation S, an offshore transaction exemption, since Mr. Wu Rui is not a U.S. person, thereby avoiding SEC registration requirements. This acquisition expands the Company's asset base and operational footprint in Asia through a related-party transaction, though investors should note the involvement of company insiders and the relatively modest dilution of approximately 33,500 new shares.
FATAQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. Form 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., initiated **Chapter 11 bankruptcy cases** on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. On May 19, 2026, the bankruptcy court approved the sale of substantially all company assets through an auction process, with four separate purchasers acquiring different brand portfolios. The largest transaction involves FBG Bid Co. LLC acquiring the FAT Brands Assets (including Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and 9 other brands) for approximately $595 million via credit bid against debt obligations, while Amazing Brands acquired Hot Dog on a Stick for $8 million and TABCO International acquired Elevation Burger for $2.5 million. These asset sales represent a comprehensive restructuring of the company's operations, with all material assets being transferred to new ownership entities, effectively ending the current company's operational control of its restaurant brands. For investors, this signals the company's inability to restructure operations independently and a significant equity dilution or elimination, as proceeds will be used to satisfy creditor obligations.
TWNPQ
OTC
▲ SUPER 8-K
Twin Hospitality Group Inc.
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. Form 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., are proceeding with Chapter 11 bankruptcy asset sales approved by the Southern District of Texas Bankruptcy Court on May 19, 2026. The company completed an auction on April 27, 2026, with four separate winning bidders acquiring substantially all assets: FBG Bid Co. LLC acquired the FAT Brands portfolio (14 restaurant brands including Fatburger, Johnny Rockets, and Ponderosa Steakhouse) for approximately $595 million in credit bid; TWNPKS Bid Co. LLC acquired Twin Hospitality Group assets; Amazing Brands LLC acquired Hot Dog on a Stick for $8 million; and TABCO International acquired Elevation Burger for $2.5 million. The sale orders authorize these transactions and the assumption of specified liabilities by the purchasers, with the FAT Brands Purchase Agreement expected to close on June 15, 2026. This asset sale represents a liquidation of the company's operating restaurant portfolio and signals the end of FAT Brands' independent operations, likely resulting in significant value recovery for secured creditors but equity holders receiving minimal to no recovery.
FATPQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., entered **Chapter 11 bankruptcy** on January 26, 2026, and have now completed the sale of substantially all assets following a bankruptcy auction held on April 27, 2026, with final court approval issued on May 19, 2026. The company sold four major asset portfolios: Hot Dog on a Stick for $8 million, Elevation Burger for $2.5 million, a portfolio of 13 restaurant brands (Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and others) for approximately $595 million in credit bid, and Twin Hospitality assets through separate purchase agreements. These asset sales represent the liquidation of the company's core business operations through the Chapter 11 bankruptcy process, with proceeds intended to satisfy creditor claims. For equity investors, this filing signals the likely elimination of shareholder value as the Chapter 11 reorganization converts to liquidation through asset sales, making common shares unlikely to recover any value.
FABTQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: FAT Brands Inc. and Twin Hospitality Group Inc.
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., filed this 8-K to report the completion of asset sales pursuant to Chapter 11 bankruptcy proceedings initiated on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. Following an April 27, 2026 auction and May 19, 2026 final hearing, the Bankruptcy Court approved the sale of substantially all assets to four separate purchasers: FBG Bid Co. LLC acquired the FAT Brands portfolio (Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and nine other brands) for approximately $595 million in a credit bid; Amazing Brands, LLC acquired Hot Dog on a Stick for $8 million; TABCO International acquired Elevation Burger for $2.5 million; and TWNPKS Bid Co. LLC acquired Twin Hospitality assets. These asset sales represent the restructuring outcome for investors, with existing equity holders likely facing significant dilution or elimination as the company exits bankruptcy through asset disposition rather than reorganization.
AVAT
NASDAQ
▲ SUPER 8-K
Avalanche Treasury Corporation Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,9.01
# Summary of Avalanche Treasury Corporation 8-K Filing
On June 11, 2026, Avalanche Treasury Corporation (AVAT) completed its business combination with Avalanche Treasury Company LLC, a cryptocurrency-focused digital asset company. The transaction involved the domestication of Mountain Lake Acquisition Corp. (a Cayman Islands SPAC) into a Delaware corporation, followed by mergers that resulted in Avalanche Treasury Company becoming the operating subsidiary. The company received approximately $216 million in capital from Company Unit Investors through a private placement of units converted into Class A common stock, along with a commitment from the Avalanche Foundation to sell a minimum of $200 million in AVAX tokens to the company.
The transaction structure created two classes of stock: Pubco Class A (non-voting) held by MLAC shareholders and Company Unit Investors, and Pubco Class B (voting) held by the Seller Related Parties and Dragonfly venture funds, giving the founders significant voting control despite a diluted economic stake. Investors should note that the company operates in the cryptocurrency sector with exposure to AVAX token holdings and that voting control remains concentrated with the original sellers, which may impact corporate governance dynamics and shareholder influence on future strategic decisions.
PLAG
AMEX
▲ SUPER 8-K
Planet Green Holdings Corp.
EDGAR Items: 2.01,9.01
# Planet Green Holdings Corp. - 8-K Summary
On June 15, 2026, Planet Green Holdings Corp. completed the disposition of its entire equity interest in Bless Chemical Co., Ltd. HK (and its subsidiary Jingshan Sanhe Luckysky New Energy Technologies) to an unaffiliated third party for nominal consideration. The Board determined that divesting this non-operating subsidiary—which had ceased active operations and generated no revenue—would streamline operations, reduce future funding requirements and liabilities, and allow management to concentrate on the company's core consumer products and digital advertising businesses. Following the disposition, Bless HK and Jingshan will no longer be consolidated in the company's financial statements. This strategic exit allows Planet Green to reallocate capital and management resources toward higher-priority business segments while eliminating exposure to the unprofitable subsidiary's obligations.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Summary: Ashford Hospitality Trust, Inc.
**Material Event:** Ashford Hospitality Trust completed the sale of the Hilton Garden Inn Jacksonville - Deerwood Park in Jacksonville, Florida on June 11, 2026, for $11.3 million in cash to Maco Properties, LLC.
**Investor Impact:** This asset divestiture represents portfolio reduction and likely reflects the company's strategy to manage its real estate holdings. The sale generates $11.3 million in proceeds that could be used for debt reduction, dividend payments, or other capital allocation priorities. As a hospitality REIT, individual property sales are routine portfolio management activities, though investors should monitor whether this aligns with broader strategic direction and whether proceeds are effectively deployed to enhance shareholder value.
HLLK
OTC
▲ SUPER 8-K
SDR Drone, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.06,5.07,9.01
# Summary of Hallmark Venture Group 8-K Filing
On June 9, 2026, Hallmark Venture Group, Inc. completed a change of control transaction in which EQUORIX LLC acquired 100% of the Series A Preferred Stock (from Selkirk Global Holdings) and approximately 75.55% of outstanding common stock, resulting in new board leadership and a shift from shell company status to an active drone technology business. The company simultaneously acquired a portfolio of drone-related intellectual property—including 12 Korean patents and associated trade secrets—from Cho Sun Sik and Sundori Drone Co., Ltd., while granting Sundori Korea an exclusive royalty-free license to operate domestically in South Korea and providing manufacturing/engineering services. EQUORIX also funded the transaction through an 8% convertible promissory note with a $100,000 face value and flexible conversion pricing that adjusts based on regulatory compliance, creating potential dilution for existing shareholders. The company intends to rebrand as "SDR Drone Inc." and pursue drone development, manufacturing, and training operations, marking a fundamental business transformation with significant control concentration risk and execution uncertainty in a competitive technology sector.
NTRP
NASDAQ
▲ SUPER 8-K
NextTrip, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# NextTrip, Inc. (NTRP) - 8-K Summary
NextTrip, Inc. completed its acquisition of a 51% controlling stake in Yada Commerce Inc. on June 10, 2026, paying 50,000 restricted shares of NTRP common stock as consideration. Under a concurrent Cooperation and Earnout Agreement, the founding shareholders retain operational control of Yada while NextTrip gains exclusive rights as Yada's preferred travel provider, booking processor, and gift card distributor, with profits shared between the parties over a three-year term. The earnout agreement establishes an incentive pool of up to 225,000 restricted shares and 225,000 warrants (exercise price $2.75) to be awarded to founding shareholders based on their share of net profits generated from specified activities. The transaction involves significant equity dilution to existing shareholders and creates contingent future equity obligations dependent on Yada's operational performance.
BIRD
NASDAQ
▲ SUPER 8-K
Smartbird, Inc. Class A Common Stock
EDGAR Items: 2.01,9.01
# Summary of Allbirds, Inc. Form 8-K Filing
Allbirds, Inc. has completed the sale of its footwear business assets to American Exchange Group affiliate Allbirds IP LLC for $40.7 million in cash, with the transaction closing on June 9, 2026. The asset sale included intellectual property (trademarks, patents, domain names), inventory, customer lists, and related business assets, while the buyer assumed certain liabilities including accounts payable. The company established a $3.0 million escrow fund to cover potential purchase price adjustments and breaches of representations for 60 days post-closing. Management plans to distribute a portion of the sale proceeds to shareholders as a special dividend, with a record date set for June 25, 2026 and payment expected within 60 days. This represents a significant strategic transformation for the company, essentially monetizing its core footwear business operations while maintaining other potential business activities.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Sheraton Mission Valley hotel in San Diego, California on June 9, 2026, for approximately $45.3 million in cash. This asset disposition represents a portfolio reduction by the hospitality REIT but provides liquidity that could be used for debt reduction, capital improvements, or distributions. The company has included pro forma financial information reflecting the sale's impact for the three months ended March 31, 2026, and the full year 2025. While the sale generates near-term cash, investors should monitor how management deploys these proceeds and assess whether this disposition signals broader portfolio optimization or financial restructuring needs.
LBUY
OTC
▲ SUPER 8-K
LEAFBUYER TECHNOLOGIES, INC.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.03,9.01
# Summary of DATZ World Holdings Corp. 8-K Filing
On June 8, 2026, DATZ World Holdings Corp. (formerly LeafBuyer Technologies, Inc.) completed its merger with RagingBull.com, LLC, issuing 15 million shares to RagingBull's equity holders, who now beneficially own approximately 95% of the company's outstanding stock. The company executed a 1-for-156 reverse split and completely reconstituted its board and management, with Anthony Bell appointed as the new CEO. In related transactions, the company sold its LB Media subsidiary to Foundation AI for $750,000 in cash and restructured its debt obligations by exchanging outstanding promissory notes (plus $750,000 cash repayment) for new convertible notes bearing 3% interest and convertible at $0.05 per share. These transactions represent a near-complete change in ownership and control, with substantial dilution to existing shareholders due to the reverse split and massive new share issuance, significantly reducing the value and voting power of pre-merger shareholders.
LBUYD
OTC
▲ SUPER 8-K
DATZ WORLD HOLDINGS CORP.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.03,9.01
# Summary of SEC 8-K Filing: DATZ World Holdings Corp.
On June 8, 2026, DATZ World Holdings Corp. (formerly LeafBuyer Technologies, Inc.) completed its merger with RagingBull.com, LLC, with RagingBull surviving as a wholly-owned subsidiary. The company issued 15 million shares to RagingBull's equityholders, who now control approximately 95% of outstanding common stock, and executed a 1-for-156 reverse stock split. The former LeafBuyer leadership (CEO Kurt Rossner, CFO Mark Breen, and CTO Michael Goerner) resigned, replaced by Anthony Bell as CEO.
In related transactions, the company disposed of LB Media Group LLC to Foundation AI for $750,000 in cash, restructured $991,878 in existing debt into convertible notes bearing 3% interest with a $0.05 conversion price, and sold Series A Preferred Stock to Jeff Bishop for $1,000. The combined effect creates substantial dilution for existing shareholders, with control shifting entirely to the RagingBull owners and major investors like Jeff Bishop (63.9% beneficial ownership) and Jason Bond LLC (23.9%), while the reverse split and equity issuance significantly reduce proportional ownership for pre-merger shareholders.
RCKT
NASDAQ
▲ SUPER 8-K
Rocket Pharmaceuticals, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# Rocket Pharmaceuticals SEC 8-K Summary
Rocket Pharmaceuticals completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) to a large pharmaceutical company on June 10, 2026, receiving $180 million in gross proceeds. The PRV was originally earned through FDA approval of KRESLADI, the company's gene therapy for severe leukocyte adhesion deficiency-I in pediatric patients. This asset sale represents a significant liquidity event that provides the company with substantial cash to support operations and future development initiatives. For investors, the $180 million injection provides near-term financial resources but also indicates the company's shift in monetizing regulatory assets rather than leveraging them for commercial advantage of its own pipeline programs.
ADIL
NASDAQ
▲ SUPER 8-K
Adial Pharmaceuticals, Inc
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
# Summary of Adial Pharmaceuticals 8-K Filing
On June 11, 2026, Adial Pharmaceuticals, Inc. completed its acquisition of Azora Therapeutics, Inc. through a two-step merger structure, issuing 437,474 shares of common stock and 12,930.617 shares of Series A Non-Voting Convertible Preferred Stock (each convertible into 1,000 common shares) to Azora shareholders. The transaction results in a significant shift in ownership control: pre-merger Adial shareholders will hold approximately 13.1% of fully diluted common stock while former Azora shareholders will hold approximately 86.9%, constituting a change of control under Nasdaq rules. The company plans to raise additional capital through a concurrent financing and has assumed Azora's outstanding stock options (convertible into 1,177,782 shares) and agreed to issue pre-funded and common warrants subject to stockholder approval and future milestone achievements. Investors should note that Adial will hold a stockholder meeting to approve the conversion of preferred stock, warrant exercises, charter amendments (potentially including a reverse stock split to maintain Nasdaq compliance), and new equity incentive plans—all material items that could affect share value and equity dilution.
IONI
OTC
▲ SUPER 8-K
I-ON Digital Corp.
EDGAR Items: 1.01,2.01,9.01
# I-ON Digital Corp. Form 8-K Summary
On June 1, 2026, I-ON Digital Corp. completed an assignment of rights to acquire 21 gold mining claims located on Bureau of Land Management (BLM) land in the southwestern United States, with an estimated 1 to 1.5 million ounces of in situ gold reserves plus platinum, rare earth elements, and other minerals. The company assumed a $25 million purchase obligation (with initial $500,000 escrow deposit plus deferred installment payments) and all associated development and feasibility study obligations, receiving the assignment at no cost from Tall Ship Resource Development LLC—an entity owned and controlled by the company's CEO and majority shareholder, Carlos Montoya. This transaction presents a significant related-party transaction risk, as the CEO transferred assets he controlled to the company without compensation while the company assumes substantial financial and operational obligations. Investors should monitor the company's ability to fund the $25 million purchase price and complete required technical work, as failure to meet payment or development obligations could result in loss of the claims.
VSEE
NASDAQ
▲ SUPER 8-K
VSee Health, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# VSee Health, Inc. – 8-K Summary
VSee Health, Inc. completed a significant corporate restructuring on May 31, 2026, in which co-CEO and Chairman Milton Chen purchased all equity securities of the company's wholly-owned subsidiary VSee Lab in exchange for transferring his 2,870,069 common shares to the company. Chen resigned from his executive and board positions effective at closing, with Dr. Imoigele Aisiku assuming sole control as CEO and Chairman. The transaction effectively separates VSee Lab as an independent entity under Chen's ownership while allowing the parent company to divest a major operating subsidiary. This restructuring materially alters the company's asset base and governance structure, reducing investor exposure to VSee Lab's operations and liabilities while concentrating leadership under Aisiku; however, the company retains all pre-closing liabilities and obligations of VSee Lab, which could represent a significant financial burden for remaining shareholders.
CEIN
OTC
▲ SUPER 8-K
CAMBER ENERGY, INC.
EDGAR Items: 1.01,2.01,9.01
# Camber Energy, Inc. – 8-K Summary (June 1, 2026)
Camber Energy completed an amalgamation of its subsidiary Viking Energy Group's minority-owned Canadian generator services company, Simson-Maxwell Ltd., with T&T Power Group Inc., resulting in a consolidated entity (T&T Power Group Inc.) in which Viking now holds only non-voting preferred shares. Viking's ownership stake was converted from 49% common equity to 5.75 million Class A Preference Shares with no voting rights, while T&T's sole shareholder gained 100% voting control through 100,000 Class A Common Shares. This transaction materializes a significant loss of operational control for Camber/Viking despite retaining a financial interest in the business.
The restructuring includes protective provisions for Viking: the preferred shares carry a redemption price of CDN$5.75 million (approximately US$4.15 million) through March 31, 2028, increasing to CDN$7.75 million thereafter, with an 8% conditional cumulative dividend and priority liquidation rights. However, Viking has limited influence—it cannot appoint directors and faces restricted retraction rights until 2028, with the operator having significant discretion over redemptions and the ability to defer payments up to 12 months.
**Investor Impact:** While Camber maintains a financial claim on the Amalgamated Corporation, the loss of operational control and voting power represents a diminished strategic position. The conditional dividend and deferred payment options create earnings uncertainty, and the transaction effectively transforms an operating subsidiary investment into a subordinated claims position, increasing financial risk for shareholders.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Silversmith Hotel Chicago Downtown on June 1, 2026, for $16 million in cash to SHH Chicago LLC. This asset disposition represents a portfolio rationalization move by the hospitality REIT. The filing includes pro forma financial statements reflecting the impact of this property sale, though the transaction's materiality to the company's overall portfolio and financial position would need to be assessed against total assets. For investors, this sale could indicate management's strategy to reduce debt, improve liquidity, or optimize the property portfolio, though the limited disclosure suggests the transaction is not considered a major event relative to the company's scale.
SDOT
NASDAQ
▲ SUPER 8-K
Sadot Group Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Sadot Group Inc. Acquisition of Anira Consulting
**Material Event:** Sadot Group Inc. (NASDAQ: SDOT) completed the acquisition of Anira Consulting FZC, a UAE-based commodity trading and consulting company, on June 2, 2026, for a total purchase price of $12 million.
**Transaction Structure:** The acquisition was funded entirely through equity and debt securities: $405,000 in common stock (135,000 shares at $3.00/share), $6.595 million in newly designated Series B Convertible Preferred Stock (1,000 shares), and a $5 million zero-interest Convertible Promissory Note maturing June 2, 2028. Both convertible securities have a fixed conversion price of $3.00 per share and are subject to beneficial ownership blockers and NASDAQ approval requirements.
**Business Acquired:** Anira operates TradeOS, a proprietary enterprise-grade Commodity Trading and Risk Management (CTRM) platform featuring 11 integrated modules covering trade capture, risk management, logistics, regulatory compliance, and treasury functions on a straight-through processing model.
**Investor Impact:** While the acquisition expands Sadot's business capabilities in commodity trading technology, investors face dilution risk from the potential conversion of $11.595 million in preferred stock and convertible debt into common shares. The company must obtain NASDAQ shareholder approval and will file audited financial statements of Anira within 75 days.
RR
NASDAQ
▲ SUPER 8-K
Richtech Robotics Inc. Class B Common Stock
EDGAR Items: 2.01,8.01,9.01
# Summary of Richtech Robotics Inc. 8-K Filing
Richtech Robotics Inc. completed the acquisition of a 79,325 square foot industrial property located at 9530 S. Rainbow Boulevard in Las Vegas, Nevada for $21.18 million in cash on May 29, 2026, through its wholly-owned subsidiary Richtech Rainbow Holdings LLC. The company plans to utilize the facility for warehousing, assembly, light manufacturing, research and development, and AI/robotics training operations to support its robotics and artificial intelligence systems development. This strategic asset acquisition provides the company with dedicated domestic infrastructure to enhance its operational capabilities and product development efforts. The transaction was previously disclosed on April 7, 2026, and the purchase agreement was assigned to the subsidiary on May 15, 2026 before closing.
ANY
NASDAQ
▲ SUPER 8-K
Sphere 3D Corp. Common Shares
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,7.01,9.01
# Summary of Sphere 3D Corp. 8-K Filing
On June 1, 2026, Sphere 3D Corp. completed its acquisition of Cathedra Bitcoin Inc. in a stock-for-stock transaction, with Cathedra becoming a wholly-owned subsidiary of Sphere. The acquisition was announced on March 5, 2026, and executed pursuant to a plan of arrangement under British Columbia law. Concurrent with closing, Sphere entered into an employment agreement with Joel Block as Chief Executive Officer, providing for a base salary of $425,000, a target annual bonus of 125% of base salary, and an inducement grant of 500,000 restricted stock units vesting over two years. Mr. Block is also eligible for a $1.6 million transaction-related cash retention bonus tied to performance milestones and continued employment through January 1, 2027, along with comprehensive severance protections including 18 months of salary continuation and accelerated equity vesting upon termination without cause.
**Investor Impact:** The acquisition materially changes Sphere's business profile through integration with Cathedra's operations, while the significant executive compensation package (including potential total value exceeding $2.5 million in cash and equity) commits substantial resources to leadership retention and may impact near-term profitability.
KLXE
NASDAQ
▲ SUPER 8-K
KLX Energy Services Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# KLX Energy Services 8-K Summary
KLX Energy Services Holdings, Inc. completed a $17.0 million asset acquisition from Wolf Pack Rentals, LLC on June 2, 2026, with $14.0 million paid at closing and $3.0 million in deferred payments due over the next year payable in cash or stock. The deferred payments are capped at 19.9% of outstanding shares (approximately 3.96 million shares based on April 2026 figures), limiting shareholder dilution. Additionally, the company executed debt-for-equity exchanges converting $2.19 million in principal of its Senior Secured Notes due 2030 into 627,521 common shares, reducing outstanding debt to approximately $252.5 million. These transactions reflect the company's efforts to strengthen its balance sheet and expand operations through strategic acquisitions while maintaining disciplined capital structure management.
RPAY
NASDAQ
▲ SUPER 8-K
Repay Holdings Corporation Class A Common Stock
EDGAR Items: 1.01,1.02,2.01,2.03,7.01,9.01
# REPAY Holdings Corporation 8-K Summary
On June 1, 2026, REPAY Holdings completed the acquisition of KUBRA (a Canadian-U.S. customer communications software company) for approximately $372 million in cash, funded through a new $500 million senior secured term loan and $100 million revolving credit facility arranged with Truist Bank as administrative agent. The company simultaneously refinanced its existing credit agreement, repaying all prior obligations with proceeds from the new term loan facility. The new credit agreement carries a term SOFR-based margin of 5.5% on the term loan and an initial 4.25% on the revolving facility, with a maximum total net leverage covenant of 6.10x and maturities tied to the company's 2029 convertible notes. These financing activities represent a significant capital restructuring to support the KUBRA acquisition while maintaining financial flexibility for working capital and future growth.
BHR
NYSE
▲ SUPER 8-K
Braemar Hotels & Resorts Inc. Common Stock
EDGAR Items: 2.01,7.01,8.01,9.01
# Summary of Braemar Hotels & Resorts Inc. 8-K Filing
Braemar Hotels & Resorts completed the sale of the Park Hyatt Beaver Creek Resort & Spa in Colorado on May 26, 2026, for $176 million in cash, generating approximately $104.5 million in net proceeds after debt repayment and transaction costs. Using these proceeds, the company repaid in full $86.25 million of its 4.50% Convertible Senior Notes due 2026 at scheduled maturity on June 1, 2026, thereby eliminating this debt obligation and terminating the associated indenture. The company also clarified that the Hotel sale, combined with other property dispositions during the applicable lookback periods, does not trigger a Change of Control under its advisory agreement with Ashford. For investors, this sale represents a material deleveraging event that improves the company's balance sheet and financial flexibility, while the debt elimination removes near-term refinancing risk and reduces interest expense going forward.
HDRN
NASDAQ
▲ SUPER 8-K
Hadron Energy, Inc. Common Stock
EDGAR Items: 2.01,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01
# Summary of Hadron Energy, Inc. 8-K Filing (May 22, 2026)
Hadron Energy, Inc. (formerly GigCapital7 Corp.) completed its business combination with Hadron Energy Operating Company Inc. on May 22, 2026, creating a combined public company now trading on Nasdaq under ticker HDRN (common stock) and HDRNW (warrants). The transaction involved significant shareholder redemptions, with approximately 84% of GigCapital7's public shareholders redeeming their shares for $10.71 per share (totaling $180.3 million), leaving approximately $33.9 million in the trust account for the combined company's operations. Post-closing, the combined company has 71.5 million shares outstanding, with insiders owning approximately 77.2% of equity and former GigCapital7 shareholders holding 23%. This SPAC merger marks Hadron Energy's transition from a private company to a publicly-traded nuclear energy technology company with operations now subject to SEC reporting requirements.
CYH
NYSE
▲ SUPER 8-K
Community Health Systems, Inc.
EDGAR Items: 2.01,8.01,9.01
# Summary of Community Health Systems, Inc. 8-K Filing
Community Health Systems, Inc. completed the sale of four hospital facilities and associated outpatient operations in Arkansas (Northwest Medical Center locations in Bentonville and Springdale, Willow Creek Women's Hospital, and Siloam Springs Regional Hospital) to Freeman Health System for $110 million in cash on June 1, 2026. The transaction represents a significant disposition that reduces the company's operational footprint in the Arkansas market. CHS will use proceeds from the asset sale to manage its balance sheet and capital structure, though the filing does not specify intended uses such as debt reduction or reinvestment. For investors, this divestiture signals management's strategic focus on core markets and may improve near-term liquidity, though it reduces overall revenue-generating capacity and represents an exit from the Northwest Arkansas region.
May 2026
31 filings
▼
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Sheraton Indianapolis City Centre Hotel on May 21, 2026, for a gross purchase price of approximately $32.1 million to Keystone Realty Group LLC, with the net proceeds reduced by purchaser credits of approximately $15.2 million and customary adjustments. This asset disposition represents a portfolio rationalization move by the REIT as it continues to manage its hotel holdings. The filing includes pro forma financial information reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, and for the year ended December 31, 2025, though limited details on the transaction's financial impact are provided in the 8-K itself. Investors should review the attached pro forma statements to assess the implications for the company's earnings, cash flow, and debt metrics.
OLOX
NASDAQ
▲ SUPER 8-K
Olenox Industries Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.03,7.01,8.01,9.01
# Summary of Olenox Industries Inc. 8-K Filing
On May 26, 2026, Olenox Industries Inc. (NASDAQ: SGBX) completed its acquisition of CS Digital Ventures, LLC for total consideration of up to $70 million, consisting of $30 million in upfront payments (comprising $14 million in Series D Preferred Stock and $16 million in an unsecured promissory note), 1.5 million warrants, and up to $20 million in additional preferred stock tied to revenue and EBITDA milestones. The Series D Preferred Stock and Warrants cannot be converted or exercised into common stock until Olenox obtains stockholder approval required under Nasdaq Listing Rule 5635, which the company must seek within 90 days and every three months thereafter until obtained. Investors should note that the acquisition significantly dilutes existing shareholders, introduces debt obligations, and conditions future conversion rights on stockholder approval and a 19.9% beneficial ownership cap, while CS Digital's sellers have agreed to two-year non-compete restrictions.
BESS
AMEX
▲ SUPER 8-K
Bimergen Energy Corporation
EDGAR Items: 1.01,2.01,9.01
# Bimergen Energy Corporation (BESS) 8-K Summary
On May 21, 2026, Bimergen Energy's subsidiary Emergen Energy LLC contributed 100% equity interests in three battery energy storage system (BESS) project companies to a joint venture with Cerberus Capital Management's Frontier Power & Utilities platform, receiving 7.5% ownership (75 Class B Units) and a $1.18 million reimbursement in return. Concurrently, Emergen entered into a Joint Development Agreement providing up to $5.69 million in development fees and milestone-based payments for advancing the contributed BESS portfolio and identifying additional utility-scale battery projects in the ERCOT market. The transaction effectively monetizes Bimergen's existing BESS assets while maintaining ongoing involvement through development services and retained equity upside, representing a strategic partnership with a major institutional capital provider but also a dilution of direct asset ownership.
TMGI
OTC
▲ SUPER 8-K
Transglobal Management Group, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary: Transglobal Management Group Acquires Golf Management Software Platform
On March 20, 2026, Transglobal Management Group, Inc. (TMGI) completed its acquisition of Continuum Software Technologies, Inc. (CSTI), a developer of cloud-based golf course management software, in exchange for issuing 50.6 million shares of TMGI common stock. The CSTI Platform provides comprehensive golf operations management including tee sheet management, point-of-sale systems, payment processing, marketing tools, and hardware solutions, enabling TMGI to expand its service offerings to large golf operators across the United States. The transaction was structured as a stock-for-stock exchange with CSTI shareholders receiving TMGI common stock exempt from SEC registration under Section 4(2) of the Securities Act. The significant share issuance (50.6 million shares) represents substantial dilution to existing TMGI shareholders, which could materially impact earnings per share and voting power depending on the company's current share count.
TBNRL
OTC
▲ SUPER 8-K
Tamboran Resources Corp
EDGAR Items: 2.01,3.02,7.01,8.01,9.01
# Summary of Tamboran Resources Corporation 8-K Filing
On May 28, 2026, Tamboran Resources Corporation completed its acquisition of Falcon Oil & Gas Ltd.'s subsidiaries through a plan of arrangement, acquiring approximately 98.1% of Falcon Australia and 100% of Falcon's interests in Hungary, Ireland, and South Africa. Tamboran paid $23.7 million in cash and issued 6.54 million common shares (valued at the exchange rate applicable at closing) to Falcon shareholders. The transaction was structured as a tax-efficient cross-border arrangement and received court approval from the British Columbia Supreme Court, which also addressed sanctions-related dissenting shareholder rights requiring funds to be held in a blocked account. Financial and pro forma statements will be filed within 71 days, with regulatory requirements met through Section 3(a)(10) exemption from securities registration. This acquisition expands Tamboran's global oil and gas portfolio across multiple jurisdictions, though investors should note the contingent obligation related to the dissenting shareholder's fair value determination.
ESGH
OTC
▲ SUPER 8-K
ESG Inc.
EDGAR Items: 2.01,8.01,9.01
# ESG Inc. Form 8-K Summary
On May 26, 2026, ESG Inc. completed a split-off transaction in which it transferred 100% ownership of its subsidiary ESG China Limited to shareholders in exchange for the cancellation of 10,432,800 common shares, reducing outstanding shares from approximately 25.9 million to 15.5 million shares. Following the transaction, ESG China Limited and its downstream Chinese operations are no longer consolidated with the Company, effectively divesting the company of its China operations. The Company intends to focus its business going forward on North American operations through ESG Provisions, Inc., representing a significant strategic restructuring and portfolio refocus.
**Investor Impact:** This transaction substantially reduces the company's share count, which could benefit remaining shareholders through reduced dilution, but also eliminates an entire geographic segment. Investors should review the pro forma financial statements filed on May 5, 2026 to assess the financial impact of operating as a reduced, North America-focused entity.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# Summary of Generation Income Properties, Inc. 8-K Filing
Generation Income Properties, Inc. completed the sale of a Starbucks-occupied net lease retail property located in Tampa, Florida on May 22, 2026, for a purchase price of $2,964,000, netting the company $1,959,170 after adjustments. This asset disposition represents a reduction in the company's real estate portfolio and cash-generating property holdings. The pro forma financial statements provided suggest a material impact on the company's balance sheet and operating results, with the sale now reflected as if it occurred on January 1, 2025 for operating statement purposes. For investors, this transaction indicates the company is strategically divesting assets, which may affect future rental income and property-level cash flows, though the proceeds could be deployed toward debt reduction, new acquisitions, or shareholder returns depending on management's capital allocation strategy.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of its Lakeway Resort and Spa in Austin, Texas on May 19, 2026, for $37.75 million in cash to Trestle Studio LLC. This asset disposition represents a strategic divestiture under a purchase agreement originally dated February 10, 2026, with modifications finalized in March 2026. The company has provided unaudited pro forma financial statements reflecting the impact of this transaction as of March 31, 2026, and for the year ended December 31, 2025. For investors, this sale generates approximately $37.75 million in liquidity, which the company may deploy toward debt reduction, capital improvements, or other strategic investments in its hospitality portfolio.
RTB
NASDAQ
▲ SUPER 8-K
RTB Digital, Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,9.01
# RTB Digital, Inc. (RTB) - 8-K Summary
On May 12, 2026, RTB Digital, Inc. (formerly Ryvyl Inc.) completed its merger with RTB Digital, Inc., issuing 4.38 million shares to RTB's former shareholders and creating a Web3 media platform company focused on serving major media brands and premium clients. The post-merger company now has approximately 5.77 million shares outstanding and has assumed RTB's securities, including stock options (3.39 million shares reserved), warrants (2.07 million shares reserved), and convertible debt (7.69 million shares reserved), which will be converted and exercised over time. Key insiders and larger shareholders have agreed to 12-month lock-up periods on their shares, with a gradual dribble-out over the following nine months. The company's board was reconstituted to seven members following the merger, and the stock began trading under the new ticker symbol "RTB" on Nasdaq Capital Market on May 13, 2026, representing a significant change of control for existing investors.
NNUP
OTC
▲ SUPER 8-K
NOCOPI TECHNOLOGIES INC/MD/
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# Summary of NOCOPI TECHNOLOGIES, INC. Form 8-K Filing
On May 18, 2026, Nocopi Technologies completed the acquisition of substantially all assets of Polymeric U.S., Inc., a specialized ink and coating solutions manufacturer, for aggregate consideration of $2.65 million consisting of $1.75 million in immediate cash payments, assumption of specified liabilities, and 500,000 shares of common stock. Concurrently, the company completed a private placement of 266,668 shares at $1.50 per share, expected to generate approximately $400,000 in gross proceeds by September 2, 2026. The acquisition expands Nocopi's business into industrial, digital, and screen printing applications under the "Polymeric" trade name, while the private placement provides capital to fund operations and integration activities.
**Investor Impact:** The $150,000 holdback arrangement protects the company from post-closing indemnification claims, and one investor secured registration rights requiring the company to register their shares within one year. The issuances of 766,668 new shares (~500,000 from acquisition + ~266,668 from private placement) will dilute existing shareholders' ownership, though the capital infusion supports growth and risk mitigation post-acquisition.
QNCX
NASDAQ
▲ SUPER 8-K
Quince Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,9.01
# Summary of Quince Therapeutics 8-K Filing (May 17, 2026)
Quince Therapeutics completed the acquisition of Orphai Therapeutics in a two-step merger on May 18, 2026, issuing approximately 3.26 million shares of common stock and 67,101 shares of Series C Non-Voting Convertible Preferred Stock (convertible into ~67.1 million common shares) to Orphai's stockholders. The transaction substantially dilutes existing Quince shareholders, whose ownership will decline from 17.8% to 6.9% on a fully-diluted basis after planned financing, with Orphai equityholders gaining 31.9% and new investors receiving 61.2% post-financing. The company assumed all Orphai stock options (converting to ~26.3 million shares of common stock) and issued financing warrants, and must obtain stockholder approval for the Series C preferred conversion, charter amendments to increase authorized shares to 800 million, and new equity incentive plans. Quince must file an S-3 registration statement within 75 days to register the newly issued and convertible shares for resale, indicating significant post-acquisition capital raising activity ahead.
ATXG
NASDAQ
▲ SUPER 8-K
Addentax Group Corp. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Summary: Addentax Group Corp.
**Material Event:** Addentax Group Corp. (ATXG, Nasdaq Capital Market) completed an acquisition on May 15, 2026, whereby its Hong Kong subsidiary Yingxi acquired 100% equity interests in Time Is Loan Limited from seller OR Shan Shan in exchange for 137,790 newly issued shares of common stock.
**Investor Impact:** The transaction resulted in dilution to existing shareholders through the issuance of additional shares. The acquisition was completed using an offshore Regulation S exemption, indicating the shares were issued to a non-U.S. person without SEC registration requirements. This appears to be a strategic acquisition to expand the company's operations, though the filing provides limited detail on the target company's financial condition or expected contribution to future earnings. Investors should review the full Share Exchange Agreement (referenced from the April 28, 2026 8-K filing) to assess the strategic rationale and financial implications of this transaction.
HYEX
OTC
▲ SUPER 8-K
HEALTHY EXTRACTS INC.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# Summary of Healthy Extracts Inc. 8-K Filing
Healthy Extracts Inc. completed the acquisition of Adli Gummies Inc. (doing business as Imaraÿ's Beauty) on May 15, 2026, for a total consideration of approximately $794,000 in secured promissory notes plus 3 million shares of common stock and exchangeable shares. The deal resulted in significant shareholder dilution, with the issued shares representing approximately 17.76% of total outstanding common stock on a fully-diluted basis, partially offset by the cancellation of 3 million shares held by the CEO. Aaron Hefter, the largest shareholder of Adli and a seasoned entrepreneur in the nutraceutical industry, was appointed Chief Brand Officer as a material term of the transaction and will help integrate the Imaraÿ's Beauty brand—described as a rapidly growing ingestible beauty and wellness company co-founded with fitness influencer Sommer Ray. The acquisition positions Healthy Extracts to leverage Hefter's extensive experience (over two decades in the sector, including co-CEO roles at other nutrition companies) and Imaraÿ's established product portfolio to expand its presence in the wellness market.
FORA
NASDAQ
▲ SUPER 8-K
Forian Inc. Common Stock
EDGAR Items: 2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# Summary of Forian Inc. 8-K Filing (May 15, 2026)
Forian Inc. completed its acquisition by 2025 Acquisition Company, LLC on May 15, 2026, with the company merging into a subsidiary of the acquirer at $2.17 per share in cash. The tender offer closed on May 14, 2026, with approximately 91% of outstanding shares tendered, satisfying all conditions for the acquisition. Following the merger, Forian became a wholly owned subsidiary of Parent, and the company initiated delisting from The Nasdaq Capital Market. This transaction eliminates Forian as an independent public company, and shareholders who did not tender their shares during the offer will receive the $2.17 merger consideration, while option holders and RSU holders receive equivalent cash payments based on the offer price.
SSP
NASDAQ
▲ SUPER 8-K
The E.W. Scripps Company
EDGAR Items: 2.01,9.01
# E.W. Scripps Company 8-K Summary
On May 15, 2026, The E.W. Scripps Company completed a previously announced stations swap transaction with Gray Media, Inc., acquiring five television stations (KKTV and KMVT in the Mountain West region, along with related low-power affiliates) in exchange for transferring two stations (WSYM and KATC) to Gray. The transaction involved an even exchange of comparable assets with no cash consideration paid by either party, representing a strategic reallocation of broadcast media properties. This swap allows Scripps to consolidate its presence in certain regional markets while exiting others, potentially affecting its future revenue streams and operational footprint in those geographic areas. Investors should monitor how this portfolio rebalancing impacts Scripps' profitability and market reach in the coming quarters.
EMBC
NASDAQ
▲ SUPER 8-K
Embecta Corp. Common Stock
EDGAR Items: 2.01,7.01,9.01
# Embecta Corp. (EMBC) 8-K Summary
Embecta Corp. completed its acquisition of Owen Mumford Holdings Limited, a UK-based medical device and drug-delivery technology manufacturer, on May 15, 2026, for an upfront payment of £100 million with potential milestone payments of up to £50 million through June 2029 based on sales performance of the Aidaptus® auto-injector platform. This strategic acquisition expands Embecta's product portfolio in the high-growth drug-delivery sector and adds a proprietary next-generation auto-injector platform to its medical device offerings. The milestone-based payment structure ties future cash outlays to commercial success, reducing upfront financial burden while providing sellers with incentives to achieve sales targets. Investors should monitor Owen Mumford's integration progress and the achievement of commercial milestones, as these will trigger the additional £50 million in earnout payments and impact future cash flow.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
PMGC Holdings Inc. (NASDAQ: ELAB) completed its acquisition of 100% of A&B Aerospace, Inc. on May 12, 2026, for approximately $4.5 million in cash at closing plus contingent adjustments based on final net working capital and cash balance calculations. The acquisition includes a $225,000 indemnification holdback related to pending litigation, with sellers providing six months of transition services and agreeing to three-year non-compete restrictions in California's IT packaging business. The target company will continue operating at its existing facility under a new commercial lease, with its president retained as an employee, positioning PMGC to expand into the aerospace sector. Post-closing adjustments for cash balance and net working capital variations will be settled in cash within five business days of final determination, with the net working capital target set at $855,669.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of its 150-room Embassy Suites by Hilton Dallas Near the Galleria property on May 6, 2026, for $17 million in cash to DG Lodging, LLC. This asset disposition represents a portfolio rationalization move by the company, reducing its property count and potentially freeing up capital. The filing includes unaudited pro forma financial information reflecting the impact of this transaction on the company's financial position as of year-end 2025. For investors, this sale generates liquidity but may signal continued portfolio optimization efforts as the company manages its real estate holdings.
PAAPU
OTC
▲ SUPER 8-K
PLAINS ALL AMERICAN PIPELINE LP
EDGAR Items: 1.02,2.01,7.01,9.01
# Plains All American Pipeline (PAA) 8-K Summary
Plains All American Pipeline completed the sale of its Canadian natural gas liquids (NGL) business to Keyera Corp. on May 12, 2026, for CAD $5.13 billion (approximately USD $3.76 billion), generating approximately $3.3 billion in net proceeds after taxes and expenses. The company intends to use these proceeds to reduce leverage by repaying outstanding debt, including a $1.1 billion term loan that will be terminated by May 14, 2026, commercial paper borrowings, and senior notes due December 2026. This transaction represents a strategic divestiture of a non-core asset and significantly strengthens PAA's balance sheet by reducing overall debt levels. The sale has been classified as discontinued operations in PAA's recent financial statements, so the transaction impact on ongoing operations should be minimal going forward.
MREO
NASDAQ
▲ SUPER 8-K
Mereo BioPharma Group plc American Depositary Shares
EDGAR Items: 2.01,9.01
# Summary of Mereo BioPharma Group PLC 8-K Filing
On May 12, 2026, Mereo BioPharma Group PLC announced its Q1 2026 financial results (quarter ended March 31, 2026) and provided updates on corporate developments. The 8-K references a press release (Exhibit 99.1) containing the detailed financial results and operational updates, though the specific financial metrics and business developments are not disclosed in the 8-K filing itself. As an emerging biopharmaceutical company, investors should review the attached press release for material information regarding cash position, pipeline progress, and burn rate that would impact near-term operational viability. The company trades on Nasdaq under the ticker MREO through American Depositary Shares.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 2.01,2.03,3.02,9.01
# SEC 8-K Summary: Global Asset Management Group, Inc.
On May 6, 2026, Global Asset Management Group, Inc. completed the acquisition of an 83.125% membership interest in Memorial Real Estate Group LLC (MREG), which owns a historic 385,000-square-foot former hospital property in Pawtucket, Rhode Island being redeveloped into mixed-use residential and commercial space. The company financed this $6.455 million acquisition through a $6 million convertible promissory note (6% interest, maturing April 2027, convertible at 90% of 30-day VWAP) plus $455,000 in cash, along with a separate $3.5 million convertible note issued on April 6, 2026 for a 16.875% stake in the subsidiary holding company. The MREG property is planned as a major mixed-use development with approximately 40% affordable housing, 40% market-rate luxury apartments, and 20% veteran-focused housing, featuring community amenities and proximity to Boston commuter rail. Investors should note the material debt obligations ($9.5 million in convertible notes due 2027) and dilution risk from conversion provisions, as well as the significant execution risk inherent in a large-scale real estate redevelopment project.
UDMY
NASDAQ
▲ SUPER 8-K
Udemy, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Summary: Udemy, Inc.
On May 11, 2026, Udemy, Inc. completed its merger with Coursera, Inc., with Udemy becoming a wholly-owned subsidiary of Coursera. Udemy shareholders received 0.800 shares of Coursera common stock for each Udemy share held, based on a merger consideration value of $3.824 per Udemy share (calculated using a $4.78 average Coursera stock price). In connection with the transaction, Udemy terminated its $200 million credit facility with Citibank with all obligations satisfied and liens released. Following the merger closing, Udemy's common stock was suspended from trading on NASDAQ and Coursera requested delisting and deregistration of Udemy shares under Section 12(b) of the Securities Exchange Act. This merger effectively consolidates the two online education platforms under Coursera's ownership, eliminating Udemy as a separately traded public company.
APADR
NASDAQ
▲ SUPER 8-K
A Paradise Acquisition Corp. Rights
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary: Enhanced Group Inc.
Enhanced Group Inc. (formerly A Paradise Acquisition Corp.) completed a domestication and business combination on May 6-7, 2026, converting from a British Virgin Islands blank check company to a Texas corporation and merging with Enhanced Ltd. The domestication involved converting A Paradise's Class B ordinary shares to Class A shares on a one-for-one basis, then converting all ordinary shares to Class A common stock of Enhanced Group, while establishing a new Class B common stock with ten votes per share. The subsequent merger with Enhanced Ltd resulted in Enhanced shareholders receiving Enhanced Group Class A common stock at a specified exchange ratio, with Enhanced Options, Top-Up Awards, and Consultant Warrants converted into equivalent Enhanced Group equity instruments. The Business Combination resulted in the issuance of approximately 136.2 million shares of Enhanced Group Class A common stock to various security holders, fundamentally transforming the company's capital structure and ownership. Investors should note the significant dilution from this equity issuance and the shift in voting structure with the introduction of supervoting Class B shares.
GBCS
OTC
▲ SUPER 8-K
SELECTIS HEALTH, INC.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: Selectis Health, Inc.
On May 1, 2026, Selectis Health, Inc. completed the sale of two skilled nursing facilities (Glen Eagle Healthcare and Rehab in Abbeville, Georgia, and Eastman Healthcare and Rehab in Eastman, Georgia) to GA SNF Abbeville GA LLC and GA SNF Eastman GA LLC for an aggregate purchase price of $15.7 million. After repaying mortgage debt and other liabilities, the company received approximately $9 million in net proceeds at closing, with an additional $1.57 million held in escrow pending potential indemnity claims. Concurrently, the facilities' operations were transferred to subsidiaries of the purchasers under an Operations Transfer Agreement. This asset disposition represents a significant restructuring event that reduces the company's real estate and nursing facility portfolio while generating liquidity through debt paydown and cash proceeds, which could impact investors' assessments of the company's operational scale and financial position going forward.
SHPH
NASDAQ
▲ SUPER 8-K
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,9.01
# Summary of Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing
On May 6, 2026, Shuttle Pharmaceuticals Holdings, Inc. completed its merger with United Dogecoin Inc., with United Dogecoin becoming a wholly owned subsidiary of Shuttle. Under the merger agreement, existing United Dogecoin shareholders received 8,403 shares of Series B-1 convertible preferred stock, which are convertible into approximately 33.9 million shares of Shuttle common stock at $1.24 per share, plus conditional pre-funded warrants for up to 122.9 million additional shares upon achievement of certain milestones. Simultaneously, Shuttle closed a $9.55 million PIPE financing with accredited investors who received Series B-2 convertible preferred stock convertible into 9.3 million shares at $1.03 per share, plus additional pre-funded warrants for up to 31.5 million shares conditional on milestone achievements. **For investors, this represents significant potential dilution from the combined issuance of convertible securities and warrants, with approximately 173+ million potential shares outstanding contingent on stockholder approval and milestone achievement**, fundamentally altering the company's capital structure and substantially reducing existing shareholders' ownership percentages.
BWEN
NASDAQ
▲ SUPER 8-K
Broadwind, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.02,9.01
# Summary of Broadwind, Inc. 8-K Filing
**Key Event:** Broadwind completed the sale of its Abilene, Texas production facility to Freeman Enclosure Systems (a subsidiary of IES Holdings) on April 30, 2026, for up to $19.5 million in cash, with a $1 million escrow holdback. The company retained a short-term leaseback at below-market rates through approximately September 5, 2026.
**Strategic Shift:** This transaction represents Broadwind's complete exit from the wind energy market, following a prior sale of its Manitowoc, Wisconsin facility in September 2025. The company has made a deliberate strategic decision to abandon wind-related manufacturing operations.
**Financial Impact:** Broadwind withdrew its previously announced 2026 financial guidance in connection with this transaction, indicating material impacts on expected financial performance. Updated guidance is expected during the company's Q1 2026 earnings call on May 12, 2026.
**Investor Implications:** This marks a significant strategic pivot that will reshape Broadwind's business model and operational footprint, though the long-term direction remains unclear pending the earnings call disclosure.
OTLC
OTC
▲ SUPER 8-K
Oncotelic Therapeutics, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Oncotelic Therapeutics 8-K Filing (May 1, 2026)
Oncotelic Therapeutics completed a significant merger transaction where its subsidiary merged a patent holding company (Neurobridge IP Holdings) into Lunai Bioworks, Inc., receiving $20 million in Series B Convertible Preferred Stock (with Oncotelic receiving 62.5% or $12.5 million). Concurrent with the merger, Oncotelic assigned its intellectual property portfolio to the holding company while retaining an exclusive, royalty-free license to use most of the assets, except in the Biodefense and Alzheimer's Disease fields—which are now exclusively held by Lunai. The transaction effectively restructures Oncotelic's IP ownership and creates a partnership with Lunai around its therapeutic intellectual property, particularly regarding OT-101 applications.
**For investors:** This represents a material capital infusion and strategic repositioning that provides Oncotelic with funding while carving out potential upside in biodefense and Alzheimer's applications for Lunai. The exclusive license-back ensures Oncotelic retains control of its core therapeutic development (OT-101), though the company has ceded significant patent rights in specialized fields that could represent future value.
LEEEF
OTC
▲ SUPER 8-K
Leef Brands Inc.
EDGAR Items: 2.01,3.02,8.01,9.01
# 8-K Summary: Leef Brands, Inc. - Merger Completion
Leef Brands, Inc. completed its merger with Standard Holdings, Inc. (SHI) on March 27, 2026, with SHI now operating as a wholly-owned subsidiary of the company. As consideration, Leef issued approximately 12.6 million shares to SHI's senior preferred stockholders and paid $10,000 in cash to common and series seed preferred stockholders, with the shares subject to a 12-month staggered lock-up agreement. Additionally, the company issued 1.1 million incentive shares and warrants to purchase 547,520 shares to continuing SHI executives, while all outstanding SHI stock options and warrants were cancelled without compensation. All securities issued in the transaction were unregistered under the Securities Act and offered under the Section 4(a)(2) exemption. For investors, this acquisition significantly increases share count and dilutes existing shareholders, though the staggered lock-up provides some near-term price protection by limiting insider selling pressure.
FARM
NASDAQ
▲ SUPER 8-K
Farmer Brothers Company Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,7.01,9.01
# Summary of Farmer Bros. Co. 8-K Filing
On May 5, 2026, Farmer Bros. Co. (ticker: FARM) completed its acquisition by Royal Cup, Inc. in an all-cash merger transaction valued at approximately $28.3 million. Each share of Farmer Bros. common stock was converted into $1.29 in cash, and all equity awards (RSUs, CSRSUs, PBRSUs, and stock options) were converted to cash payments based on the merger consideration. The company's shares have been delisted from the Nasdaq Global Select Market, and Farmer Bros. is now a wholly-owned subsidiary of Royal Cup. This represents a material change of control event, and the company intends to terminate its SEC reporting obligations by filing a Form 15.
UHG
NASDAQ
▲ SUPER 8-K
United Homes Group, Inc Class A Common Stock
EDGAR Items: 1.02,2.01,3.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01
# United Homes Group, Inc. - Form 8-K Summary
United Homes Group, Inc. completed its merger with Stanley Martin Homes, LLC on May 4, 2026, with shareholders receiving $1.18 per share in cash for both Class A and Class B common stock. The company simultaneously delisted from Nasdaq and repaid all outstanding debt under its credit facilities with Wells Fargo and Kennedy Lewis. Employee equity awards (stock options, RSUs, and PSUs) were canceled and converted to cash payments based on the per-share merger price, with performance stock units deemed 100% vested. Additionally, the company issued 21.9 million shares to satisfy prior earn-out obligations before the merger closed. For investors, this represents the conclusion of United Homes Group's public life as it becomes a wholly owned subsidiary of Stanley Martin Homes, eliminating any further public equity investment opportunities in the standalone company.
LNAI
NASDAQ
▲ SUPER 8-K
Lunai Bioworks Inc. Common Stock
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,5.03,9.01
# Summary of Lunai Bioworks 8-K Filing (April 27, 2026)
Lunai Bioworks completed a merger with Neurobridge IP Holdings on May 1, 2026, acquiring a multi-jurisdictional patent portfolio from two shareholders (Oncotelic and Pelerin) in exchange for 8 shares of newly created Series B Convertible Preferred Stock valued at $20 million total ($12.5M to Oncotelic, $7.5M to Pelerin). The Series B Preferred Stock is convertible into up to 13.3 million common shares at $1.50 per share, but conversion is contingent on obtaining stockholder approval under Nasdaq Listing Rule 5635, which the company has committed to seek within 180 days. The transaction involves significant protections for the company, including a beneficial ownership blocker (4.99%), indemnification set-off rights, and an IP clawback mechanism that allows the company to forfeit shares if patent validity claims arise. For investors, this represents a dilutive event pending stockholder approval, with the actual impact dependent on the patent portfolio's strategic value and whether conversion ultimately occurs.
April 2026
13 filings
▼
SOBR
NASDAQ
▲ SUPER 8-K
SOBR Safe, Inc. Common Stock
EDGAR Items: 1.01,2.01,5.01,5.02,7.01,9.01
# SOBR Safe, Inc. 8-K Summary
SOBR Safe, Inc. announced a merger agreement with Clean World Ventures, Inc. (CWV) on April 24, 2026, in which CWV will merge into a SOBR subsidiary, with CWV becoming a wholly owned subsidiary of SOBR. Upon closing, pre-Merger CWV stockholders are expected to own approximately 98.3% of the combined company while pre-Merger SOBR stockholders will own only 1.7%, representing a significant change of control. The transaction, expected to close in Q3 2026, requires approval from both companies' stockholders, Nasdaq listing approval, and an effective S-4 registration statement, with SOBR's board and executive officers to be determined by CWV post-closing. Additionally, SOBR will pay $1.5 million to terminate its financial advisor agreement with H.C. Wainwright & Co. upon merger completion.
**Investor Implications:** Current SOBR shareholders face substantial dilution, with their ownership stake declining from 100% to approximately 1.7%, effectively making this a reverse merger where CWV becomes the controlling entity. The transaction structure suggests SOBR is the publicly listed shell being acquired by CWV, requiring a reverse stock split to maintain Nasdaq compliance.
FCUV
NASDAQ
▲ SUPER 8-K
Focus Universal Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,9.01
# Focus Universal Inc. (FCUV) 8-K Summary
Focus Universal Inc. completed a significant $17.7 million acquisition of a Class A office and commercial property in Monterey Park, California on April 17, 2026, financed through an $11.05 million term loan from East West Bank and $5.8 million in cash. The 464,955 sq. ft. property, assessed at approximately $28.4 million, is currently 99.2% occupied by 16 tenants with lease terms of 5-8 years, and includes a four-level parking structure with solar panels. The company secured the property with a floating-rate loan at 6.25% for the first three years, then Prime + 0.25% thereafter, with principal and interest payments beginning May 2026 and a substantial balloon payment due in April 2036.
**For investors:** This acquisition signals Focus Universal's strategic pivot into real estate investment, adding a substantial income-generating asset to its portfolio. However, the high leverage ratio (65% debt financing) and personal guarantee by CEO Dr. Desheng Wang increase financial risk, while the 99% occupancy rate provides near-term cash flow stability that should help service the $11.05 million debt obligation.
MDLK
OTC
▲ SUPER 8-K
ModuLink Inc.
EDGAR Items: 2.01,7.01,9.01
# Summary of ModuLink Inc. 8-K Filing
ModuLink Inc. completed its acquisition of a 60% equity stake in ASA Robotics Limited, a Hong Kong-based robotics and artificial intelligence company, on April 23, 2026, for approximately $641,026 (HKD 5 million) in Series A Convertible Preferred Stock. Following the transaction, ASA Robotics became a majority-owned subsidiary of ModuLink, with the remaining 40% held by existing minority shareholders, and the company will consolidate ASA Robotics' financial results going forward. The board of ASA Robotics will be reconstituted to reflect the new ownership structure, and the parties plan to execute an amended shareholders' agreement to formalize governance arrangements. While this acquisition expands ModuLink's portfolio into robotics and AI solutions, the company states its core business operations remain unchanged.
TELO
NASDAQ
▲ SUPER 8-K
Telomir Pharmaceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# Telomir Pharmaceuticals 8-K Summary
**Material Event:** Telomir Pharmaceuticals completed its acquisition of TELI Pharmaceuticals on April 22, 2026, issuing 34.4 million restricted shares to TELI shareholders as consideration, with valuations determined by independent third parties.
**Key Changes:** The transaction consolidates global rights to Telomir-1 (Telomir-Zn) under a single corporate entity, eliminating the previous geographic fragmentation where North American and international rights were held separately. This provides unified development and commercialization control across major markets.
**Additional Consideration:** Bayshore Trust, a TELI shareholder, contributed $1 million at closing and entered into an option agreement to invest up to $4 million more upon achievement of key milestones, including FDA acceptance of an IND application and initiation of Phase 1/2 clinical trials for Telomir-1.
**Investor Implications:** While the deal consolidates IP rights and demonstrates shareholder support (through Bayshore's additional commitments), the substantial share issuance (34.4M shares) causes dilution, and success is contingent on achieving early-stage clinical development milestones, which carry significant execution risk for this emerging growth company.
MSGM
NASDAQ
▲ SUPER 8-K
Motorsport Games Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.03,5.01,5.02,5.03,5.07,9.01
# Motorsport Games Inc. (MSGM) - 8-K Summary
**Key Events:**
Motorsport Games Inc. completed a significant corporate restructuring on April 22, 2026, repurchasing 904,395 shares from its largest shareholder, Driven Lifestyle Group LLC, at $4.11 per share, which simultaneously triggered the cancellation of all Class B Common Stock held by that entity. This transaction caused a major shift in control: Driven Lifestyle's voting power dropped from majority control to just 6.10%, while Sharp Arrow Global Tech Ventures L.P. became the new largest shareholder with 32.15% voting power.
**Material Changes:**
The company also implemented significant governance amendments to its Certificate of Incorporation and Bylaws, including elimination of shareholder written consent rights (requiring all stockholder actions to occur at formally called meetings), simplified amendment procedures for charter and bylaws, and increased the equity incentive plan share authorization from 100,000 to 600,000 shares.
**Investor Implications:**
These changes represent a fundamental shift in ownership structure and corporate control, reducing founder/early investor concentration and potentially making the company more accessible to future investors. However, the elimination of written consent rights may limit minority shareholders' ability to force certain corporate actions, while the expanded equity plan could create dilution concerns depending on future grant decisions.
IVHI
OTC
▲ SUPER 8-K
Invech Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# Invech Holdings, Inc. - 8-K Summary
Invech Holdings, Inc. completed the acquisition of the sports betting platform www.sportypick.com from Arpita Day on April 21, 2026, paying 5 million restricted shares of common stock for the website and associated code. The company simultaneously created a wholly owned subsidiary, Sporty Pick, Inc., to house the acquired assets. The share issuance was conducted as a private placement under SEC regulations (Section 4(a)(2) and Regulation D Rule 506), meaning it was not a public offering and the shares carry resale restrictions.
**For investors:** This represents a significant equity dilution event, as the company issued 5 million shares for a single asset acquisition. The lack of disclosed financial details about the platform's current value, user base, or revenue-generating potential makes it difficult to assess whether this was a fair exchange or strategic necessity. The substantial share issuance to acquire a relatively niche sports betting website warrants investor caution regarding dilution and management's capital allocation decisions.
NXGL
NASDAQ
▲ SUPER 8-K
NexGel, Inc Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,8.01,9.01
# NexGel Inc. (NXGL) 8-K Summary
**Material Events:**
NexGel amended its Asset Purchase and Exclusive License Agreement with Celularity Inc. on April 17, 2026, restructuring the consideration for acquiring Celularity's regenerative biomaterials portfolio. The total consideration was adjusted to $13.3 million, consisting of an $8.3 million upfront cash payment and a $5 million convertible promissory note from NexGel to Celularity.
**Key Changes:**
Simultaneously, NexGel completed a private placement raising $6.9 million through convertible notes and warrants from accredited investors, with an additional $475,000 in commitments. The convertible notes feature a 10% interest rate, 18-month maturity, and $0.60 conversion price with full-ratchet anti-dilution protection and automatic price adjustments at 12 and 18 months.
**Investor Implications:**
The financing and restructured deal enable NexGel to complete the Celularity acquisition while securing capital, though the aggressive conversion terms (particularly the automatic downward price adjustments and full-ratchet anti-dilution) suggest significant dilution risk for existing shareholders if the stock underperforms. The $0.60 conversion price will likely reset lower in 12 months based on trading volume metrics, potentially increasing dilution.
HRZN
NASDAQ
▲ SUPER 8-K
Horizon Technology Finance Corporation
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# Horizon Technology Finance Corporation (HRZN) - 8-K Summary
**Key Events:**
Horizon Technology Finance Corporation completed its acquisition of Monroe Capital Corporation (MRCC) on April 14, 2026, issuing approximately 20.4 million shares at a 0.9402 exchange ratio and receiving ~$141 million in cash proceeds from MRCC's asset sale. The transaction combined two BDC (business development company) platforms and was structured to comply with Investment Company Act safe harbor provisions.
**Material Changes:**
The company's board was restructured, with five directors resigning effective at closing and one new independent director (Thomas J. Allison) being appointed, reducing the board size to four members. Additionally, the investment adviser (HRZN Advisor) agreed to waive $4 million in management and incentive fees ($1 million per quarter through June 30, 2027) to help offset merger-related costs.
**Investor Implications:**
The merger significantly expands HRZN's asset base and diversifies its portfolio through MRCC's acquisition, though shareholders face dilution from the 20+ million new shares issued. The fee waiver provides near-term earnings support, but investors should monitor the combined entity's portfolio performance and how effectively management integrates the two platforms over the coming quarters.
CCTC
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Summary: Catalyst Crew Technologies Corp.
**Key Events:** Catalyst Crew Technologies acquired AI-enabled healthcare analytics intellectual property and operational assets from its CEO Kevin Rodan Levy in a series of transactions between February and April 2026. The company acquired proprietary software, machine learning models, and three registered AI platforms (CardioAI, PulmoAI, and NeuroAI) through an Asset Purchase Agreement, followed by acquiring a 100% stake in a Venezuelan subsidiary to house these assets and serve as the company's Latin American operating entity.
**Material Implications for Investors:** This transaction consolidates control of potentially valuable healthcare AI technology within the company and establishes operational infrastructure in Latin America, positioning the company to commercialize its AI healthcare solutions. However, investors should note that the CEO was the seller, raising potential concerns about related-party transaction valuation and pricing. The limited financial disclosure regarding acquisition consideration and the company's micro-cap status (no exchange listing) suggest higher risk and less transparency than typical public companies.
NWBO
OTC
▲ SUPER 8-K
NORTHWEST BIOTHERAPEUTICS INC
EDGAR Items: 2.01
# Northwest Biotherapeutics 8-K Summary
Northwest Biotherapeutics completed its acquisition of Advent BioServices Ltd., a UK-based contract manufacturing organization (CDMO) that had previously provided manufacturing and cryostorage services for the company's DCVax® product platform, on October 24, 2025. The total consideration includes approximately $1.9 million in purchase price plus $8.3 million in outstanding accounts payable owed to Advent for prior services, payable in installments over two years at 7.5% annual interest, with potential acceleration following regulatory approval of DCVax®-L. As part of the transaction, the company recovered 12 million treasury shares and 5.5 million options that had been previously issued to Advent as service compensation.
**Key Investor Implications:** This is a related-party transaction (the CEO is the seller's controlling member) that vertically integrates manufacturing capabilities into the company, potentially reducing costs and improving control over the critical manufacturing process for its lead therapeutic candidate. However, investors should note the modest valuation and the contingent payment structure tied to regulatory approval, which introduces execution risk.
VREOF
OTC
▲ SUPER 8-K
Vireo Growth Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,8.01,9.01
# Vireo Growth Inc. 8-K Summary
Vireo Growth Inc. completed its acquisition of Eaze Inc. on April 1, 2026, issuing approximately 90.4 million subordinate voting shares as merger consideration (valued at ~$47 million in base consideration). The transaction includes earnout provisions that could grant former Eaze shareholders additional shares based on achieving an imputed EBITDA target of $76.8 million by December 31, 2026, with share valuations ranging from $1.05 to higher market prices. Former Eaze stockholders face staggered lock-up restrictions releasing 20% of their shares quarterly beginning March 2027, designed to limit immediate share dilution and market pressure. The company also granted 3.5 million restricted stock units to certain Eaze employees as retention incentives, plus additional earnout-tied RSUs that vest upon determination of the final earnout amount.
For investors, this acquisition expands Vireo's cannabis operations but introduces significant dilution risk—earnout payments could potentially match the initial 90 million shares issued if EBITDA targets are met. The lock-up schedule and earnout mechanics create near-term catalysts (earnout determination in early 2027) while mitigating immediate share supply concerns.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,9.01
# SEC 8-K Summary: ProCap Financial, Inc.
**Material Event:** ProCap Financial, Inc. completed its acquisition of CFO Silvia, Inc. on April 6, 2026, following stockholder approval on March 27, 2026. The transaction was structured as a merger with CFO Silvia becoming a wholly-owned subsidiary.
**Deal Structure:** The acquisition consideration totaled approximately 7.5 million shares at closing (reduced from 8.1 million to account for liabilities), plus 900,000 escrow shares held for 12 months as indemnification security, and up to 9 million earnout shares contingent on the company's stock price reaching $9.00 per share during a five-year period.
**Key Terms for Investors:** The sellers are subject to lock-up restrictions until either six months post-closing or when the stock reaches $9.00 (whichever is later), and face a two-year restriction on participating in any stock repurchases. The earnout structure aligns seller interests with stock price performance, incentivizing operational success.
**Implications:** This acquisition expands ProCap Financial's capabilities in financial services. However, investors should note the significant dilution from approximately 16.4 million potential new shares (closing + escrow + earnout) and the relatively ambitious $9.00 earnout threshold, which will require substantial stock appreciation to achieve full value.
BMNM
OTC
▲ SUPER 8-K
BIMINI CAPITAL MANAGEMENT, INC.
EDGAR Items: 2.01,7.01,9.01
# Summary of Bimini Capital Management 8-K Filing
Bimini Capital Management completed its acquisition of 80% of Tom Johnson Investment Management LLC (TJIM) on April 1, 2026, for $12.3 million (2.5x 80% of TJIM's 2025 revenue), with $12 million paid in cash at closing and the remaining $318,492 due in one year with 5% interest. The seller, Richard's Trust, retained a 20% equity stake and has a put right to force Bimini to buy the remaining interest after three years (contingent on Richard's continued employment and TJIM achieving at least 30% EBITDA margins), while Bimini has a corresponding call right after three years.
**Key implications for investors:** This acquisition expands Bimini's asset management capabilities through a registered investment adviser, with management continuity ensured through new employment agreements for TJIM's team. However, the deferred payment structure and conditional put/call options on the remaining 20% stake create ongoing financial and operational contingencies that could affect future earnings and share dilution depending on TJIM's performance and Richard Parry's employment status.
March 2026
21 filings
▼
ORMP
NASDAQ
▲ SUPER 8-K
Oramed Pharmaceuticals Inc.
EDGAR Items: 1.01,2.01
# 8-K Filing Summary: Oramed Pharmaceuticals Inc.
**Filing Date:** March 31, 2026 | **Period:** March 25, 2026
This 8-K filing by Oramed Pharmaceuticals (CIK: 1176309) reports two material events: the **entry into a material definitive agreement** (Item 1.01) and the **completion of an acquisition or disposition of assets** (Item 2.01). While the HTML document provided does not contain the detailed substance of these agreements, the dual reporting of both execution and completion suggests the company has finalized a significant corporate transaction.
**For investors:** This filing indicates Oramed has undertaken a major strategic action—either acquiring assets/a business or divesting operations. Shareholders should review the full 8-K document (available via the iXBRL link) to understand the financial terms, strategic rationale, and potential impact on the company's operations and financial position. The materiality of this transaction warrants careful analysis of how it affects Oramed's pipeline, cash position, and future earnings potential.
CYAB
NASDAQ
▲ SUPER 8-K
Cyabra, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# SEC 8-K Filing Summary: Cyabra, Inc.
**Filing Date:** March 31, 2026 | **Period:** March 26, 2026
This 8-K filing indicates **substantial corporate restructuring** at Cyabra, Inc., with the company reporting multiple material events including a change in control, acquisition/disposition of assets, creation of financial obligations, and issuance of convertible preferred stock (Series A, B, and C). The filing also documents changes in certifying accountants, modifications to articles of incorporation, and transition from shell company status.
**Key Material Events:** The company entered into material definitive agreements, completed asset transactions, and made unregistered equity sales while modifying security holder rights. Additionally, there were changes in the registrant's certifying accountant and directorate/officer composition, suggesting significant governance restructuring.
**Investor Implications:** This filing signals a major corporate transformation with potential dilution from new convertible preferred stock issuances and new debt obligations. The multiple simultaneous changes—including control shift, accounting firm replacement, and shell status transition—warrant careful review of the detailed 8-K document to understand valuation impact and new ownership structure, as such comprehensive restructuring can significantly affect existing shareholders' interests and future company direction.
MFON
OTC
▲ SUPER 8-K
MOBIVITY HOLDINGS CORP.
EDGAR Items: 2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary
Based on this March 31, 2026 8-K filing, the company reported several material events: **completion of an acquisition or disposition of assets** (Item 2.01), **unregistered sales of equity securities** (Item 3.02), and **amendments to articles of incorporation or bylaws** (Item 5.03). These concurrent items suggest the company completed a significant corporate transaction, likely financed through equity issuance and involving structural changes to the organization. The filing includes amended governance documents and XBRL financial data, indicating a substantial capital event. Investors should review the full 8-K document to understand the acquisition details, the terms and scope of equity dilution, and any strategic implications for the company's future direction.
CRCW
OTC
▲ SUPER 8-K
Crypto Co
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** March 26, 2026 | **Period:** March 23, 2026
This 8-K filing indicates the company (CIK 1688126) has completed **material transactions** including entry into a definitive agreement, completion of an acquisition/disposition of assets, and an unregistered equity issuance. The filing includes two substantive exhibit agreements (EX-10.1 and EX-10.2) and supplemental disclosure materials, suggesting a significant corporate restructuring or M&A event occurred on or around March 23, 2026.
**Key Items Reported:**
- Material definitive agreement executed
- Asset acquisition or disposition completed
- Unregistered securities issued
- Regulation FD disclosure provided
**Investor Implications:** This appears to be a substantial transaction that could materially affect the company's capital structure, operations, or strategic direction. Investors should review the full filing and attached agreements (EX-10.1 and EX-10.2) to understand deal terms, financing structure, dilution from equity issuance, and any material risks or contingencies affecting the company's future performance and valuation.
ATLN
NASDAQ
▲ SUPER 8-K
Atlantic International Corp. Common Stock
EDGAR Items: 1.01,2.01,5.03,9.01
# SEC 8-K Filing Summary: Atlantic Interest, Inc.
**Filing Date:** March 26, 2026 | **Period:** March 20, 2026
Atlantic Interest, Inc. completed a material securities transaction on March 20, 2026, involving the entry into a definitive securities purchase agreement and the issuance of Series B preferred stock with associated warrants. The company also amended its articles of incorporation to establish the new preferred stock class with specific designations, preferences, and rights. This transaction represents a significant capital-raising event that will dilute existing shareholders' ownership stakes and potentially introduce new governance considerations through the preferred stock structure. Investors should review the Securities Purchase Agreement and Certificate of Designations to understand the terms, liquidation preferences, voting rights, and warrant exercise prices, as these preferred securities typically have priority over common equity in liquidation scenarios.
VREOF
OTC
▲ SUPER 8-K
Vireo Growth Inc.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Summary
Based on this March 25, 2026 filing, the company has completed a **material acquisition or disposition of assets** and entered into **significant definitive agreements**, with associated financial obligations. The 8-K encompasses multiple acquisition-related exhibits (including purchase agreements and supplemental documents) along with new debt or financial arrangements, suggesting a substantial corporate transaction. The extensive documentation (19 files including large exhibit files exceeding 600KB) indicates this is a complex, multi-party deal rather than a simple asset purchase. For investors, this represents a significant strategic shift that could materially impact the company's financial position, capital structure, and operational focus—requiring careful review of the full agreement details to assess integration risks, financing impact, and strategic rationale.
CDLX
NASDAQ
▲ SUPER 8-K
Cardlytics, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Cardlytics Inc. (CDLX) filed an 8-K on March 24, 2026, reporting the completion of an acquisition or disposition of assets.
**Material Event:** The company completed a significant acquisition or asset transaction, as indicated by Item 2.01. The filing includes unaudited pro forma financial statements (Exhibit 99.1), suggesting the transaction will have material impacts on the company's financial position and results going forward.
**Key Implications for Investors:** This acquisition could represent a strategic expansion of Cardlytics' business operations or a significant capital deployment. The pro forma financials should help investors understand the combined entity's projected financial metrics. Investors should review the full 8-K details and pro forma statements to assess the acquisition's terms, integration risks, and potential impact on earnings, debt levels, and growth prospects.
GRUSF
OTC
▲ SUPER 8-K
Grown Rogue International Inc.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary
**Company:** GrubHub Inc. (Accession No. 0001279569-26-000221)
**Filing Date:** March 18, 2026 | **Period of Report:** March 9, 2026
## Key Material Events:
The 8-K discloses multiple significant corporate actions: (1) **entry into a material definitive agreement** (Item 1.01), (2) **completion of an acquisition or asset disposition** (Item 2.01), and (3) **creation of a direct financial obligation** (Item 2.03). These items collectively indicate the company has completed a major M&A transaction and taken on new debt financing.
## Investor Implications:
Without access to the full document text, the specific nature of the acquisition target and financing terms cannot be determined; however, investors should review the detailed 8-K filing and accompanying news release (dated March 12, 2026) to assess strategic rationale, financial impact, debt-to-equity implications, and whether this represents an accretive or dilutive transaction. The combined filing of acquisition completion with new financial obligations suggests meaningful capital structure changes requiring careful analysis of synergy potential and integration risks.
NXTS
NASDAQ
▲ SUPER 8-K
Nexentis Technologies Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary - March 17, 2026
**Company:** Nexts (CIK: 1789192)
**Key Event:** The company completed an acquisition or disposition of assets as of March 15, 2026 (Item 2.01). The filing provides the formal notification of this transaction's completion, though the specific details of the assets involved and financial terms are contained in the full 8-K document.
**What This Means for Investors:** Material M&A activity has been completed, which could represent a strategic shift in the company's operations, asset base, or market positioning. Investors should review the full 8-K filing to understand the nature of the acquired/divested assets, the purchase price, financing structure, and expected impact on future earnings and business strategy. The completion of this transaction may affect revenue streams, profitability, and the company's competitive positioning in its industry.
TRNR
NASDAQ
▲ SUPER 8-K
Interactive Strength Inc. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this March 16, 2026 8-K filing, the company completed a significant acquisition or disposition of assets (Item 2.01) and also conducted an unregistered sale of equity securities (Item 3.02) as of March 11, 2026. The filing indicates material corporate activity involving both asset transactions and equity issuance, though the specific details of the transaction, valuation, and terms would require reviewing the full document. For investors, this suggests strategic repositioning through M&A activity, though the unregistered equity sale indicates potential dilution to existing shareholders. **To fully assess the investment impact, investors should review the complete 8-K document to understand the transaction details, financing structure, and management's strategic rationale.**
PFSA
NASDAQ
▲ SUPER 8-K
Profusa, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,9.01
# SEC 8-K Filing Summary - ProFUSA Inc. (March 13, 2026)
ProFUSA Inc. reported three material events: **(1) Termination of a Material Definitive Agreement** - the company terminated an Account Control Agreement with Ascent Partners on March 12, 2026; **(2) Completion of Acquisition or Disposition of Assets** - indicating the company has divested or completed a significant asset transaction; and **(3) Delisting Notice** - the company faces potential delisting or transfer of its listing status, suggesting compliance issues with continued listing standards.
**For investors:** These combined events signal potential financial distress or a major strategic restructuring. The loss of the control agreement with Ascent Partners, coupled with asset dispositions and delisting concerns, suggests the company may be addressing liquidity challenges or undergoing a significant business transition. Investors should review the full filing details to understand the implications for ownership and shareholder value.
IDAI
NASDAQ
▲ SUPER 8-K
T Stamp Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
Based on this March 12, 2026 8-K filing (for events occurring March 6, 2026), the company has announced **multiple material events**: completion of an acquisition or disposition of assets, entry into a material definitive agreement, and officer/director changes with new compensatory arrangements. The filing includes a share purchase agreement, shareholder agreement, and consulting agreement as exhibits, indicating a significant M&A transaction has closed.
**Key implications for investors**: This represents a potentially transformative corporate event—likely an acquisition or major asset sale—that may alter the company's business structure, financial profile, and management. Investors should review the full agreements (Exhibits 10.1-10.3) and disclosure documents to understand deal terms, consideration paid, and any new strategic direction or leadership changes that could impact future performance and shareholder value.
GRML
NASDAQ
▲ SUPER 8-K
Greenland Mines Ltd. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary: Klotho (CIK: 1907223)
**Filing Date:** March 10, 2026 | **Period:** March 4, 2026
## Key Material Events:
Klotho announced multiple significant corporate transactions including: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) unregistered equity issuance, and (4) amendments to articles of incorporation. The filing includes an Agreement and Plan of Merger and a Subscription, Joint Venture and Option Agreement, along with a new Series C Preferred Stock designation.
## Investor Implications:
These concurrent filings suggest Klotho is undergoing a major strategic restructuring involving merger activity, new equity issuance, and joint venture arrangements. The combination of structural changes and equity dilution (unregistered securities) warrants careful review of the merger terms and new capital structure to assess valuation impact and ownership dilution. Investors should review the detailed merger agreement and subscription documents to understand the financial terms and strategic rationale.
IVFH
OTC
▲ SUPER 8-K
INNOVATIVE FOOD HOLDINGS INC
EDGAR Items: 2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on March 9, 2026, by a company (CIK 312257) reporting a material event from March 6, 2026.
**Material Event - Item 2.01: Completion of Acquisition or Disposition of Assets**
The company completed an acquisition or disposition of assets, representing a significant corporate transaction. While the specific details of the assets, valuation, and counterparty are not visible in this document header, this is a material event that required immediate disclosure to shareholders.
**Investor Implications:**
This acquisition/disposition could materially impact the company's financial position, operational structure, and future earnings potential. Investors should review the full 8-K filing document (available via the linked iXBRL file) to understand the transaction's financial terms, strategic rationale, and potential effects on shareholder value. The timing and nature of such transactions often influence stock price movements and warrant careful analysis.
HWNI
OTC
▲ SUPER 8-K
HIGH WIRE NETWORKS, INC.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** HighWire (CIK: 1413891) filed an 8-K on March 6, 2026, reporting material corporate events as of March 3, 2026.
**Key Material Events:**
The filing discloses a **change in control of the company** along with a **material acquisition/disposition of assets** and an associated **securities exchange agreement**. Additionally, there was a **global settlement and mutual release agreement** executed, and changes in the company's board or officer compensation arrangements occurred.
**Investor Implications:**
This combination of items—particularly the change of control, asset transaction, and settlement agreement—suggests HighWire underwent a significant corporate restructuring or merger/acquisition that may substantially alter its business operations, ownership structure, and strategic direction. Investors should carefully review the full filing documents, especially the Securities Exchange Agreement and Settlement Agreement exhibits, to understand the transaction terms, dilution impacts, and any contingent liabilities resolved. The management changes disclosed could also signal shifts in company strategy or leadership priorities.
CAMP
NASDAQ
▲ SUPER 8-K
CAMP4 Therapeutics Corporation Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
Based on this March 5, 2026 8-K filing, **the company completed an acquisition or disposition of assets** (Item 2.01), which represents a material corporate event. The filing includes supplemental disclosures (Item 7.01) and financial statements/exhibits documenting the transaction details across 36 supporting documents.
**For investors, this signals a strategic business development**, though the specific nature, size, and financial impact of the acquisition/disposition cannot be determined from this filing summary alone—these details would be found in the actual 8-K document and exhibits. Investors should review the full filing to understand how this transaction affects the company's future growth prospects, financial position, and strategic direction.
IDAI
NASDAQ
▲ SUPER 8-K
T Stamp Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This 8-K was filed on March 5, 2026 (for the period ending February 27, 2026) by a company with CIK 1718939, covering three material items.
**Key Material Events:** The filing discloses two significant corporate actions: (1) entry into a material definitive agreement (Item 1.01), and (2) completion of an acquisition or disposition of assets (Item 2.01). The specific terms and details are contained in Exhibit 10.1, which appears to be a substantial agreement document.
**Investor Implications:** The simultaneous reporting of both a new material agreement and a completed acquisition suggests the company has engaged in significant M&A activity or strategic business restructuring. Investors should review the full agreement in Exhibit 10.1 to understand the financial impact, any potential dilution, debt obligations, or changes to the company's business operations that could affect future earnings and shareholder value.
IVHI
OTC
▲ SUPER 8-K
Invech Holdings, Inc.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**InVivo Technologies** filed an 8-K on March 4, 2026, reporting two material events: (1) entry into a material definitive agreement and (2) completion of an acquisition or disposition of assets. The filing includes an Asset Purchase Agreement and a Convertible Promissory Note as key exhibits, indicating the company has either acquired or divested significant assets and secured financing through a convertible debt instrument. Without access to the detailed agreement text, the specific transaction terms, valuation, and strategic rationale remain unclear, but investors should note that convertible debt can dilute existing shareholders upon conversion. This appears to be a significant corporate transaction that could materially impact the company's capital structure, financial position, and strategic direction, warranting careful review of the complete filing documents.
HAIN
NASDAQ
▲ SUPER 8-K
Hain Celestial Group Inc
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary: The Hain Celestial Group (March 4, 2026)
The Hain Celestial Group completed a significant acquisition or disposition of assets as of March 2, 2026, which is the primary material event disclosed in this Form 8-K filing. The filing includes Item 2.01 (Completion of Acquisition or Disposition of Assets), supplemented by Regulation FD disclosures and financial statements, though specific transaction details are not visible in this cover page excerpt. Investors should review the full 8-K document (hain-20260227.htm) and attached exhibits to understand the transaction's financial impact, purchase price, strategic rationale, and any pro forma financial effects on The Hain Celestial Group's future earnings and balance sheet.
KSCP
NASDAQ
▲ SUPER 8-K
Knightscope, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** This 8-K was filed on March 3, 2026, by a company (CIK 1600983) reporting material events as of February 27, 2026.
**Material Events:**
The filing indicates multiple significant corporate actions including:
- **Entry into a Material Definitive Agreement** (Item 1.01)
- **Completion of an Acquisition or Disposition of Assets** (Item 2.01)
- **Unregistered Sales of Equity Securities** (Item 3.02)
**Key Implications for Investors:**
This 8-K signals that the company has completed a significant M&A transaction and issued equity securities, likely as part of the deal consideration. The combination of acquisition completion and equity issuance suggests potential dilution to existing shareholders. Investors should review the detailed agreement (Exhibit 2.1) and press release (Exhibit 99.1) to understand the transaction terms, valuation, and strategic rationale. The unregistered equity sale raises questions about the shareholder base composition changes and any lock-up periods on new securities.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 2.01,9.01
# 8-K Summary
Based on this SEC filing from February 27, 2026, the company (CIK 2076163) completed an acquisition or disposition of assets, which is the material event disclosed in this Form 8-K. The filing indicates Item 2.01 was triggered, signaling a significant corporate transaction. However, the specific details of the acquisition—including the target company, transaction value, and strategic rationale—are contained in the full form8-k.htm document referenced in this index.
**For investors:** This represents a material corporate action that could affect the company's capital structure, operational scope, and financial performance. Without access to the detailed disclosure, investors should review the complete 8-K filing to understand the transaction's size, financing, expected synergies, and impact on earnings and guidance. Such transactions typically warrant portfolio review to assess alignment with investment thesis.
February 2026
18 filings
▼
CCTC
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.06,9.01
# SEC 8-K Filing Summary
This 8-K filing from February 25, 2026 (for period ending February 17, 2026) reports multiple material corporate events for the company (ticker: CCTC). The filing indicates a significant **acquisition or asset purchase transaction**, evidenced by Items 1.01 (material agreement), 2.01 (asset completion), and 3.02 (equity issuance), along with a **change in control of the registrant** (Item 5.01). Additionally, the company underwent a **shell company status change** (Item 5.06) and experienced **management changes** with departures/appointments of directors and officers (Item 5.02), suggesting a potential reverse merger or transformational business combination.
**For investors:** This represents a major structural shift for the company. The combination of control change, asset acquisition completion, equity issuance, and shell company status change suggests the company either emerged from shell status or underwent significant recapitalization. The accompanying intellectual property and asset purchase agreements indicate the transaction involves material business operations. Investors should review the full 8-K and attached agreements to understand valuation, dilution, and how the new business aligns with their investment thesis.
PTIX
OTC
▲ SUPER 8-K
Protagenic Therapeutics, Inc.\new
EDGAR Items: 1.01,1.02,2.01,3.02,8.01,9.01
I appreciate your request, but I'm unable to provide a meaningful summary of this 8-K filing based on the HTML provided. The document shown is only the **filing index page** from the SEC's EDGAR system, which displays metadata (filing date, accession number, item categories) but not the actual content of the filing.
To summarize this 8-K properly, I would need access to the actual filing document itself (form8-k.htm or the exhibits). The index indicates this filing covers several significant items including:
- **Item 1.01 & 1.02**: Entry into and termination of material agreements
- **Item 2.01**: Completion of acquisition/disposition of assets
- **Item 3.02**: Unregistered equity sales
- **Item 8.01**: Other events
**What I can tell you:** This is a material filing with multiple significant corporate actions (acquisitions, agreements, equity issuance) filed on February 24, 2026, but the specific details, dollar amounts, and investor implications require reviewing the actual filing documents.
**Recommendation:** Click the "form8-k.htm" link in the document table to view the full filing content, and I'd be happy to summarize it then.
IVF
NASDAQ
▲ SUPER 8-K
INVO Fertility, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,8.01,9.01
# 8-K Filing Summary
Based on this SEC 8-K filing dated February 24, 2026, the company has disclosed several material events:
**Key Changes & Events:**
The filing indicates completion of a significant acquisition or disposition of assets (Item 2.01), entry into material definitive agreements (Item 1.01), and unregistered equity issuances (Item 3.02). Additionally, the company amended its articles of incorporation or bylaws (Item 5.03), suggesting potential structural or governance changes.
**Investor Implications:**
This multi-item filing signals a major corporate transaction—likely an acquisition, merger, or substantial asset sale—coupled with equity dilution from unregistered securities issuance. The amendments to corporate governance documents indicate this transaction may have reshaped the company's capital structure or ownership composition. Investors should review the attached exhibits (particularly EX-10.1 through EX-10.4, which contain the definitive agreements) to understand deal terms, financing structure, and potential impacts on earnings and shareholder value.
CRDF
NASDAQ
▲ SUPER 8-K
Cardiff Oncology, Inc. Common Stock
EDGAR Items: 2.01,9.01
# 8-K Filing Summary - CardioFlow Inc. (CIK: 1213037)
**Filing Date:** February 24, 2026
This 8-K filing reports the **completion of an acquisition or disposition of assets** (Item 2.01), indicating CardioFlow has either acquired or divested a significant business asset or subsidiary. The filing includes supplementary financial statements and exhibits (Item 9.01) to detail the transaction's terms and financial impact.
**Key Implications for Investors:**
- The completion of this M&A transaction represents a material corporate restructuring that could alter the company's business profile, revenue streams, and growth trajectory
- Investors should review the full 8-K document and attached exhibits to understand acquisition/divestiture details, purchase price, financing terms, and any associated risks or synergies
- Depending on whether this was an acquisition (expanding operations) or divestiture (streamlining operations), this could signal management's strategic direction and capital allocation priorities
Without access to the detailed filing content, investors should examine the exhibits closely to assess the transaction's financial materiality and strategic rationale.
SEGG
NASDAQ
▲ SUPER 8-K
Sports Entertainment Gaming Global Corporation Common Stock
EDGAR Items: 1.01,2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on February 23, 2026 (CIK: 1673481) for the period ending February 17, 2026, covering two material events.
**Key Material Events:**
The filing reports two significant corporate actions: (1) **Entry into a Material Definitive Agreement** (Item 1.01) and (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01). These dual disclosures suggest the company has both signed a major deal and already closed a transaction involving asset acquisition or divestiture.
**Investor Implications:**
Without access to the full document content, the specific details cannot be determined from this index page alone. However, the concurrent reporting of both a new agreement and a completed transaction suggests active M&A activity. Investors should review the complete 8-K filing (form8-k.htm) to understand: the nature of the transaction, financial impact, strategic rationale, and any contingent obligations or risks that could affect shareholder value.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This is an 8-K filing from GIPR (CIK: 1651721) filed on February 23, 2026, reporting on a material event from May 29, 2025.
**Material Event:**
The filing reports the completion of an acquisition or disposition of assets (Item 2.01), with 19 supporting documents including purchase agreements and related transaction documents attached as exhibits.
**Key Implications for Investors:**
Without access to the actual filing content, the completion of this acquisition represents a significant corporate action that likely involves strategic repositioning, potential changes to the company's asset base, revenue streams, or business operations. Investors should review the detailed exhibits (particularly EX-10.1 and EX-10.2, which appear to be substantial transaction documents) to understand the deal terms, valuation, financing structure, and expected impacts on future financial performance and shareholder value.
AETN
OTC
▲ SUPER 8-K
AETERNUM HEALTH, INC.
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,9.01
# SEC 8-K Filing Summary
**Filing:** Form 8-K for company CIK 764630, filed February 23, 2026
**Material Events:**
This filing reports several significant corporate actions: (1) completion of an acquisition or disposition of assets, (2) unregistered sales of equity securities, (3) a change in control of the registrant, (4) changes in the company's board and officer compensation arrangements, and (5) amendments to the company's articles of incorporation or bylaws.
**Key Implications for Investors:**
The combination of these items—particularly the change in control, asset acquisition/disposition, and equity issuance—indicates a major corporate restructuring or M&A transaction. The unregistered equity sales and board changes suggest new ownership/management post-transaction. Investors should review the attached acquisition agreement (EX-2.1) and detailed 8-K filing to understand the transaction terms, deal structure, and potential impacts on share value and control.
**Recommendation:** Review the complete filing documents (form8-k.htm and merger agreement) for full details on pricing, dilution, and governance implications.
NGTF
OTC
▲ SUPER 8-K
NightFood Holdings, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Form 8-K filed on February 19, 2026 (Period of Report: February 17, 2026) by CIK 1593001.
**Material Events:**
The filing discloses four significant items: (1) Entry into a Material Definitive Agreement, (2) Completion of an Acquisition or Disposition of Assets, (3) Regulation FD Disclosure, and (4) Financial Statements and Exhibits. The company has completed a material transaction and entered into binding contractual obligations, as evidenced by three substantial exhibits (EX-10.1, EX-10.2, and EX-10.3).
**Key Takeaway for Investors:**
This 8-K indicates a major corporate event—likely a merger, acquisition, or significant asset sale—that has been completed as of February 17, 2026. Investors should review the detailed exhibits and the full 8-K document to understand the transaction's financial impact, terms, and strategic rationale. The size and complexity of the filing (17 documents with multiple substantial contracts) suggests this is a significant development that could materially affect the company's future performance and investor returns.
ALBT
NASDAQ
▲ SUPER 8-K
Avalon GloboCare Corp. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Avalon Holdings Corporation
**Filing Date:** February 19, 2026 | **Period:** February 18, 2026
Avalon Holdings Corporation completed a material acquisition and entered into a definitive agreement on February 18, 2026, as detailed in this 8-K filing. The company amended an unsecured bridge note dated December 11, 2025, and executed an amended and restated membership interest purchase agreement, indicating refinancing or restructuring of the transaction financing.
**Key Implications for Investors:** This filing suggests Avalon is actively pursuing growth through acquisition while managing debt obligations. The amendment to the bridge note may indicate negotiated changes to financing terms, which could affect the company's capital structure and debt burden. Investors should review the complete purchase agreement and note amendment documents to understand deal terms, valuation, expected synergies, and any impact on near-term financial performance or shareholder equity.
AQMS
NASDAQ
▲ SUPER 8-K
Aqua Metals, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on February 11, 2026, by Aquamarine Technologies (CIK: 1621832), reporting events as of February 6, 2026.
**Material Events:**
The filing discloses two significant corporate actions: (1) **Entry into a Material Definitive Agreement** (Item 1.01) and (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01). The company has also attached substantive exhibits including an agreement document and underwriting-related materials, suggesting either a significant acquisition, divestiture, or financing transaction.
**Investor Implications:**
Without access to the full document text, the specific nature of the transaction cannot be determined from the filing structure alone. However, the presence of both a definitive agreement and completion disclosure indicates this was an already-executed material transaction. Investors should review the full 8-K document and attached exhibits (particularly Exhibits 1.1 and 10.1) to understand the financial impact, terms, and strategic rationale for this transaction, as it could materially affect the company's financial position and future prospects.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the filing metadata dated February 11, 2026, this 8-K reports the **completion of an acquisition or disposition of assets** (Item 2.01), with the transaction period ending February 5, 2026. The filing includes a purchase agreement (EX-2.1), related agreements (EX-10.1), and a press release (EX-99.1), though the specific details of the deal are not visible in this document index.
**Key implications for investors:** This material transaction signals a significant strategic shift for the company. Investors should review the complete agreement and press release to understand the acquisition target/divested asset, purchase price, financing structure, and management's rationale. The deal's impact on future earnings, debt levels, and company direction will be critical to assessing whether this creates or destroys shareholder value.
LRHC
NASDAQ
▲ SUPER 8-K
La Rosa Holding Corp. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**LaRosa Holdings Corp.** filed an 8-K on February 10, 2026, announcing a material acquisition and establishment of licensing agreements. The company entered into a Membership Interest Purchase Agreement to acquire assets from Horeb Kissimmee Realty and simultaneously established a Trademark and Brand Licensing Agreement with the same party, indicating a strategic expansion of the LaRosa brand.
**Key implications for investors:** This acquisition suggests the company is pursuing growth through asset purchases and brand extension, though the specific financial terms and strategic rationale would require review of the actual agreement documents. The timing and structure—pairing an asset acquisition with a licensing agreement—suggests a phased or partnership-based expansion strategy rather than a full integration.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this February 9, 2026 8-K filing, the company disclosed **multiple significant corporate events**, including the completion of an acquisition or disposition of assets, entry into material definitive agreements, unregistered equity issuances, and management/compensation changes. The filing contains seven key disclosure items with substantial supporting documentation (24 total exhibits), including a merger/acquisition agreement (EX-2.1) and several material contracts (EX-10.1 through EX-10.6).
**Key implications for investors:** This is a comprehensive transaction announcement affecting the company's capital structure, leadership, and strategic direction. The mix of items—particularly the acquisition completion, equity issuances, and officer compensation arrangements—suggests a transformative deal. Investors should review the detailed agreements (especially the purchase agreement and employment/compensation contracts in the exhibits) to understand valuation, earnout provisions, dilution impact, and new management incentives, as these will directly affect shareholder value and future company direction.
CWGL
OTC
▲ SUPER 8-K
Crimson Wine Group, Ltd
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Crimson Wine Group (CWGL) filed an 8-K on February 9, 2026, reporting a significant corporate transaction.
**Material Events:**
The filing discloses the completion of an acquisition or disposition of assets (Item 2.01) and entry into a material definitive agreement (Item 1.01), with a press release included as Regulation FD Disclosure (Item 7.01). The specific details appear to involve "Crimson Wine Extra" based on the exhibit filenames, suggesting the company has either acquired or divested a wine-related asset or business line.
**Investor Implications:**
Without access to the actual filing content, the full impact cannot be assessed, but the multiple items filed indicate this is a substantial transaction that could affect the company's operational scope, financial position, or strategic direction. Investors should review the complete 8-K and press release (Exhibit 99.1) to understand the transaction structure, financial terms, and management's rationale for the deal.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Summary: PMGC Holdings Inc. - Acquisition Completion
**Filing Details:** PMGC Holdings Inc. filed an 8-K on February 6, 2026, reporting the completion of an acquisition of assets as of February 2, 2026.
**Material Event:** The company completed the acquisition of SVM Machining, Inc., as evidenced by the executed Stock Purchase Agreement dated February 2, 2026. The filing includes audited combined financial statements for SVM Machining and unaudited pro forma condensed combined financial statements showing the integrated entity's financial position post-acquisition.
**Key Implications for Investors:** This acquisition marks a significant expansion of PMGC Holdings' operations into the machining sector. The inclusion of pro forma financial statements suggests material changes to the company's balance sheet and operating profile. Investors should review the detailed purchase agreement and pro forma financials to understand the acquisition cost, integration strategy, and expected earnings impact, as well as any financing arrangements or contingent obligations related to the transaction.
MSS
NASDAQ
▲ SUPER 8-K
Maison Solutions Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Maison Solutions, Inc.
**Filing Date:** February 4, 2026 | **Period:** January 31, 2026
Maison Solutions, Inc. reported the entry into a material definitive agreement and completion of an acquisition or disposition of assets as of January 31, 2026. The company executed a Buy-Sell Agreement on this date, indicating a significant corporate transaction. The filing includes the full agreement text and supporting documentation, though the specific financial terms and counterparty details require review of the actual agreement document.
**For Investors:** This filing signals a material corporate event that could substantially impact the company's operations, financial position, or strategic direction. Investors should review the complete Buy-Sell Agreement (available in the filing) to understand the transaction's scope, financial implications, earn-out provisions (if any), and how it aligns with the company's growth strategy. The nature of this agreement—whether it represents an acquisition, divestiture, or partnership—will be critical in assessing the investment implications.
MVIS
NASDAQ
▲ SUPER 8-K
Microvision Inc
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: MVIS (February 3, 2026)
**Material Event:** MicroVision (MVIS) announced the completion of an acquisition or disposition of assets on February 3, 2026, as disclosed in Item 2.01 of this 8-K filing.
**Key Details:** The filing itself does not provide the specific details of the transaction in this preview, but the company has officially completed a significant asset transaction that warrants SEC disclosure as a material event.
**Investor Implications:** This acquisition or asset sale could represent a strategic shift for the company, potentially affecting its business operations, financial position, and future revenue streams. Investors should review the full 8-K document (form8-k.htm) to understand the transaction terms, whether it expands or contracts the company's operations, the financial impact, and management's strategic rationale for the move.
NTRP
NASDAQ
▲ SUPER 8-K
NextTrip, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Entered into a Material Definitive Agreement (Item 1.01), completed an Acquisition or Disposition of Assets (Item 2.01), and conducted an Unregistered Sale of Equity Securities (Item 3.02) on February 3, 2026.
**Key Changes:** The filing indicates a significant corporate transaction involving acquisition activity, asset changes, and equity issuance. The company issued unregistered securities as part of the transaction structure, suggesting deal consideration may have included stock.
**Material Events:** This represents a substantive M&A event with multiple components—a definitive agreement, asset acquisition completion, and equity financing. The substantial size of the attached agreement (800+ KB) and the inclusion of multiple exhibits indicate this is a material transaction requiring comprehensive disclosure.
**Investor Implications:** Investors should review the full 8-K filing and exhibits to assess the acquisition's strategic rationale, financial impact, and whether it creates dilution concerns. The unregistered equity issuance requires careful analysis of the terms and potential future registration requirements. This transaction could materially alter the company's capital structure and operational profile.
January 2026
16 filings
▼
LAB
NASDAQ
▲ SUPER 8-K
Standard BioTools Inc. Common Stock
EDGAR Items: 2.01,2.02,7.01,9.01
# SEC 8-K Filing Summary
**Company:** (CIK 1162194) filed an 8-K on January 30, 2026
**Key Material Events:**
- **Completion of Acquisition:** The company completed an acquisition or disposition of assets (Item 2.01)
- **Operational Results:** Filed operational and financial condition results (Item 2.02)
- **Additional Disclosures:** Includes Regulation FD disclosure and financial statements/exhibits (Items 7.01 and 9.01)
**Investor Implications:**
This filing signals a completed M&A transaction that materially affects the company's asset base and operating structure. The inclusion of updated financial condition results suggests investors should review the specific transaction details and pro forma financials to understand the deal's financial impact on earnings, cash flow, and balance sheet composition. The timing and nature of this acquisition could significantly influence future growth prospects and shareholder value.
**Recommendation:** Investors should review the detailed 8-K filing and Exhibit 99.1 for complete transaction terms, purchase price, financing details, and management's forward guidance regarding the acquisition's strategic rationale and expected synergies.
HCTI
NASDAQ
▲ SUPER 8-K
Healthcare Triangle, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** Healthcare company (CIK 1839285) filed an 8-K on January 28, 2026, reporting material events from January 22, 2026.
**Key Material Events:**
The company entered into a material definitive agreement (Share Purchase Agreement dated January 22, 2026) and completed an acquisition or disposition of assets. The filing also includes an unregistered sale of equity securities and regulatory disclosure information.
**What Changed:**
This 8-K reports a significant M&A transaction with associated equity issuance, indicating the company has either acquired or divested a substantial business asset and raised capital through equity offerings.
**Investor Implications:**
Investors should review the Share Purchase Agreement and press release (included as exhibits) to understand the acquisition/disposition terms, valuation, financing structure, and strategic rationale. The unregistered equity sale suggests potential dilution to existing shareholders, while the transaction could impact future revenue, earnings, and the company's capital structure depending on the nature and size of the deal.
ATLN
NASDAQ
▲ SUPER 8-K
Atlantic International Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,8.01,9.01
# SEC 8-K Filing Summary: Atlantic International
**Company:** Atlantic International (CIK: 1605888)
**Filing Date:** January 28, 2026
**Period of Report:** January 22, 2026
## Key Material Events:
Atlantic International has disclosed a significant acquisition transaction completed on January 22, 2026, along with material financing and executive compensation arrangements. The filing indicates the company entered into a definitive acquisition agreement, created new financial obligations through a convertible promissory note issued on January 23, 2026, and completed unregistered equity sales. Additionally, the company made changes to its board and executive officer compensation structure, including new employment agreements and amendments to existing executive arrangements.
## Investment Implications:
The multiple concurrent actions—particularly the combination of debt financing via convertible notes, equity issuances, and executive hiring/restructuring—suggest Atlantic International is executing a significant strategic expansion or pivot. Investors should carefully review the acquisition agreement and convertible note terms to assess dilution risk, debt burden, and whether the new leadership appointments align with long-term value creation. The unregistered equity sales and executive compensation details will be critical to evaluating whether insider interests are properly aligned with shareholder interests.
SONM
NASDAQ
▲ SUPER 8-K
DNA X, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from January 27, 2026 (for period ending January 23, 2026) reports multiple material corporate events for the filing company. The filing includes significant items covering entry into and termination of material agreements, completion of an asset acquisition or disposition, amendments to corporate governance documents, and regulatory disclosures. The breadth of items disclosed—particularly the combination of new agreements, terminations, and acquisition completion—suggests substantial strategic restructuring or a major corporate transaction. Investors should review the detailed exhibits, especially the material definitive agreement (EX-2.1) and amended bylaws (EX-3.1), to understand the full scope and financial impact of these changes on the company's operations and capital structure.
OSRH
NASDAQ
▲ SUPER 8-K
OSR Health, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# 8-K Summary: OSR Holdings - Woori IO Acquisition Completion
**Material Event:** OSR Holdings completed its acquisition of Woori IO on January 26, 2026, as reported in this 8-K filing dated January 27, 2026. The filing includes Item 2.01 (Completion of Acquisition), Item 7.01 (Regulation FD Disclosure), and a press release detailing the transaction completion.
**Key Implications for Investors:** The completed acquisition represents a significant corporate action that may impact OSR Holdings' capital structure, operational scope, and financial position going forward. Investors should review the full press release and accompanying documents to understand the acquisition terms, financing method, and expected synergies or strategic benefits. This merger activity could affect future earnings, debt levels, and the company's competitive positioning in its market.
AGEN
NASDAQ
▲ SUPER 8-K
Agenus Inc.
EDGAR Items: 2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary - AGEN (Accession No. 0001193125-26-014678)
**Filing Date:** January 16, 2026 (Period: January 15, 2026)
This 8-K filing reports the completion of an acquisition or disposition of assets (Item 2.01), along with an unregistered sale of equity securities (Item 3.02). The company has disclosed additional financial and operational details through regulatory filings (Items 7.01 and 9.01), with supporting documentation including financial statements and exhibits attached.
**Key Implications for Investors:**
The completion of this acquisition signals a material corporate event that could impact the company's capital structure, operational scope, and financial performance. The concurrent unregistered equity issuance suggests the deal may have been funded, at least partially, through stock consideration. Investors should review the detailed exhibits and financial statements to understand the transaction's size, terms, and potential dilution to existing shareholders. This transaction could represent either a strategic growth opportunity or a significant capital allocation decision with material consequences for shareholder value.
HGBL
NASDAQ
▲ SUPER 8-K
HERITAGE GLOBAL INC
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of SEC 8-K Filing (January 12, 2026)
Based on this 8-K filing by Hecla Mining Company (ticker: HGBL), the company entered into a material definitive agreement and completed an acquisition or disposition of assets as of January 9, 2026. The filing includes multiple exhibits (two substantial agreements and supplemental disclosures), indicating a significant transaction, though the specific details of the deal are contained in the linked documents. The company has also made additional regulatory filings disclosures under Regulation FD.
For investors, this represents a potentially material corporate action that could affect Hecla's operational scope, financial position, or strategic direction—details about whether this represents an accretive or dilutive transaction, the purchase price, and asset composition would be critical to understanding the investment implications.
KUST
NASDAQ
▲ SUPER 8-K
Kustom Entertainment, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the filing metadata from January 12, 2026, this 8-K reports **material business developments** including the entry into a material definitive agreement (Item 1.01) and the completion of an acquisition or disposition of assets (Item 2.01). The filing contains 17 documents with multiple exhibits, including what appears to be significant transaction agreements (EX-1.1 and EX-1.2) and supplemental information materials.
**Key Takeaway for Investors:** While the HTML metadata alone doesn't provide full details, the combination of a "Material Definitive Agreement" entry and "Completion of Acquisition or Disposition" indicates the company has either completed a major M&A transaction or entered into a significant business arrangement. Investors should review the actual 8-K document (form8-k.htm) and exhibits to understand the transaction's financial impact, terms, and strategic implications for the company's future earnings and competitive position.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This 8-K was filed on January 8, 2026 (CIK 1435064), reporting on material events that occurred on the same date.
**Key Material Events:** The filing reports the completion of an acquisition or disposition of assets (Item 2.01), along with other events (Item 8.01) and related financial statements/exhibits (Item 9.01). The specific transaction details are contained in the attached documents but are not visible in this header information.
**Investment Implications:** Investors should review the full 8-K document (form8-k.htm) and Exhibit 99.1 for specifics on the acquisition/disposition, including purchase price, financing structure, expected synergies, and integration plans. Such transactions can materially impact shareholder value, depending on whether the deal is accretive or dilutive to earnings and the company's strategic positioning.
**Next Steps:** To fully assess the impact, analysts should examine the complete filing documents, particularly the transaction terms and management's commentary on expected outcomes.
AIHS
NASDAQ
▲ SUPER 8-K
Senmiao Technology Limited Common Stock
EDGAR Items: 1.01,2.01,5.02,9.01
# SEC 8-K Summary: Senmiao Technology Limited
**Filing Date:** January 7, 2026 (Period ending December 31, 2025)
**Material Events:**
Senmiao Technology Limited completed a material acquisition of assets on December 31, 2025, as reported in this 8-K filing. The filing includes a definitive acquisition agreement, pro forma balance sheet, and indicates changes to the company's officer and director compensation arrangements, suggesting significant corporate restructuring alongside the transaction.
**Key Implications for Investors:**
The completion of this acquisition represents a substantial strategic shift for the company and warrants careful review of the acquisition terms, financing structure, and pro forma financial impact. Investors should examine the pro forma balance sheet to assess how the deal affects the company's leverage, liquidity, and earnings potential. Additionally, the concurrent executive compensation changes may signal new management direction or potential dilution concerns that warrant further investigation into the acquisition's terms and the company's future strategic direction.
ONAR
OTC
▲ SUPER 8-K
Onar Holding Corp
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**OnAir Inc.** (CIK: 1682265) filed an 8-K on January 7, 2026, reporting the completion of an asset acquisition or disposition effective December 31, 2025. The filing includes an Asset Purchase Agreement, pro forma financial statements, and a press release, indicating a significant business transaction was finalized at year-end. The inclusion of unaudited pro forma consolidated financial information suggests the acquisition will have a material impact on the company's financial profile going forward. Investors should review the attached Asset Purchase Agreement and pro forma financials to understand the transaction terms, purchase price, and expected earnings accretion or dilution from the deal.
GRDX
NASDAQ
▲ SUPER 8-K
GridAI Technologies Corp. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Filing:** Form 8-K filed January 7, 2026 (Period ending December 31, 2025)
**Key Material Event:** The company completed an acquisition or disposition of assets, as disclosed under Item 2.01. This is the primary substantive change reported in the filing.
**Investor Implications:** While the 8-K confirms a completed transaction, the actual details regarding the acquired/disposed assets, financial impact, and strategic rationale are contained in the referenced exhibits. Investors should review Exhibit 99.1 for comprehensive information on transaction terms, valuation, and expected financial effects. The timing (end of 2025) suggests this was a significant year-end corporate action that could materially affect the company's 2026 financial position and operational structure.
**Note:** Without access to the actual exhibit content, investors should examine the full filing documents to understand the transaction's magnitude and strategic significance.
RNGE
OTC
▲ SUPER 8-K
RANGE IMPACT, INC.
EDGAR Items: 1.01,2.01,2.03,8.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filing dated January 7, 2026 (for period ending December 31, 2025), the company has reported **multiple material events**: entry into a material definitive agreement, completion of an acquisition or disposition of assets, and creation of direct financial obligations. The filing includes six significant exhibits (EX-10.1 through EX-10.6) documenting detailed agreements and transaction terms, with the main 8-K document exceeding 98KB in size, suggesting substantial transaction complexity.
**For investors:** This multi-item 8-K indicates a significant corporate transaction was completed at year-end 2025. The combination of new agreements, asset completion items, and new financial obligations suggests either a major acquisition, divestiture, or substantial restructuring that will materially impact the company's balance sheet and operations going forward. Investors should review the full filing and exhibits to understand the transaction's financial terms, strategic rationale, and implications for future earnings and cash flow.
APYP
OTC
▲ SUPER 8-K
Techlott Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,9.01
# SEC 8-K Filing Summary
Based on this January 7, 2026 8-K filing, the company has undergone **significant corporate restructuring** involving multiple material events: a major acquisition or asset disposition was completed, material agreements were entered into, unregistered equity securities were issued, and there were changes to the board of directors and/or officer compensation arrangements. The filing also indicates amendments to the company's articles of incorporation or bylaws, along with a potential fiscal year change.
**Key Implications for Investors:**
- The completion of a substantial acquisition/disposition will likely impact the company's financial profile, revenue streams, and balance sheet
- Unregistered equity issuances suggest either private financing or strategic partnerships, which could affect share dilution
- Management and board changes may signal a strategic pivot or leadership transition
- The multiple concurrent corporate actions indicate a transformative period for the company
Investors should review the actual 8-K document and exhibits (EX-10.1, EX-10.2) to understand the specific terms, financial impact, and strategic rationale for these changes.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Spectral Capital Corporation 8-K Filing (January 5, 2026)
**Material Events:**
Spectral Capital Corporation completed the acquisition of Telvantis, Inc., with closing occurring on December 31, 2025. The filing includes a definitive stock purchase agreement and closing certificate, indicating this was a significant M&A transaction.
**Key Filing Items:**
The 8-K reports entry into a material definitive agreement (Item 1.01), completion of an acquisition (Item 2.01), and unregistered equity sales (Item 3.02), suggesting Spectral Capital issued stock as consideration for the Telvantis acquisition.
**Investor Implications:**
This acquisition represents a strategic expansion for Spectral Capital, though the specific financial terms and strategic rationale are detailed in the attached purchase agreement. Investors should review the definitive stock purchase agreement and press release for deal valuation, financing structure, and management's strategic vision for integrating Telvantis operations.
NCRA
NASDAQ
▲ SUPER 8-K
Nocera, Inc. Common Stock
EDGAR Items: 2.01
# SEC 8-K Filing Summary: Nocera, Inc.
**Filing Details:**
- **Company:** Nocera, Inc. (CIK: 1756180)
- **Filing Date:** January 5, 2026
- **Report Period:** January 1, 2026
- **Material Event:** Item 2.01 - Completion of Acquisition or Disposition of Assets
**Key Takeaway for Investors:**
Nocera, Inc. has completed an acquisition or disposition of assets as of January 1, 2026. While the HTML document provided does not contain the detailed substance of the transaction, this 8-K filing indicates a significant corporate event that could materially impact the company's operations, financial position, or strategic direction. Investors should review the complete 8-K document (nocera_8k.htm) to understand the specific details of the transaction, including the target asset/company, purchase price, financing terms, and expected impact on earnings and operations. This type of event typically signals either an expansion strategy or a divestiture of assets that warrant careful evaluation of the company's future prospects.
December 2025
13 filings
▼
EZRA
NASDAQ
▲ SUPER 8-K
Reliance Global Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** This Form 8-K was filed on December 30, 2025, reporting material events that occurred on December 23, 2025.
**Material Events:**
The filing discloses two significant corporate actions under Items 1.01 and 2.01:
- **Entry into a Material Definitive Agreement** – The company has entered into a binding contract with unspecified terms (detailed in Exhibit 10.1)
- **Completion of Acquisition or Disposition of Assets** – The company has completed an asset transaction
**Key Implications for Investors:**
While the precise nature of the transaction is not evident from this summary page alone, the concurrent reporting of both a definitive agreement and its completion suggests a significant M&A activity or substantial asset transaction. Investors should review the attached exhibits, particularly EX-10.1 (the definitive agreement) and the press release (EX-99.1), to understand the transaction's size, strategic rationale, and potential impact on earnings, cash flow, and shareholder value. This type of disclosure typically signals material changes to the company's operations or financial position that warrant careful analysis.
BAER
NASDAQ
▲ SUPER 8-K
Bridger Aerospace Group Holdings, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
Bridger Aerospace (CIK 1941536) filed an 8-K on December 30, 2025, reporting a material event that occurred on December 23, 2025.
**Key Material Events:**
The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), along with additional regulatory disclosures and financial statements. A press release dated December 30, 2025, was included as an exhibit, providing public announcement of the transaction.
**Investor Implications:**
Without access to the detailed content of the press release and 8-K body, the specific nature of the acquisition/disposition cannot be confirmed; however, investors should review the complete filing to understand the transaction terms, impact on financial position, and strategic rationale. The inclusion of Item 7.01 (Regulation FD Disclosure) suggests material information was simultaneously disclosed to the public, indicating this is a significant corporate event that could affect stock valuation and future operations.
MWYN
NASDAQ
▲ SUPER 8-K
Marwynn Holdings, Inc. Common stock
EDGAR Items: 2.01,5.03,9.01
# SEC 8-K Filing Summary: Marwynn (December 23, 2025)
**Material Events:** Marwynn completed an acquisition or disposition of assets and amended its Articles of Incorporation on December 22, 2025, as reported in this Form 8-K filing.
**Key Changes:** The company's second amended and restated Articles of Incorporation have been officially updated (EX-3.1), and unaudited pro forma condensed combined financial information has been included, suggesting a significant business combination or asset transaction.
**Investor Implications:** The pro forma financial statements will help investors assess the combined entity's projected financial position and performance post-acquisition. However, without access to the detailed 8-K body text, the specific terms, financial magnitude, and strategic rationale of the transaction cannot be fully evaluated. Investors should review the complete filing for transaction details, purchase price, and integration plans to assess the deal's impact on future earnings and shareholder value.
ATHR
NASDAQ
▲ SUPER 8-K
Aether Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the December 22, 2025 8-K filing (Accession No. 0001493152-25-028671), the company reported **material transactions involving entry into a definitive agreement and completion of an acquisition or disposition of assets**. The filing includes significant exhibits, notably a substantial material agreement (EX-10.1 at 474KB) and supporting documentation, indicating a substantial business transaction has been completed. While the specific details of the transaction are contained in the linked documents, the combination of Items 1.01 (material agreement), 2.01 (asset transaction completion), and 8.01 (other events) suggests a meaningful M&A or asset restructuring event that could impact the company's strategic direction and financial position. **Investors should review the full 8-K and attached agreements to understand the transaction's terms, financial impact, and implications for the company's future operations and shareholder value.**
OLOX
NASDAQ
▲ SUPER 8-K
Olenox Industries Inc. Common Stock
EDGAR Items: 2.01,2.03,9.01
# SEC 8-K Filing Summary: Safe & Green Holdings Corp.
**Filing Date:** December 19, 2025 (Period: December 18, 2025)
Safe & Green Holdings Corp. completed an acquisition or disposition of assets and created a direct financial obligation, as reported in this 8-K filing. The company executed a Stock Purchase Agreement dated December 18, 2025, and simultaneously issued a Promissory Note, indicating it either acquired a business using debt financing or divested assets while taking on new financial obligations. The filing includes 14 documents with detailed transaction documentation and financial exhibits.
**Key Implications for Investors:** This transaction signals potential business expansion or strategic repositioning, but the debt financing component raises questions about capital structure changes and future cash flow commitments. Investors should review the full Stock Purchase Agreement and Promissory Note to understand the acquisition target, debt terms (interest rate, maturity, covenants), and whether this move enhances shareholder value or increases financial risk.
SONM
NASDAQ
▲ SUPER 8-K
DNA X, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,8.01,9.01
# SEC 8-K Filing Summary
Based on this December 18, 2025 8-K filing, the company has announced **multiple material corporate events**. The filing indicates entry into a material definitive agreement, completion of an acquisition or asset disposition, creation of direct financial obligations, unregistered equity issuance, and modifications to security holder rights. These items collectively suggest a significant corporate transaction—likely a merger, acquisition, or major financing deal—that materially impacts the company's capital structure and financial position.
**Key implications for investors:**
- The company has taken on new financial obligations (Item 2.03) and issued unregistered securities (Item 3.02), which could dilute existing shareholders
- Changes to security holder rights (Item 3.03) may affect voting power or dividend preferences
- The complexity and breadth of disclosed items indicate a transformative transaction requiring careful review of the detailed agreements and exhibits provided
Investors should review the full 8-K document and attached exhibits (particularly EX-10.1 and EX-10.2) to understand the transaction terms, financial impact, and implications for future earnings and shareholder value.
GLTK
OTC
▲ SUPER 8-K
GlobalTech Corp
EDGAR Items: 2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on December 18, 2025, by Global (CIK: 1938338) for the period ending December 15, 2025, reporting material events that occurred on that date.
**Material Events Reported:**
The filing discloses four significant items: (1) **Completion of an Asset Acquisition or Disposition** (Item 2.01), (2) **Unregistered Equity Issuance** (Item 3.02), (3) regulatory disclosure information (Item 7.01), and (4) financial statements and supporting exhibits (Item 9.01). The company completed a transaction involving the acquisition or sale of assets and simultaneously issued unregistered securities.
**Investor Implications:**
The combination of a completed acquisition/disposition with concurrent unregistered equity issuance suggests the company may have funded the transaction through stock issuance, potentially diluting existing shareholders. The specific details of the transaction value, asset composition, and equity terms are contained in the attached press release and financial exhibits, which would require review to fully assess the strategic and financial impact on the company and its shareholders.
FTFT
NASDAQ
▲ SUPER 8-K
Future FinTech Group Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filing dated December 17, 2025, **the company has completed an acquisition or disposition of assets**, as indicated by Item 2.01. The transaction was formalized through a Securities Transfer Agreement dated November 18, 2025, which is attached as an exhibit to the filing. While the specific details of the acquisition/disposition are not visible in the HTML structure provided, this represents a material corporate event that required immediate disclosure to investors.
**For investors:** This filing signals a significant strategic action by the company that could impact its business operations, financial position, and future growth trajectory. Investors should review the complete 8-K document and the Securities Transfer Agreement to understand the nature of the transaction, assets involved, consideration paid, and any potential synergies or risks. The timing between the agreement (November 18) and the completion announcement (December 16-17) suggests this was a recently executed transaction.
CIMG
OTC
▲ SUPER 8-K
CIMG Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Form 8-K filed on December 17, 2025, with a period of report date of October 20, 2025 (CIK 1527613).
**Material Events:** The filing discloses four significant items: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) regulatory fair disclosure, and (4) financial statements and exhibits. The 56 supporting documents, including multiple exhibits and graphics, suggest a substantial corporate transaction.
**Key Implications for Investors:** This 8-K indicates a completed major acquisition or asset disposition with associated material contractual agreements. The comprehensive documentation and exhibits suggest a complex, significant deal that could materially impact the company's operations, financial position, or strategic direction. Investors should review the full filing documents (particularly EX-10.1 and EX-10.2 containing the definitive agreements) to understand the transaction's terms, valuation, and potential impact on shareholder value.
DTCX
NASDAQ
▲ SUPER 8-K
Datacentrex, Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** December 15, 2025 | **Company CIK:** 1853825
## Key Material Events:
This 8-K reports a **change of control transaction** involving completion of an acquisition, unregistered equity issuance, and significant corporate restructuring. The filing indicates multiple major events including:
- **Acquisition completion** (Item 2.01) with asset or equity transfers
- **Change in control of the registrant** (Item 5.01), suggesting new ownership or management structure
- **Unregistered equity securities issuance** (Item 3.02), likely issued as acquisition consideration
- **Officer and director changes** (Item 5.02) with new compensatory arrangements
- **Corporate governance amendments** (Item 5.03) to articles of incorporation and/or bylaws
## Investor Implications:
This represents a **significant corporate transformation** that could substantially impact shareholder value, voting rights, and company direction. Investors should review the complete 8-K filing, exhibit documents (including amended bylaws and organizational documents), and press releases to understand: the acquisition terms, new management team, dilution from equity issuance, and any changes to shareholder rights or capital structure. The 35 accompanying documents suggest a complex transaction requiring detailed analysis.
ALBT
NASDAQ
▲ SUPER 8-K
Avalon GloboCare Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
# 8-K Filing Summary
**Avalon Globo (Filing Date: December 15, 2025)**
This 8-K reveals a significant material transaction: Avalon Globo has entered into a merger agreement (dated December 12, 2025) and simultaneously completed a major financing/acquisition event. The filing includes multiple material agreements including a merger plan, bridge financing, securities purchases, and the creation of Series E convertible preferred stock, indicating the company is undergoing substantial corporate restructuring. Additionally, there are changes to the company's articles of incorporation/bylaws and officer/director compensation arrangements being disclosed.
**Key Implications for Investors:** This represents a transformative event for the company involving both M&A activity and significant equity dilution through new preferred stock issuance and securities purchases. Investors should carefully review the merger agreement terms and financing structure, as the multiple financing instruments (bridge notes, securities purchases) suggest the deal may involve complex capital structures that could impact existing shareholders' positions.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from December 11, 2025 (with a report date of December 5, 2025) indicates a **significant corporate restructuring event**. The filing covers multiple material items including a change in control of the registrant, completion of an acquisition, entry into material definitive agreements, creation of new financial obligations, unregistered equity sales, and changes to the company's certificate of incorporation and bylaws. The extensive list of items—particularly Items 5.01 (change in control), 2.01 (acquisition completion), and 5.03 (charter/bylaw amendments)—suggests this company has undergone a **merger, acquisition, or substantial recapitalization**.
**Key implications for investors:** This appears to be a transformational event that fundamentally alters the company's ownership structure and governance. The involvement of warrant amendments, registration rights agreements, and equity issuances suggests new investors or acquirers have taken control. Shareholders should carefully review the detailed filing documents to understand dilution implications, new capital structures, and any changes to voting rights or company direction.
GREE
NASDAQ
▲ SUPER 8-K
Vulcan Infrastructure and Power Inc. Class A Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Summary: Green Thumb Industries (GREE)
**Filing Date:** December 11, 2025
Green Thumb Industries completed a significant asset acquisition or disposition, as indicated by Item 2.01 of this 8-K filing. The filing includes a press release describing the transaction closing and supplementary documentation. While the specific details require review of the complete filing documents, the company has reported the completion of what appears to be a material transaction involving the sale or purchase of assets.
**Key Points for Investors:**
- The company has closed a previously announced transaction
- This represents a material corporate event that may affect the company's asset base and financial position
- Investors should review the attached press release and full 8-K details to understand the financial terms, strategic rationale, and expected impact on future earnings and operations
The filing was accepted on December 11, 2025, and contains 15 supporting documents including financial statements and exhibits.
November 2025
10 filings
▼
DMNIF
OTC
▲ SUPER 8-K
Damon Inc.
EDGAR Items: 1.01,2.01,5.02,8.01,9.01
# SEC 8-K Filing Summary: Damon Inc.
**Filing Date:** November 28, 2025
Damon Inc. has entered into a material definitive agreement and completed an acquisition of assets, as evidenced by a Share Purchase Agreement dated November 28, 2025, with Grafit. The filing includes changes to officer compensation arrangements and director-related matters (Item 5.02), suggesting significant corporate restructuring alongside the transaction. This acquisition represents a material event that could meaningfully impact the company's operational footprint, financial position, and strategic direction. Investors should review the complete Share Purchase Agreement and related disclosures to understand the transaction terms, consideration paid, and potential synergies or risks associated with integrating the acquired assets.
SHPH
NASDAQ
▲ SUPER 8-K
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Summary - November 26, 2025
Based on the filing metadata, this 8-K documents **three material events** for the company (CIK: 1757499):
1. **Material Definitive Agreement (Item 1.01)**: The company entered into a significant binding agreement, though specific details require reviewing the full 8-K document.
2. **Asset Acquisition or Disposition (Item 2.01)**: The company completed an acquisition or sale of assets, representing a material business transaction.
3. **Unregistered Equity Offering (Item 3.02)**: The company issued equity securities through an unregistered offering, suggesting either private placement financing or a stock deal component related to the transaction.
**Investor Implications**: This filing indicates significant corporate activity—likely an M&A transaction or major financing event that could materially affect shareholder value, capital structure, and future earnings. Investors should review the full 8-K document (form8-k.htm) and the material agreement (Exhibit 10.1) to understand deal terms, valuation, dilution impact, and strategic rationale.
LIXT
NASDAQ
▲ SUPER 8-K
Lixte Biotechnology Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,7.01,9.01
# SEC 8-K Filing Summary
Based on the filing dated November 25, 2025, this 8-K reports several material corporate events:
**Key Items:**
The company has entered into a material definitive agreement (Item 1.01), completed an acquisition or disposition of assets (Item 2.01), conducted unregistered equity sales (Item 3.02), and amended its articles of incorporation or bylaws (Item 5.03). These items together suggest a significant **M&A transaction or capital restructuring event**.
**Material Implications for Investors:**
The combination of acquisition completion, unregistered equity issuance, and bylaw amendments indicates a substantial corporate transaction that likely involves new financing, ownership changes, or business consolidation. The multiple exhibits (material agreements and amended bylaws) point to complex deal terms that warrant careful review. Investors should examine the full filing documents to understand the transaction's financial impact, dilution effects, and strategic rationale.
FDCT
OTC
▲ SUPER 8-K
FDCTECH, INC.
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This Form 8-K was filed on November 24, 2025 (for period ending November 18, 2025) by a company with CIK 1722731, containing 15 documents.
**Material Events Reported:**
The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), along with supplemental information disclosure (Item 7.01) and financial statements/exhibits. The company has provided supporting documentation including exhibits and financial data files.
**Key Implications for Investors:**
This acquisition completion represents a significant corporate event that may impact the company's operational structure, financial position, and future earnings potential. Investors should review the full 8-K document and exhibits to understand the deal terms, consideration paid, expected synergies, and any material changes to business operations or financial forecasts. The timing and scope of this transaction could affect near-term financial performance and shareholder value.
SDOT
NASDAQ
▲ SUPER 8-K
Sadot Group Inc. Common Stock
EDGAR Items: 2.01,9.01
# 8-K Summary: Completion of Acquisition (November 19, 2025)
**Key Filing Details:**
This 8-K filing from Solid Dot (ticker: SDOT) reports the completion of an acquisition or disposition of assets as of November 19, 2025. The filing includes 14 documents with an earnings release attached as Exhibit 99.1, suggesting material financial implications from the transaction.
**What This Means for Investors:**
Without access to the full document contents, the specific details of the acquisition target, purchase price, and strategic rationale are not visible in this metadata. However, investors should review the complete 8-K and earnings release to understand: (1) what assets were acquired and their strategic value; (2) any material changes to the company's financial position, debt levels, or cash position; (3) expected synergies or integration timelines; and (4) any impact on earnings guidance or future operations. The filing's interactive data tools should help investors analyze the quantitative impact on the balance sheet.
CREX
NASDAQ
▲ SUPER 8-K
CREATIVE REALITIES, INC.
EDGAR Items: 1.01,2.01,2.02,2.03,3.02,3.03,5.02,5.03,5.08,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Crexendo, Inc. (CIK: 1356093) filed an 8-K on November 12, 2025, reporting events as of November 6, 2025, with 24 supporting documents.
**Material Events Disclosed:** This is a multi-item 8-K indicating significant corporate activity, including: entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), changes to financial obligations (Item 2.03), unregistered equity issuance (Item 3.02), modifications to security holder rights (Item 3.03), executive personnel changes and compensation arrangements (Item 5.02), and amendments to corporate governance documents (Items 5.03 and 5.08).
**Key Implications for Investors:** The breadth of disclosed items—spanning M&A activity, equity issuance, debt obligations, executive changes, and charter amendments—suggests Crexendo has undertaken substantial corporate restructuring or strategic transactions. The unregistered equity sale and material agreement warrant close examination of potential dilution and financial impact. Investors should review the detailed exhibits to assess the transaction's terms, financing structure, and implications for shareholder value.
ITHUF
OTC
▲ SUPER 8-K
iANTHUS CAPITAL HOLDINGS, INC.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** iThuf Enterprises (CIK: 1643154) filed an 8-K on November 12, 2025.
**Material Event:** The filing reports the **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has closed a significant transaction involving the purchase or sale of business assets or operations.
**Key Details:** The 8-K includes supporting exhibits and financial statement information, though the specific details of the acquired/divested assets, purchase price, and target company are contained in the referenced exhibits that would need to be reviewed for complete transaction analysis.
**Investor Implications:** This transaction could materially impact the company's financial position, revenue streams, and strategic direction. Investors should review the full filing and exhibits to understand the transaction's size, financing structure, expected synergies, and how it aligns with the company's strategic objectives to assess potential impacts on future earnings and shareholder value.
BFRI
NASDAQ
▲ SUPER 8-K
Biofrontera Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated November 7, 2025 (for the period ending November 6, 2025) reports a **material acquisition or asset disposition** along with related definitive agreements. The filing includes four key items: entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), regulatory disclosure (Item 7.01), and financial statements/exhibits (Item 9.01).
The specific details of the transaction are contained in Exhibit 2.1 (the transaction agreement) and supplemental disclosures in Exhibit 99.1, though the HTML preview doesn't display the full content. For investors, this signals a **significant corporate action** that could materially affect the company's operations, financial position, and stock value—requiring review of the complete filing documents to assess impact on earnings, cash flow, and strategic direction.
CRIS
NASDAQ
▲ SUPER 8-K
Curis Inc
EDGAR Items: 1.02,2.01,2.02,8.01,9.01
# SEC 8-K Filing Summary
**Company:** Crises Inc. (CIK: 1108205)
**Filing Date:** November 6, 2025
## Key Events:
This 8-K discloses multiple material events including the **termination of a material definitive agreement** (Item 1.02), **completion of an acquisition or asset disposition** (Item 2.01), and **results of operations** (Item 2.02). The filing indicates significant corporate restructuring activity with a Q3 2025 earnings press release included as an exhibit.
## Implications for Investors:
The combination of agreement termination, asset transaction completion, and financial results reporting suggests the company is undergoing substantial operational changes. Investors should review the detailed filing and earnings release to understand the financial impact of these transactions, how they affect future guidance, and whether they represent strategic repositioning or responses to business challenges. The materiality of these events warrants careful analysis of the company's updated financial position and forward-looking statements.
LFMD
NASDAQ
▲ SUPER 8-K
LifeMD, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated November 4, 2025 (CIK: 948320)
**Material Events:** This 8-K reports the completion of a material acquisition or disposition of assets (Item 2.01) and the entry into a material definitive agreement (Item 1.01). The filing includes a substantial exhibit (708KB agreement document) and supplementary disclosure materials.
**Key Implications for Investors:** The company has finalized a significant transaction involving either the purchase/sale of assets or business operations. The substantial size of the attached agreement and the inclusion of regulatory FD disclosure suggests this is a material event that could meaningfully impact the company's financial position, operations, or strategic direction. Investors should review the full 8-K document and attached exhibits to understand the transaction details, financial terms, and potential impact on earnings and business strategy.
October 2025
16 filings
▼
HTCR
NASDAQ
▲ SUPER 8-K
Heartcore Enterprises, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from October 31, 2025 (CIK: 1892322) reports a **material acquisition or disposition of assets** along with entry into a material definitive agreement. The filing includes multiple items indicating significant corporate activity: completion of an acquisition/disposition (Item 2.01), a material definitive agreement (Item 1.01), regulatory disclosures (Item 7.01), and other events (Item 8.01).
**Key for Investors:** The presence of Items 1.01 and 2.01 suggests the company has completed a substantial M&A transaction or asset transaction. The substantial size of the attached agreement exhibit (EX-10.1 at ~545KB) indicates complex deal terms. Investors should review the actual agreement and press release (EX-99.1) to understand the transaction's financial impact, terms, and strategic rationale, as this type of event can significantly affect company valuation, debt levels, and future earnings potential.
CLRO
NASDAQ
▲ SUPER 8-K
ClearOne, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** Celero (CIK: 840715) filed an 8-K on October 30, 2025, reporting the entry into a material definitive agreement and completion of an acquisition or disposition of assets.
**Key Material Changes:** The filing indicates two significant corporate actions: (1) execution of a material definitive agreement (Item 1.01), and (2) completion of an acquisition or asset disposition (Item 2.01). The substantial exhibits included (188 KB agreement and 307 KB supporting document) suggest a significant transaction.
**What This Means for Investors:** Investors should review the attached exhibits—particularly Exhibit 10.1 (the definitive agreement) and Exhibit 99.1 (likely a press release or transaction summary)—to understand the transaction's scope, terms, and financial impact on Celero. This could represent a strategic acquisition, divestiture, or major partnership with material implications for the company's future direction and shareholder value.
BAER
NASDAQ
▲ SUPER 8-K
Bridger Aerospace Group Holdings, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,7.01,9.01
# Summary of Bridger Aerospace 8-K Filing (October 29, 2025)
Bridger Aerospace announced multiple material financial transactions, including entry into a new credit agreement dated October 28, 2025, and completion of a sale-leaseback transaction. The filing covers Items 1.01 (material agreement entry), 1.02 (agreement termination), and 2.01 (asset disposition), indicating significant refinancing and capital structure changes. These transactions appear designed to improve liquidity and manage the company's debt obligations, suggesting potential financial restructuring to support operations or growth initiatives. Investors should review the detailed credit agreement and press releases included in the filing to understand the specific terms, interest rates, covenants, and impact on shareholder equity and future financial flexibility.
FUSE
NASDAQ
▲ SUPER 8-K
Fusemachines Inc. Common stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated October 28, 2025 (reporting period October 22, 2025) indicates **major corporate restructuring activity** involving the company. The filing covers multiple significant items including a material definitive agreement, completion of an acquisition/disposition, unregistered equity sales, changes in control of the registrant, modifications to security holder rights, changes in directors/officers, amendments to articles of incorporation, and a change in shell company status.
**Key Material Events:**
The breadth of disclosed items—particularly Items 5.01 (Changes in Control), 5.06 (Shell Company Status), and Item 2.01 (Acquisition/Disposition)—suggests this company has undergone a **transformative transaction**, likely a merger, reverse merger, or significant asset acquisition that fundamentally altered corporate control and structure.
**Investor Implications:**
Investors should carefully review the detailed exhibits (merger agreement, new articles of incorporation, officer compensation arrangements) to understand the new ownership structure, management team, and capitalization. The change in shell company status and control shift could significantly impact voting rights, stock dilution, and company direction. This represents a high-impact event requiring thorough due diligence before making investment decisions.
BFRI
NASDAQ
▲ SUPER 8-K
Biofrontera Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on October 24, 2025, covering events from October 20, 2025 (CIK: 1858685).
**Material Events Disclosed:**
The filing reports four significant items: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) unregistered sales of equity securities, and (4) other events. The presence of multiple exhibits (including two substantial agreements) suggests a complex transaction.
**Key Implications for Investors:**
Without access to the actual document content, the combination of a new material agreement, asset transaction completion, and equity issuance indicates the company has completed a significant corporate action—likely an acquisition, merger, or substantial asset deal involving equity financing. Investors should review the full 8-K and attached exhibits (EX-10.1 and EX-10.2) to understand the transaction terms, financial impact, dilution effects, and strategic rationale, as these events could materially affect shareholder value and the company's future financial performance.
NXTS
NASDAQ
▲ SUPER 8-K
Nexentis Technologies Inc. Common Stock
EDGAR Items: 2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** On October 23, 2025, the company completed an acquisition or disposition of assets and conducted an unregistered sale of equity securities, as disclosed in this 8-K filing.
**Key Changes & Material Events:** The filing indicates three significant items: (1) completion of an asset acquisition or disposition, (2) an unregistered equity issuance, and (3) other material events. The company included 14 supporting documents with financial data in XBRL format, suggesting substantial transactional activity.
**Investor Implications:** The unregistered equity sale suggests potential dilution to existing shareholders, while the asset transaction could represent either a strategic acquisition to drive growth or a divestiture to raise capital or streamline operations. Investors should review the full 8-K filing details to understand the transaction's scale, financing structure, and strategic rationale, as these events typically have material impacts on share valuation and capital structure.
CRCW
OTC
▲ SUPER 8-K
Crypto Co
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this October 16, 2025 8-K filing, the company reported **multiple material events including a significant acquisition/asset transaction and a material definitive agreement**. The filing indicates completion of an acquisition or disposition of assets (Item 2.01) coupled with entry into a material definitive agreement (Item 1.01), along with unregistered equity securities issuance (Item 3.02), suggesting the company may have acquired or divested a substantial asset or business unit, potentially using equity as partial consideration.
While the HTML provided only shows the filing metadata, the inclusion of these specific items signals a transformative corporate event that could meaningfully impact the company's financial position, operational structure, and shareholder value. Investors should review the complete 8-K document and the Material Definitive Agreement (Exhibit 10.2) to understand the transaction's terms, consideration amount, and strategic rationale, as such transactions typically carry implications for future earnings, debt levels, and capital allocation.
HWNI
OTC
▲ SUPER 8-K
HIGH WIRE NETWORKS, INC.
EDGAR Items: 1.01,2.01,5.02,9.01
# SEC 8-K Filing Summary: High Wire Networks, Inc.
**Filing Date:** October 14, 2025 (reporting period: July 9, 2025)
High Wire Networks, Inc. completed two material asset purchase agreements: one with OW Cyber LLC and another between its Secure Voice Corp. subsidiary and Secure Voice LLC. The filing indicates significant corporate restructuring through the acquisition/disposition of assets, accompanied by changes to the company's officer and director composition with new compensatory arrangements. These transactions represent notable strategic moves that could affect the company's operational structure and shareholder value, though the specific financial details and strategic rationale would require review of the actual agreements and 8-K narrative to fully assess investor impact.
MNKD
NASDAQ
▲ SUPER 8-K
Mannkind Corporation
EDGAR Items: 1.01,2.01,2.03,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Mannkind Corporation (MNKD) filed an 8-K on October 9, 2025, reporting material corporate developments dated October 7, 2025.
**Key Material Events:**
The filing discloses entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and creation of a direct financial obligation (Item 2.03). These items suggest the company executed a significant business transaction, likely involving either an acquisition, asset sale, or substantial financing arrangement.
**Financial Impact:**
The company has taken on new direct financial obligations as part of this transaction, which could materially affect the balance sheet and future cash flows. The specific terms and financial details are contained in the attached definitive agreement (Exhibit 10.1).
**Investor Implications:**
Investors should review the complete 8-K filing and attached agreements to understand the transaction's strategic rationale, funding structure, potential dilution, and impact on future financial performance. The simultaneous disclosure of a material agreement, asset transaction, and new financial obligations suggests a transformative event that warrants careful analysis of the company's financial health and strategic direction.
NEOV
NASDAQ
▲ SUPER 8-K
NeoVolta Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# SEC 8-K Summary: NeoVolta, Inc.
**Filing Date:** October 7, 2025 (Period: October 1, 2025)
NeoVolta, Inc. announced a material acquisition/asset purchase and significant management changes effective October 1, 2025. The company entered into an asset purchase agreement and appointed new executives, including Amany Ibra and Thomas Enz, under new employment agreements. Additionally, the filing indicates an unregistered equity issuance occurred in connection with these transactions.
**Key Implications for Investors:** This represents a significant corporate restructuring event that could indicate a strategic pivot, change in business direction, or acquisition of new operations. Investors should review the detailed asset purchase agreement and executive compensation arrangements to assess the transaction's terms, potential dilution from equity issuance, and management's confidence in the new strategic direction. The specific nature of acquired assets and their accretion to earnings will be critical in determining whether this transaction creates or destroys shareholder value.
BRFH
NASDAQ
▲ SUPER 8-K
Barfresh Food Group Inc. Common Stock
EDGAR Items: 2.01,2.03,9.01
# SEC 8-K Filing Summary
Based on this October 7, 2025 Form 8-K filing, the company reported two significant material events: **completion of an acquisition or disposition of assets** (Item 2.01) and **creation of a direct financial obligation** (Item 2.03). While the filing itself doesn't contain the detailed content in this document index, these items indicate the company has either acquired or sold a substantial asset and taken on new debt or financial obligations related to the transaction.
For investors, this signals a meaningful corporate transaction that may impact the company's capital structure, balance sheet, and strategic direction. The filing includes related agreements (Exhibits 10.1 and 10.2) and a press release (Exhibit 99.1) that would provide specifics on the deal terms, financing, and strategic rationale. Investors should review the full 8-K document and exhibits to understand the transaction's financial impact and implications for future growth and shareholder value.
ELUT
NASDAQ
▲ SUPER 8-K
Elutia Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,7.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated October 7, 2025, reporting events as of October 1, 2025 (CIK: 1708527)
**Material Events:**
This 8-K discloses multiple significant corporate transactions and agreements, including: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, and (3) other material events. The filing includes substantial exhibits, including a large agreement document (Exhibit 10.2) and detailed disclosures (Exhibits 99.1 and 99.2), suggesting a substantial business combination or major contract.
**Investor Implications:**
The filing's focus on completed acquisitions/dispositions and material agreements indicates the company has undergone significant structural or operational changes. Investors should carefully review the detailed exhibits and agreement terms to understand the deal's financial impact, funding sources, and strategic rationale, as this likely represents a transformative event for the company.
*Note: The HTML provided does not contain the actual filing content details; investors should access the full 8-K document (tm2528122d1_8k.htm) for complete specifics on the transaction terms, valuation, and implications.*
GRDX
NASDAQ
▲ SUPER 8-K
GridAI Technologies Corp. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this October 6, 2025 Form 8-K filing, the company has undergone several significant corporate events: **completion of an acquisition or disposition of assets, entry into material definitive agreements, unregistered equity issuances, and amendments to articles of incorporation**. The filing includes a merger/acquisition agreement (Exhibit 2.1), amended bylaws (Exhibit 3.1), and related transaction documents, indicating a major corporate restructuring or M&A transaction has been finalized.
**For investors, this represents a material event that could substantially alter the company's capital structure, ownership, and strategic direction.** The inclusion of multiple items—particularly unregistered equity sales and corporate bylaw changes—suggests potential dilution to existing shareholders and governance modifications. Investors should review the full merger agreement and transaction details in the exhibits to understand the deal terms, consideration paid, and any conditions or contingencies that may affect value.
NGTF
OTC
▲ SUPER 8-K
NightFood Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this October 6, 2025 8-K filing (Period ending September 30, 2025), the company reported **a material acquisition or asset disposition** along with a significant definitive agreement and unregistered equity issuance. The filing includes Items 1.01 (Material Definitive Agreement), 2.01 (Completion of Acquisition/Disposition), and 3.02 (Unregistered Equity Sales), indicating the company completed a major transaction and raised capital through equity.
**Key implications for investors:** The company has undergone significant structural changes, potentially acquiring new assets or divesting existing ones while simultaneously issuing new equity securities. This could signal strategic repositioning, though the specific details would require reviewing the actual agreement document (EX-2.1). Investors should carefully review the transaction terms, financing structure, and any potential dilution from the equity issuance to assess the long-term value creation potential of this transaction.
FNGR
NASDAQ
▲ SUPER 8-K
FingerMotion, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary
**Company:** Fingerprint Technology (FNGR) | **Filing Date:** October 6, 2025
This 8-K filing reports three significant corporate events: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, and (3) unregistered sales of equity securities. The filing indicates major business restructuring or strategic transaction activity as of September 30, 2025.
While the specific details of the agreement and acquisition require review of the full 8-K document and Exhibit 10.1, these items collectively suggest the company has undertaken a substantial business combination or capital transaction that could materially impact shareholders. Investors should review the complete filing to understand the transaction terms, financial impact, and any potential dilution from the equity issuance.
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 2.01,3.02
# SEC 8-K Filing Summary: GD Culture (CIK 1641398)
**Filing Date:** October 2, 2025 | **Period:** September 29, 2025
This 8-K reports two significant corporate events: the **completion of an acquisition or disposition of assets** (Item 2.01) and **unregistered sales of equity securities** (Item 3.02). The filing indicates material changes to the company's asset base and capitalization structure, though the specific details of the transaction would require reviewing the full disclosure document to understand the transaction value, parties involved, and strategic rationale. These transactions could materially impact shareholder value and the company's operational scope, making this a critical event for investors to analyze in detail.
September 2025
16 filings
▼
MIRA
NASDAQ
▲ SUPER 8-K
MIRA Pharmaceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed by Mira Pharmaceuticals (CIK: 1904286) on September 30, 2025, reporting events as of September 29, 2025.
**Material Events Reported:**
The filing covers multiple significant items including: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) unregistered sales of equity securities, and other events. The substantial size of the attached agreement document (EX-10.1 at 346KB) suggests a major transaction.
**Key Implications for Investors:**
Without access to the complete filing content, the combination of a material agreement, asset acquisition completion, and equity issuance indicates Mira Pharmaceuticals has executed a significant corporate transaction—likely a merger, acquisition, licensing deal, or major financing. Investors should review the full 8-K document to understand the deal terms, financial impact, dilution from new equity, and strategic rationale, as these transactions can materially affect shareholder value and the company's future direction.
SMNRW
OTC
▲ SUPER 8-K
Semnur Pharmaceuticals, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the filing dated September 26, 2025 (for the period ending September 22, 2025), this is a **highly material 8-K with multiple significant corporate events**:
The company has undergone a **transformational transaction involving a change in control, acquisition/disposition of assets, and substantial restructuring**. Key material events include: a material definitive agreement entry, completion of an asset acquisition or disposition, new debt obligations, unregistered equity issuances, amendments to articles of incorporation/bylaws, changes in registrant's certifying accountant, changes in the board of directors and officer appointments, potential shell company status change, and security holder rights modifications.
**For investors, this signals** a major strategic pivot or merger/acquisition activity that fundamentally alters the company's ownership structure, capital structure, and governance. The breadth of items filed (14 total) suggests a complex transaction with significant financial, legal, and operational implications. Investors should carefully review the detailed 8-K filing and accompanying exhibits to understand the transaction terms, new management, financing arrangements, and how these changes affect their investment thesis and risk profile.
ONAR
OTC
▲ SUPER 8-K
Onar Holding Corp
EDGAR Items: 1.01,2.01,2.03,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This Form 8-K was filed on September 19, 2025 by a company (CIK 1682265) covering material events from September 15, 2025.
**Key Material Events:**
The filing discloses six major items: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) creation of direct financial obligations, (4) unregistered equity securities sales, (5) regulatory disclosures, and (6) financial statements/exhibits. The submission includes a Securities Purchase Agreement and press release as supporting documents.
**What Changed & Investor Implications:**
The company has entered into significant transaction(s) involving both debt and equity financing, along with acquisition activity. This suggests the company is undergoing strategic growth or restructuring. The combination of new financial obligations and unregistered equity issuance indicates potential dilution to existing shareholders, while the acquisition completion signals business expansion. Investors should review the detailed Securities Purchase Agreement to understand the specific terms, valuation, and potential impact on future earnings and shareholder value.
LMFA
NASDAQ
▲ SUPER 8-K
LM Funding America, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Lemonade Inc. (LMFA) filed an 8-K on September 18, 2025, reporting events that occurred on September 15, 2025.
**Material Events:**
The filing indicates multiple significant developments: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, and (3) creation of direct financial obligations. These items are supported by substantial exhibit documents including legal agreements and financial arrangements.
**Key Implications for Investors:**
This 8-K signals major corporate activity at Lemonade, likely involving either a strategic acquisition, significant asset sale, or new financing arrangement. The multiple items filed suggest a complex transaction with material financial implications. Investors should review the detailed exhibits and press release (EX-99.1) to understand the transaction terms, financial impact, and strategic rationale before making investment decisions.
**Next Steps:** Review the full 8-K document and exhibits to assess whether this transaction strengthens or weakens the company's competitive position and financial health.
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Summary: GD Culture Group
**Material Event:** GD Culture Group entered into a share exchange agreement dated September 10, 2025, to acquire an unspecified target company, representing a significant acquisition transaction requiring disclosure under Items 1.01 (material definitive agreement) and 2.01 (completion of acquisition).
**Key Details:** The filing includes a share exchange agreement, unaudited pro forma condensed combined financial statements as of June 30, 2025, and a press release announcing the transaction. The company also disclosed unregistered equity securities issuance (Item 3.02) as consideration for the deal.
**Investor Implications:** This acquisition signals GD Culture's growth strategy through M&A activity. Investors should review the pro forma financials to assess the combined entity's financial impact, scrutinize the exchange ratio and deal structure to understand dilution, and monitor for any contingencies or closing conditions that may affect the transaction completion.
HWH
NASDAQ
▲ SUPER 8-K
HWH International Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on September 16, 2025 (reporting period September 10, 2025) by a company with CIK 1897245, covering material corporate events.
**Material Events:** The filing reports two significant items: (1) Entry into a Material Definitive Agreement (Item 1.01) and (2) Completion of an Acquisition or Disposition of Assets (Item 2.01). These items suggest the company either completed a major acquisition/divestiture or entered into a significant binding business agreement during the reporting period.
**Key Documents:** The filing includes detailed exhibits—a definitive agreement document (EX-10.1) and what appears to be a press release or investor presentation (EX-99.1)—which contain the specifics of the transaction or agreement terms and financial implications.
**Investor Impact:** Without access to the full document text, the precise nature and materiality cannot be assessed, but the dual reporting of both a new agreement and asset completion suggests a major M&A transaction or strategic business restructuring that could significantly impact the company's financial position, operations, or shareholder value. Investors should review the complete exhibit documents for transaction terms, valuation, and financial projections.
MLCI
NASDAQ
▲ SUPER 8-K
Mount Logan Capital Inc. Common Stock
EDGAR Items: 2.01,2.03,3.03,5.01,5.02,5.03,7.01,9.01
# SEC 8-K Filing Summary
**Company:** Yukon Drilling (CIK: 2051820)
**Filed:** September 16, 2025 (Event Date: September 12, 2025)
## Key Material Events:
This 8-K discloses a **significant corporate transaction and restructuring**. The filing indicates a **change in control of the registrant** (Item 5.01), completion of an **acquisition or disposition of assets** (Item 2.01), and the creation of **new financial obligations** (Item 2.03). Additionally, there are **modifications to security holder rights** (Item 3.03) and **amendments to articles of incorporation/bylaws** (Item 5.03), suggesting a major merger, acquisition, or leveraged recapitalization.
## Investor Implications:
The multiple simultaneous disclosures—particularly the change of control, new debt obligations, and governance amendments—indicate a transformational event that will likely affect ownership structure, capital structure, and shareholder rights. Investors should carefully review the attached exhibits (especially the acquisition agreement in Exhibit 2.1 and new governance documents) to understand the transaction terms, debt levels, and any dilution to existing shareholdings. The breadth of items disclosed suggests this is a material event requiring thorough due diligence.
DTST
NASDAQ
▲ SUPER 8-K
Data Storage Corporation Common Stock
EDGAR Items: 1.01,2.01,5.07,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on September 16, 2025 (reporting period September 10, 2025) and covers multiple material events.
**Key Material Events:**
1. **Material Definitive Agreement (Item 1.01)** - The company entered into a significant binding agreement, though specific details require review of Exhibit 10.1.
2. **Acquisition/Disposition Completed (Item 2.01)** - The company completed an asset acquisition or disposition transaction, representing a substantive change to the company's business operations or asset base.
3. **Shareholder Vote (Item 5.07)** - The company submitted matters to shareholder vote, likely related to approving the transaction noted above.
4. **Additional Disclosure (Item 7.01)** - Supplementary information was provided to investors via Regulation FD.
**Investor Implications:**
This filing signals a significant corporate transaction or strategic shift. The combination of a material agreement, completed transaction, and shareholder vote suggests a major M&A event (acquisition, merger, or substantial asset sale). Investors should review the exhibits and full 8-K document to understand the transaction terms, financial impact, and strategic rationale for this material change to the company's operations.
COBA
OTC
▲ SUPER 8-K
Chilean Cobalt Corp.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary: Chilean Cobalt Corp.
**Filing Date:** September 15, 2025 | **Period:** September 12, 2025
Chilean Cobalt Corp. filed a Form 8-K disclosing material acquisitions and agreements entered into on September 12, 2025. The filing indicates the company completed an acquisition or disposition of assets and entered into a mining concession purchase agreement, with details provided in the attached agreement exhibit. The company also conducted unregistered sales of equity securities in connection with these transactions.
**Key Implications for Investors:** This filing suggests Chilean Cobalt Corp. is actively pursuing mining asset expansion in Chile, likely to strengthen its cobalt production capabilities in response to growing demand for battery metals. However, investors should review the complete mining concession purchase agreement and press release to assess the purchase price, terms, financing structure, and strategic fit. The unregistered equity issuance indicates potential dilution to existing shareholders, which warrants further scrutiny into valuation and deal structure.
BGMSP
OTC
▲ SUPER 8-K
Bio Green Med Solution, Inc.
EDGAR Items: 2.01,3.03,5.03,7.01,9.01
# SEC 8-K Filing Summary
Based on this September 12, 2025 8-K filing, the company has undergone several significant corporate changes: **completion of an acquisition or disposition of assets** (Item 2.01), **material modifications to security holder rights** (Item 3.03), and **amendments to articles of incorporation or bylaws** (Item 5.03). These concurrent filings indicate a substantial corporate restructuring or M&A transaction has been completed.
The filing includes multiple exhibits and exhibits relating to amended governance documents and transaction agreements, suggesting the transaction involved meaningful changes to the company's capital structure, shareholder rights, and organizational framework. **For investors**, this signals either a completed merger, acquisition, significant divestiture, or substantial recapitalization that may affect voting rights, share classes, or dividend priorities.
To fully assess the investment implications, shareholders should review the detailed 8-K document and exhibits (particularly EX-10.1 containing transaction agreements and EX-99 exhibits with press releases or transaction details) to understand the specific nature of the transaction, any dilution or value creation potential, and how it impacts their ownership position and rights.
MYSZ
NASDAQ
▲ SUPER 8-K
My Size, Inc
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
Based on the filing dated September 12, 2025 (for period ending September 8, 2025), this 8-K reports several material corporate events:
The company completed a significant acquisition or disposition of assets and entered into material definitive agreements, as evidenced by the multiple exhibits attached (EX-10.1 through EX-10.4 containing detailed contractual documents). Additionally, the filing includes unregistered sales of equity securities, suggesting the company may have issued stock as part of the transaction consideration. The breadth of items reported—spanning new agreements, asset completion, equity issuance, and regulatory disclosures—indicates a substantial corporate transaction that will impact the company's capital structure and operations.
For investors, this represents a major strategic event that could significantly affect financial position, ownership structure, and future earnings potential. The specific details of the acquisition/disposition and equity terms would be critical for investors to review in the attached exhibits to fully assess the impact on shareholder value.
NRXP
NASDAQ
▲ SUPER 8-K
NRX Pharmaceuticals, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Date:** NRX Pharmaceuticals (CIK: 1719406) filed this 8-K on September 12, 2025, reporting events from September 8, 2025.
**Material Event:** The company completed an acquisition or disposition of assets (Item 2.01), marking a significant corporate transaction that may impact its operational structure, financial position, or strategic direction.
**Key Items Disclosed:** Beyond the asset transaction, NRX provided regulatory fair disclosure (Item 7.01) and included supporting financial statements and exhibits, indicating comprehensive disclosure of the acquisition's terms and details.
**Investor Implications:** The completion of this asset transaction represents a material corporate action that could affect the company's revenue streams, cost structure, and strategic positioning. Investors should review the detailed 8-K filing and exhibits to understand the acquisition's financial impact, financing details, and implications for future earnings and shareholder value.
BGMS
NASDAQ
▲ SUPER 8-K
Bio Green Med Solution, Inc. Common Stock
EDGAR Items: 2.01,3.03,5.03,7.01,9.01
# SEC 8-K Filing Summary
Based on this September 12, 2025 8-K filing, the company completed a significant **acquisition or disposition of assets** (Item 2.01) and made material modifications to its capital structure, including **amendments to its articles of incorporation or bylaws** (Item 5.03) and **material modifications to security holder rights** (Item 3.03). The filing includes 23 supporting documents with detailed transaction agreements and disclosures (Items 10.1 and 99.1-99.3), suggesting a complex corporate restructuring.
**For investors:** This filing indicates a substantial corporate transaction that may affect share structure, voting rights, or ownership interests. The multiple exhibits suggest detailed transaction terms that warrant careful review. Investors should examine the attached acquisition agreements and disclosure documents to understand the transaction's financial impact, any dilution effects, and how it aligns with the company's strategic direction.
ROYL
OTC
▲ SUPER 8-K
Royale Energy, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Summary
Based on the filing dated September 9-10, 2025, this 8-K from Royal Gold, Inc. (CIK 1694617) reports material transactions including the entry into a definitive agreement and completion of an acquisition or disposition of assets. The filing contains four key item disclosures: a material definitive agreement (Item 1.01), completion of an acquisition/disposition (Item 2.01), regulatory disclosure (Item 7.01), and financial statements/exhibits (Item 9.01).
**For investors:** This filing indicates Royal Gold has completed a significant acquisition or asset transaction and entered into related agreements, though the specific details would require reviewing the full 8-K document and exhibits. The company appears to be engaged in active M&A activity, which could impact its financial position, asset base, and future operational strategy. Investors should review the complete filing to understand deal terms, financing implications, and any material risks.
PMCB
NASDAQ
▲ SUPER 8-K
PharmaCyte Biotech, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary: PharmaCyte Therapeutics Inc.
**Filing Date:** September 5, 2025 (Period: September 2, 2025)
PharmaCyte Therapeutics announced a material financing transaction involving the entry into a Securities Purchase Agreement dated September 2, 2025, which included the issuance of Series H Convertible Preferred Stock and warrants. The company completed this asset/securities transaction and established registration rights for the investor, indicating a significant capital raise to fund operations or strategic initiatives. This financing includes convertible preferred stock and warrants, which dilute existing shareholders but provide the company with needed capital; investors should review the registration rights agreement and conversion terms to understand potential future dilution and the investor's exit strategy.
NGTF
OTC
▲ SUPER 8-K
NightFood Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filing dated September 3, 2025, the company reported material corporate activity including the entry into a definitive agreement, completion of an acquisition or disposition of assets, and an unregistered equity issuance. The filing covers events that occurred on August 27, 2025, and includes a substantial transaction document (EX-2.1) that provides the detailed terms of the agreement. Without access to the actual filing content, the specific financial impact and strategic implications cannot be fully assessed, but the combination of these items—particularly the asset transaction and equity issuance—suggests a significant corporate event such as a merger, asset sale, or major financing that could materially affect shareholder value. Investors should review the full 8-K document and the referenced agreement exhibits to understand the transaction terms, financing structure, and any potential dilution or strategic changes.
August 2025
15 filings
▼
CCLD
NASDAQ
▲ SUPER 8-K
CareCloud, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,8.01,9.01
# Summary of 8-K Filing (August 25, 2025)
This 8-K filing indicates a significant corporate transaction involving the company (CIK: 1582982) that was completed on August 22, 2025. The filing discloses multiple material items: entry into definitive agreement(s), completion of an acquisition or asset disposition, and creation of direct financial obligations. The presence of multiple exhibits (EX-2.1 through EX-2.7) suggests complex transaction documentation, likely including purchase agreements and related contracts. Investors should review the full filing details and exhibits to understand the transaction's financial impact, including the nature of assets involved, deal consideration, financing terms, and any contingent liabilities or off-balance sheet obligations created. This transaction could materially affect the company's financial position, capital structure, and operational strategy.
NBRWF
OTC
▲ SUPER 8-K
NABORS INDUSTRIES LTD
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
Based on this August 22, 2025 8-K filing, the company has reported **material transactional activity** involving the entry into a definitive agreement and completion of an acquisition or asset disposition. The filing includes detailed exhibits (10.1, 10.2, 10.3) documenting the agreement terms and transaction specifics, along with supplemental disclosures. While the precise details require reviewing the full document text, the combination of Items 1.01 and 2.01 indicates a significant M&A event has been executed and closed.
**For investors:** This represents a potentially material corporate action that could impact the company's capital structure, operations, or strategic direction. Shareholders should review the full 8-K document and exhibits to understand the transaction's financial implications, including any changes to debt, equity, asset base, or business operations. The transaction's valuation and strategic rationale will be critical factors in assessing its impact on shareholder value.
CANN
OTC
▲ SUPER 8-K
TREES Corp (Colorado)
EDGAR Items: 1.01,2.01,2.03,5.02,9.01
# Summary of Trees Corporation 8-K Filing (August 22, 2025)
Trees Corporation filed a material 8-K on August 22, 2025, reporting several significant corporate events that occurred on June 20, 2025. The filing discloses the entry into a refinancing agreement and the completion of an acquisition or disposition of assets, along with the creation of new direct financial obligations including multiple secured notes. Additionally, there were changes to the company's officer or director compensation arrangements during this period.
For investors, this filing indicates that Trees Corporation underwent substantial financial restructuring through refinancing arrangements and debt instruments, which could affect the company's capital structure and future financial obligations. The multiple secured notes and amended debt arrangements suggest the company may be managing existing liabilities or financing new operations. Investors should review the detailed refinancing agreement and note terms to understand the impact on cash flow, interest obligations, and potential dilution or constraints on future operations.
NTHI
NASDAQ
▲ SUPER 8-K
NeOnc Technologies Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.02,3.02,5.02,7.01,9.01
# 8-K Summary: Neon C Technologies
**Filing Date:** August 22, 2025 | **Period:** August 18, 2025
Based on the disclosed items, Neon C Technologies completed a **material acquisition or asset disposition and entered into significant definitive agreements** on August 18, 2025. The filing also indicates **changes in officer/director compensation arrangements** and **unregistered equity issuances**, suggesting the transaction may have involved stock consideration or new executive incentives. Additionally, the company reported **operational results and financial condition updates**, likely reflecting the impact of the transaction.
**For investors:** This appears to be a transformational M&A event that restructured the company's operations and capital structure. The multiple disclosed items—particularly the asset/acquisition completion combined with management changes and equity issuances—warrant detailed review of the full 8-K filing to understand deal terms, dilution impact, and strategic rationale. The unregistered securities issuance may also have liquidity implications for existing shareholders.
HIND
NASDAQ
▲ SUPER 8-K
Vyome Holdings, Inc. Common Stock
EDGAR Items: 2.01,3.02,3.03,5.02,5.03,9.01
# SEC 8-K Filing Summary: Vyome Therapeutics, Inc.
**Filing Date:** August 19, 2025 | **Period:** August 13, 2025
Vyome Therapeutics completed a significant acquisition and implemented substantial corporate restructuring on August 13, 2025. The filing reveals the completion of an asset acquisition (Item 2.01), unregistered equity issuances (Item 3.02), and a merger involving Raider Lifesciences into Vyome Therapeutics. Additionally, the company amended its certificate of incorporation multiple times and modified Series C convertible preferred stock terms, indicating significant changes to the capital structure and shareholder rights.
**Key Material Changes:**
- Executive leadership modifications (Item 5.02) including appointment of new officers and an interim CFO consulting arrangement
- Multiple amendments to the articles of incorporation and security designations
- Unregistered equity issuances tied to the acquisition
**Investor Implications:** These changes suggest Vyome is executing a strategic transaction to expand operations or capabilities, though the unregistered equity issuances and modifications to preferred stock rights may impact existing shareholders' positions. Investors should review the full filing details regarding dilution, governance changes, and the specific terms of the acquisition to assess the long-term strategic value.
RHEP
OTC
▲ SUPER 8-K
REGIONAL HEALTH PROPERTIES, INC
EDGAR Items: 1.01,2.01,2.03,3.03,5.02,8.01,9.01
# SEC 8-K Filing Summary
I can see this is a Form 8-K filing dated August 14, 2025, but the actual content of the filing is not visible in the HTML provided—only the filing index and document list are shown.
Based on the **reported items**, this appears to be a **significant corporate event** involving:
- **Material acquisition or asset disposition** (Item 2.01)
- **New debt or financial obligation** (Item 2.03)
- **Executive or board changes** (Item 5.02)
- **Potential shareholder rights modifications** (Item 3.03)
**For investors:** This 8-K signals substantial company restructuring—likely a major M&A transaction with financing, leadership changes, and possible capital structure implications. To assess investment impact, review the actual 8-K document (form8-k.htm) and attached exhibits for specific transaction details, valuations, debt terms, and management implications.
ICU
NASDAQ
▲ SUPER 8-K
SeaStar Medical Holding Corporation Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company:** ICU Medical, Inc. (CIK: 1831868)
**Filing Date:** August 13, 2025
## Key Points:
ICU Medical filed a Form 8-K reporting the **completion of an acquisition or disposition of assets** (Item 2.01), indicating a material transaction has been finalized. The filing includes supplemental financial information and exhibits that provide details on the transaction structure and terms.
This acquisition completion represents a significant corporate action that could materially impact the company's balance sheet, operations, and future financial performance. Investors should review the detailed exhibit materials to understand the acquisition's size, financing method, and strategic rationale.
The timing and nature of this transaction may affect near-term earnings, debt levels, and operational integration risks, which warrant close monitoring of subsequent quarterly earnings reports and management guidance.
CHUC
OTC
▲ SUPER 8-K
Charlie's Holdings, Inc.
EDGAR Items: 1.01,2.01,5.07,9.01
# SEC 8-K Filing Summary
Based on the filing dated August 11, 2025 (for period ending August 7, 2025), this 8-K reports significant corporate activity for the company (CIK 1134765). The filing indicates **three material events**: entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and submission of matters to a shareholder vote (Item 5.07).
While the HTML provided contains only the filing structure without the substantive content, the presence of these items suggests the company has completed a significant M&A transaction and obtained shareholder approval. Investors should review the full 8-K document and attached exhibits (particularly Exhibit 10.1) for specific details regarding the transaction terms, financial impact, and strategic implications for the company's future operations and financial position.
DWSN
NASDAQ
▲ SUPER 8-K
Dawson Geophysical Company New Common Stock
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
Dawson Geophysical Company (CIK: 799165) filed an 8-K on August 11, 2025, reporting material events that occurred on August 8, 2025.
**Key Material Events:**
The filing discloses four major items: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) creation of a direct financial obligation, and (4) other regulatory disclosures with supporting financial exhibits.
**Investor Implications:**
Without access to the full 8-K document text, the specific details of the transaction cannot be fully assessed, but the combination of a material agreement, asset transaction, and new debt obligation suggests a significant corporate restructuring, acquisition, or major financing activity. Investors should review the complete filing and attached exhibits to understand the transaction terms, financial impact, and strategic rationale, as these types of simultaneous events typically have material implications for shareholders.
CTSO
NASDAQ
▲ SUPER 8-K
Cytosorbents Corp.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filed August 7, 2025 (CIK: 1175151)
**Key Material Event:** The company completed an acquisition or disposition of assets, as reported under Item 2.01 of the 8-K filing.
**What Changed:** This is a current report disclosing the completion of a significant corporate transaction involving the acquisition or disposal of assets. The filing includes 14 supporting documents and exhibits with financial statements and detailed transaction information.
**Investor Implications:** While the specific details of the transaction are not visible in this header information, the completion of an asset acquisition or disposition could materially impact the company's balance sheet, cash position, and future earning potential. Investors should review the full 8-K document and accompanying exhibits (particularly Exhibit 99-1) to understand the transaction's size, financing structure, strategic rationale, and expected financial impact on the company.
RIME
NASDAQ
▲ SUPER 8-K
Algorhythm Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# 8-K Filing Summary
Based on this August 7, 2025 SEC 8-K filing, the company has reported **multiple material events** involving a significant transaction:
The filing discloses entry into a material definitive agreement (Item 1.01) and **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has completed a major M&A transaction. The filing includes substantial supporting documentation, including a full contract (Exhibit 10.1, ~450KB) and disclosure materials (Exhibit 99.1), suggesting this is a significant business development.
**For investors:** This represents a material corporate event that could substantially alter the company's business profile, financial position, and future growth trajectory. The transaction's impact on shareholder value will depend on the deal terms, financing structure, and strategic rationale disclosed in the complete 8-K filing. Investors should review the full document and exhibits to understand the acquisition/disposition details, purchase price, funding source, and management's strategic justification.
CEIN
OTC
▲ SUPER 8-K
CAMBER ENERGY, INC.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Material Acquisition/Agreement Entry
Based on this August 6, 2025 8-K filing (Period of Report: August 1, 2025), the company has entered into a material definitive agreement and completed an acquisition or disposition of assets. The filing includes three key agreements: a Securities Purchase Agreement, an Operating Agreement, and an Assignment Agreement, indicating a significant business transaction or investment arrangement.
**Key Points for Investors:**
- This is a material transaction that could meaningfully impact the company's financial position, operations, or ownership structure
- The multiple supporting agreements (operating agreement and assignment agreement) suggest a complex transaction, potentially involving equity investment, operational changes, or asset transfers
- Investors should review the full 8-K document and attached agreements to understand the financial terms, any dilution to existing shareholders, and the strategic rationale for the transaction
The specific details regarding deal value, ownership percentages, and financial impact would be found in the complete filing documents, which should be reviewed for full transparency on how this transaction affects shareholder interests.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Spectral Capital Corporation
**Filing Date:** August 4, 2025 (reporting period August 1, 2025)
Spectral Capital Corporation completed a material acquisition or disposition of assets and entered into a definitive share exchange agreement, as indicated by Items 1.01 and 2.01 in this 8-K filing. The company issued a press release on July 31, 2025 announcing the transaction, with closing documentation dated August 1, 2025, including a closing certificate and an addendum to the original share exchange agreement.
**For Investors:** This filing signals a significant corporate transaction that may materially alter the company's business structure, asset base, or shareholder composition. Investors should review the complete 8-K document and attached exhibits (including the press release and share exchange agreement) to understand the transaction's terms, value, and strategic implications for future operations and shareholder value.
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this August 4, 2025 Form 8-K filing (for period ending July 30, 2025), the company reported **multiple material corporate events**, including: entry into a material definitive agreement, termination of a material agreement, and completion of an acquisition or disposition of assets. The filing also involves unregistered equity securities sales, indicating significant corporate restructuring or M&A activity.
**Key Items for Investors:**
- **Material Agreement Changes**: Both new agreements entered and existing agreements terminated suggest potential strategic pivots or deal completion
- **Asset Transaction**: The completion of an acquisition or asset disposition represents a substantial corporate action that could materially impact the company's operations, financial position, or shareholder value
- **Equity Issuance**: Unregistered securities sales indicate potential dilution to existing shareholders
Without access to the full 8-K document content, the precise financial impact cannot be determined, but investors should review the detailed disclosure documents (particularly Exhibit 10.1) to understand transaction terms, consideration paid/received, and implications for future earnings and capital structure.
BMPA
OTC
▲ SUPER 8-K
BMP AI Technologies, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# 8-K Filing Summary: Material Acquisition/Disposition Event
Based on this SEC 8-K filing dated July 29, 2025, the company reported a significant material event involving both the acquisition and disposition of assets. The filing indicates Items 1.01 (entry into a material definitive agreement), 2.01 (completion of acquisition or disposition), and 3.02 (unregistered equity sales), suggesting the company either purchased or sold substantial assets and potentially issued equity as part of the transaction.
The presence of an Asset Purchase Agreement and Asset Transfer Agreement indicates this was a structured transaction, though the specific dollar amounts and asset details would need to be reviewed in the full 8-K document itself. For investors, this type of transaction could signal strategic repositioning, potential changes to the company's business focus, or liquidity needs if significant equity was issued. The transaction's materiality warrants careful review of the complete filing to understand potential impacts on earnings, cash flow, and shareholder value.
July 2025
12 filings
▼
AEI
NASDAQ
▲ SUPER 8-K
Alset Inc. Common Stock (TX)
EDGAR Items: 2.01,2.03,3.02,9.01
# SEC 8-K Filing Summary
**Company:** AEI (CIK: 1750106)
**Filing Date:** July 23, 2025
## Key Material Events:
This 8-K discloses four significant items: **(1) Completion of an acquisition or disposition of assets**, **(2) Creation of new financial obligations or off-balance sheet arrangements**, **(3) Unregistered equity securities sales**, and **(4) Related financial statements and exhibits**.
## What Changed:
The company has completed a major acquisition or asset sale and concurrently raised capital through unregistered equity issuance while taking on new debt or financial obligations. The timing and coordination of these transactions suggest a significant corporate restructuring or strategic pivot.
## Investor Implications:
Investors should carefully review the full filing documents to understand deal terms, acquisition price, financing structure, debt obligations, and equity dilution. The combination of asset transactions, new debt, and unregistered equity sales could materially impact the company's capital structure, financial leverage, and ownership percentages. The specific details in the exhibits and financial statements will be critical for assessing whether this transaction enhances shareholder value.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
**Filing Date:** July 22, 2025 | **Report Period:** July 18, 2025
**Key Event:** PMGC Holdings Inc. completed a significant acquisition of assets, as reported in this 8-K filing. The company executed an acquisition agreement dated July 18, 2025, and disclosed the transaction through a contemporaneous press release.
**Material Details:** The filing includes the full acquisition agreement and press release as exhibits, indicating this was a material transaction requiring immediate public disclosure under SEC regulations. The specific terms and financial impact of the acquisition would be detailed in the attached agreement document.
**Investor Implications:** Investors should review the acquisition agreement (Exhibit 10.1) and press release (Exhibit 99.1) to understand the strategic rationale, purchase price, financing structure, and expected impact on PMGC's financial position and future operations. This transaction may affect earnings, balance sheet strength, and the company's growth trajectory going forward.
IQST
NASDAQ
▲ SUPER 8-K
IQSTEL INC. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: iQSTEL Inc. (July 21, 2025)
**Company:** iQSTEL Inc. (CIK: 1527702)
**Key Event:** iQSTEL completed an acquisition or disposition of assets, as reported in this Form 8-K filed on July 21, 2025.
**Material Details:** The filing includes Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 9.01 (Financial Statements and Exhibits), with a press release dated July 21, 2025 providing additional context on the transaction.
**Investor Implications:** While the specific details of the acquisition or asset disposition are not visible in the HTML header provided, investors should review the full 8-K document and accompanying press release to understand the strategic rationale, financial impact, and whether this transaction materially affects the company's business operations, revenue, or competitive position. The completion of this transaction could represent a significant strategic shift for the company that warrants careful analysis.
PFSA
NASDAQ
▲ SUPER 8-K
Profusa, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.01,5.02,5.06,8.01,9.01
# SEC 8-K Filing Summary - ProFUSA Inc. (July 18, 2025)
This 8-K filing indicates a **significant corporate transaction and change of control** for ProFUSA. The company entered into a material definitive agreement, completed an acquisition/disposition of assets, created new financial obligations (including a senior secured convertible note), issued unregistered equity securities through a PIPE (Private Investment in Public Equity), and experienced a change in control of the registrant, effective July 11, 2025.
**Key implications for investors:** The multiple items filed—particularly the change of control, new debt issuance, and equity dilution from the PIPE investment—suggest ProFUSA underwent a merger, acquisition, or reverse merger transaction. The senior secured convertible note and PIPE lock-up/registration rights agreements indicate dilution to existing shareholders and new creditor obligations. Investors should review the detailed documents to assess the deal's valuation, the extent of dilution, debt terms, and any management changes (Item 5.02 also filed), as these factors could materially impact shareholder value and company control structure.
OMQS
OTC
▲ SUPER 8-K
OMNIQ Corp.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# 8-K Summary Analysis
Based on this SEC filing from July 16, 2025, the company has announced **significant M&A activity and new financing arrangements**. The filing indicates completion of an acquisition or disposition of assets, entry into material definitive agreements, and creation of direct financial obligations—suggesting the company has either acquired or divested a major asset and secured financing to support this transaction.
**Key implications for investors:**
1. **Material acquisition/disposition completed** - The company has closed a significant deal that warrants immediate disclosure to the market
2. **New debt or financial obligations** - Direct financial obligations were created, indicating the company has taken on new debt or off-balance sheet arrangements to fund the transaction
3. **Strategic shift** - This transaction likely represents a meaningful change to the company's business operations and capital structure
The multiple exhibits (10 different documents including agreements and supplemental materials) suggest this is a complex transaction. **Investors should review the full 8-K document and attached agreements to understand deal terms, financing structure, potential dilution, and strategic rationale**, as this could materially impact future earnings, cash flow, and shareholder value.
OWPC
OTC
▲ SUPER 8-K
One World Products, Inc.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
Based on the July 15, 2025 8-K filing, this current report discloses several material events:
**Key Material Events:**
The filing reports the entry into material definitive agreements (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and unregistered sales of equity securities (Item 3.02). The company has also made regulatory FD disclosures and included financial statements and exhibits.
**What This Means for Investors:**
This 8-K indicates significant corporate activity including a likely M&A transaction (acquisition/disposition) with associated equity issuances. The presence of multiple exhibits (10.1-10.3) containing detailed agreements and the unregistered equity sale suggest a material business combination that could substantially affect the company's capital structure, operations, or financial position. Investors should review the full filing documents to understand the deal terms, valuation implications, and any dilution from the equity issuance.
**Note:** To provide a more precise analysis, the actual content of the 8-K form and exhibits would need to be reviewed, as this filing index only shows the document structure and item categories rather than the specific transaction details.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary: Spectral Capital Corporation
**Filing Date:** July 15, 2025 (Period: July 13, 2025)
**Key Material Events:**
Spectral Capital Corporation entered into a definitive share exchange agreement and completed an acquisition or disposition of assets involving 42 Telecom Ltd., as indicated by Items 1.01 (Material Definitive Agreement) and 2.01 (Completion of Acquisition/Disposition) in the filing.
**What Changed:**
The company has executed a binding share exchange agreement with 42 Telecom Ltd., fundamentally altering its asset base and operational structure. A press release was issued jointly by both companies on or around July 13, 2025, to announce this transaction.
**Investor Implications:**
This M&A activity signals a strategic shift for Spectral Capital, likely expanding or reorienting its business operations. Investors should review the definitive share exchange agreement (Exhibit 10.1) for critical terms including exchange ratios, earnouts, representations/warranties, and closing conditions. The transaction's financial impact on shareholder value and future earnings will depend on the valuation terms and synergy potential with 42 Telecom.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
**Filing Date:** July 11, 2025 | **Report Period:** July 7, 2025
**Key Material Event:** PMGC Holdings Inc. completed the acquisition of Pacific Sun Packaging Inc., as disclosed in this 8-K filing. The company provided audited financial statements for the acquired business and unaudited pro forma combined financial statements showing the integrated entity's financial position.
**What Changed:** This acquisition represents a significant corporate transaction that expands PMGC Holdings' operations through the addition of Pacific Sun Packaging's business. The filing includes comprehensive financial documentation, including the target company's audited financials and pro forma combined statements reflecting the merged entity.
**Investor Implications:** Investors should review the pro forma financials to understand the combined company's balance sheet, profitability, and financial position post-acquisition. The acquisition may represent a strategic expansion into packaging operations, but investors should carefully examine the terms, integration plans, and any potential dilution or synergies outlined in the accompanying press release to assess impact on shareholder value.
QTRX
NASDAQ
▲ SUPER 8-K
Quanterix Corporation Common Stock
EDGAR Items: 2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filed July 8, 2025 (CIK: 1503274)
**Key Material Events:**
This 8-K discloses the completion of an acquisition or disposition of assets (Item 2.01), combined with significant management changes including the departure and/or appointment of directors and officers with associated compensation arrangements (Item 2.02). The filing also includes regulatory disclosures and financial statements related to these transactions.
**Investor Implications:**
The simultaneous filing of acquisition completion alongside executive departures and new compensation arrangements suggests a substantial corporate restructuring or M&A transaction that resulted in leadership changes. Investors should review the detailed exhibits and financial statements to understand the transaction's terms, valuation impact, and new management's background and compensation structure, which could affect near-term operational direction and shareholder value.
SABR
NASDAQ
▲ SUPER 8-K
Sabre Corporation
EDGAR Items: 2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** On July 3, 2025, the company completed an acquisition or disposition of assets (Item 2.01), which represents a material business transaction requiring immediate disclosure.
**Key Changes:** The filing also discloses changes in executive leadership through departures and/or appointments of officers/directors (Item 5.02), including compensatory arrangements for certain officers—suggesting potential restructuring or new management in connection with the deal.
**Material Impact for Investors:** The combination of a completed acquisition and simultaneous management changes indicates significant corporate transformation. Investors should review the detailed 8-K filing to understand the financial terms of the transaction, the strategic rationale, and how new leadership may affect future operations and shareholder value.
BLMH
OTC
▲ SUPER 8-K
BLUM HOLDINGS, INC.
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of 8-K Filing (BLMH - July 3, 2025)
Bloom Health Inc. entered into material agreements effective July 1, 2025, including a binding term sheet and a management services agreement, representing significant corporate developments. The company completed or is advancing an acquisition or disposition of assets, as indicated by Item 2.01 in the filing. These transactions involve new contractual relationships that could materially impact the company's operations, ownership structure, or strategic direction. Investors should review the detailed term sheet and management services agreement to understand the financial implications, terms, and potential dilution or synergies involved in these transactions. The specific nature and financial impact of these changes warrant careful analysis of the full filing documents.
RNGE
OTC
▲ SUPER 8-K
RANGE IMPACT, INC.
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** July 3, 2025 | **Period Covered:** June 30, 2025
This 8-K filing indicates the company has completed a **material acquisition or disposition of assets** and entered into one or more **material definitive agreements**. The filing includes substantial supporting documentation (17 documents total), with two significant agreements attached as exhibits, suggesting a major corporate transaction has been completed.
The presence of Items 1.01 (Material Agreement) and 2.01 (Asset Acquisition/Disposition) together signals a significant M&A event or substantial asset transaction. Without access to the specific agreement details in the exhibits, the financial impact on shareholder value, debt levels, and future earnings guidance would need to be reviewed in the full filing documents.
**For investors:** This represents a material corporate event that could meaningfully affect the company's capital structure, operational profile, and financial trajectory. Immediate review of the attached agreements and any accompanying press release (Exhibit 99.1) is recommended to assess strategic implications and synergy potential.
June 2025
14 filings
▼
HURA
NASDAQ
▲ SUPER 8-K
TuHURA Biosciences, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary: Huize Holding Limited
**Filing Date:** June 30, 2025
**Key Material Event:** Huize Holding Limited (HURA) completed an acquisition or disposition of assets, as indicated by Item 2.01. The company also disclosed additional information via Regulation FD (Item 7.01), suggesting management provided material guidance or updates to investors.
**What Changed:** This 8-K reports the completion of a significant corporate transaction involving asset acquisition or disposal, along with supplementary disclosures that may include updated financial projections or strategic information contained in the attached exhibits.
**Investor Implications:** The completed transaction represents a substantive change to Huize's asset base and business structure. Investors should review the detailed disclosure documents (particularly Exhibit 99.1) to understand the transaction's financial impact, strategic rationale, and any changes to the company's future earnings potential or operational direction. The timing in late June 2025 suggests this was a priority transaction for management.
JSDA
OTC
▲ SUPER 8-K
JONES SODA CO.
EDGAR Items: 1.01,2.01,5.02,8.01,9.01
# SEC 8-K Filing Summary
Based on this June 30, 2025 8-K filing, the company completed a **material acquisition or disposition of assets** and entered into **significant definitive agreements** as of June 13, 2025. The filing also indicates **changes in executive leadership or compensation arrangements** for certain officers. With 21 supporting documents and multiple exhibit agreements (EX-10.1 through EX-10.5), this represents a substantial corporate transaction involving binding contracts and potentially restructured management incentives.
**For investors:** This signals a major strategic transaction that could materially impact the company's operations, financial position, and leadership structure. The specific terms and financial implications would require reviewing the detailed exhibits and agreements, but the breadth of documentation suggests a complex deal that warrants careful analysis of potential impacts on shareholder value.
BNKK
NASDAQ
▲ SUPER 8-K
Bonk, Inc. Common Stock
EDGAR Items: 2.01,2.03,2.04,3.02,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated June 27, 2025 (CIK: 1760903)
**Material Events:**
This 8-K discloses multiple significant corporate transactions: the completion of an acquisition or disposition of assets, creation of direct financial obligations, triggering events that accelerate financial obligations, unregistered equity sales, and changes in senior management/officer compensation arrangements. The filing includes 22 documents with substantial exhibits (over 1MB combined), indicating complex transaction documentation.
**Key Implications for Investors:**
The completion of an acquisition paired with new debt creation and accelerated financial obligations suggests the company has undertaken a major strategic transaction potentially funded through both equity and debt financing. The unregistered equity sales and management changes indicate potential dilution and possible leadership transitions. The multiple financial obligation triggers warrant careful review of the actual documents to assess debt levels, terms, and potential impacts on financial flexibility and shareholder value.
**Recommendation:** Investors should review the actual 8-K document (form8-k.htm) and supporting exhibits to understand the transaction details, debt structure, equity dilution impact, and management changes before making investment decisions.
DAIC
NASDAQ
▲ SUPER 8-K
CID HoldCo, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01
# SEC 8-K Filing Summary
**CID Holdco, Inc. - Material Transaction** (Filed June 26, 2025)
This 8-K reveals a **significant corporate transformation** involving multiple material events on June 18, 2025, including a change in control of the registrant, completion of an acquisition, entry into definitive agreements, and a change from shell company status. The filing documents extensive corporate restructuring with new certificate of incorporation, bylaws, and equity incentive plans, along with PIPE (Private Investment in Public Equity) subscription agreements and warrant assumption activities.
**Key implications for investors:** This appears to be a SPAC merger or similar combination transaction that fundamentally altered the company's ownership structure and capital composition. The numerous items filed—particularly changes in control, equity issuances, and accountant changes—suggest a major business combination requiring immediate investor attention to understand the new entity's ownership, management, and financial position. Investors should review the full 8-K document and referenced exhibits to assess the deal terms, dilution impact, and new company fundamentals.
HCTI
NASDAQ
▲ SUPER 8-K
Healthcare Triangle, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** Healthcare company filed an 8-K on June 23, 2025, reporting a material acquisition or asset/stock transfer agreement dated June 16, 2025, along with new financing obligations and unregistered equity issuance.
**Key Changes:** The filing indicates the company completed an acquisition or significant asset disposition, created direct financial obligations, and issued unregistered equity securities as part of the transaction structure. Multiple material agreements were entered into simultaneously.
**Material Impact for Investors:** This represents a transformational corporate event involving debt financing, equity dilution, and asset restructuring. Investors should review the attached Asset and Stock Transfer Agreement (Exhibit 10.1) and press release (Exhibit 99.1) for transaction details, pricing, financing terms, and strategic rationale, as these items collectively indicate a significant capital allocation decision with implications for future earnings, debt levels, and shareholder ownership structure.
ALDS
OTC
▲ SUPER 8-K
APPlife Digital Solutions Inc
EDGAR Items: 2.01,3.02,5.02,5.03,7.01,9.01
# Summary of AppLife Digital Solutions 8-K Filing (June 20, 2025)
AppLife Digital Solutions completed a significant acquisition or disposition of assets and simultaneously issued multiple series of preferred stock (Series A, B, C, and D) as of June 13, 2025. The company also underwent corporate restructuring, including amendments to its articles of incorporation and bylaws, along with changes to officer compensation arrangements. The filing includes four detailed certificates of designation for the new preferred stock series, indicating a material capital restructuring event. For investors, this suggests the company raised capital through preferred equity issuance, likely to fund the acquisition, though the specific terms and financial impact require review of the detailed certificates and press release to fully assess dilution and voting rights implications.
BINI
OTC
▲ SUPER 8-K
BOLLINGER INNOVATIONS, INC.
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Summary: Mullen Automotive (MULN)
**Filing Date:** June 12, 2025 | **Period:** June 5, 2025
Mullen Automotive filed a Form 8-K reporting the **completion of an acquisition or disposition of assets** (Item 2.01), along with regulatory disclosure information and financial exhibits. The filing includes 15 documents and interactive data files, though the specific details of the transaction are contained in the linked exhibit documents.
**Key Takeaway for Investors:** This is a material corporate transaction that may significantly impact Mullen's asset base, financial position, or operational structure. Investors should review the full 8-K document and Exhibit 99.1 to understand the nature of the acquisition/disposition, financial terms, and strategic implications for the company's future performance.
NCRA
NASDAQ
▲ SUPER 8-K
Nocera, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Nocera Inc. (June 10, 2025)
**Material Events:**
Nocera Inc. filed an 8-K on June 10, 2025, reporting two significant transactions completed on June 5, 2025: (1) entry into a Stock Purchase Agreement and (2) completion of an Equity Transfer Agreement. These transactions represent material definitive agreements and asset acquisitions that required immediate SEC disclosure.
**Key Implications for Investors:**
The filing indicates Nocera has either acquired or divested a significant asset or equity stake. Without access to the full agreement details, investors should review the attached Stock Purchase Agreement and Equity Transfer Agreement exhibits to understand the transaction value, terms, strategic rationale, and potential impact on earnings, balance sheet, and future operations. The dual agreements suggest a complex transaction structure that could meaningfully alter the company's operational footprint or ownership structure.
IVPR
OTC
▲ SUPER 8-K
INSPIRE VETERINARY PARTNERS, INC.
EDGAR Items: 2.01,3.02,8.01,9.01
# SEC 8-K Summary: Inspire Entertainment Holdings Inc.
**Filing Date:** June 10, 2025 (Period: June 5, 2025)
Inspire Entertainment Holdings Inc. completed a significant asset acquisition and real estate purchase, as detailed in this 8-K filing. The company executed an asset purchase agreement and a separate real estate asset purchase agreement involving Suarez Enterprises, LLC and IVP FL Holding Company. Additionally, the filing indicates an unregistered sale of equity securities occurred in connection with these transactions.
**Key Implications for Investors:**
- The company has expanded its asset base through acquisition activity, which could indicate growth strategy or strategic repositioning
- The unregistered equity issuance suggests potential dilution to existing shareholders
- Investors should review the detailed purchase agreements (Exhibits 10.1 and 10.2) to understand deal terms, purchase price, financing structure, and any contingencies that could affect shareholder value
The press release (dated June 5) and complete acquisition documents are available in the filing for more specific transaction details.
BNC
NASDAQ
▲ SUPER 8-K
CEA Industries Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Form 8-K filed on June 10, 2025 (reporting period June 6, 2025) by an undisclosed company (CIK: 1482541).
**Material Event:** The filing reports the completion of an acquisition or disposition of assets (Item 2.01), indicating the company has finalized a significant business transaction. Additional details are provided in exhibits and supporting documentation.
**Key Items Reported:** The 8-K covers three main areas—completion of an asset acquisition/disposition, other events, and financial statements with exhibits—suggesting a structurally complex transaction requiring comprehensive disclosure.
**Investor Implications:** The completion of this acquisition/disposition could materially impact the company's financial position, operational structure, and future earnings potential. Investors should review the full 8-K document and attached exhibits to understand the transaction's terms, financing, and expected impacts on revenue, profitability, and strategic positioning.
**Recommendation:** Access the full filing documents (particularly the main 8-K and exhibits) for detailed information on deal terms, consideration paid, synergies expected, and any risks or contingencies that could affect shareholder value.
IVF
NASDAQ
▲ SUPER 8-K
INVO Fertility, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** InvestView Inc. (CIK 1417926) filed an 8-K on June 6, 2025, reporting the completion of an acquisition or disposition of assets as of June 2, 2025.
**Key Material Event:** The filing indicates the completion of an acquisition or disposition of assets (Item 2.01), though the specific details of the transaction are contained in the attached exhibit (EX-99.1). Without access to the full exhibit content, the precise nature, terms, and financial impact cannot be determined from this summary.
**Investor Implications:** This acquisition/disposition represents a significant corporate action that could materially affect InvestView's business operations, asset base, financial position, and strategic direction. Investors should review the complete 8-K filing and exhibit to understand the transaction's scope, financing structure, expected synergies or divestitures, and management's rationale for the transaction to assess its impact on company valuation and future performance.
FBIO
NASDAQ
▲ SUPER 8-K
Fortress Biotech, Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: Forgium Bio Inc.
**Filing Details:** Forgium Bio Inc. filed an 8-K on June 5, 2025, reporting a material event from May 30, 2025.
**Key Event:** The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has finalized a significant business transaction. The exact nature, target, valuation, and financial impact details would be contained in the full 8-K document and accompanying exhibits.
**Investor Implications:** This represents a material corporate event that could substantially alter the company's business profile, financial position, and strategic direction. Investors should review the complete filing and supplementary exhibits to understand the transaction terms, synergy expectations, integration plans, and any impact on earnings or financial guidance. The timing and terms of the deal will be critical factors in assessing whether this transaction creates shareholder value.
RENX
NASDAQ
▲ SUPER 8-K
RenX Enterprises Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated June 4, 2025 (for the period ending May 29, 2025) reveals significant corporate restructuring activities at the company. The filing documents multiple material events including entry into definitive agreements, completion of asset acquisitions, creation of financial obligations, issuance of unregistered equity securities (Series A Convertible Preferred Stock), and amendments to the company's bylaws.
**Key Material Changes:**
- The company completed an acquisition or disposition of assets and entered into amended membership interest purchase agreements
- New debt obligations were created, evidenced by promissory notes (including one to James Burnham)
- Series A Convertible Preferred Stock was issued, indicating new financing through preferred equity
- Corporate governance changes were made through bylaw amendments
**Investor Implications:**
These actions suggest the company is undergoing significant capital restructuring, likely involving debt and equity financing to support operational or acquisition activities. The conversion rights embedded in the preferred stock and multiple promissory notes indicate potential dilution to common shareholders. Investors should carefully review the detailed exhibits to understand the conversion terms, debt covenants, and governance impacts of these transactions.
CHUC
OTC
▲ SUPER 8-K
Charlie's Holdings, Inc.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary
Based on this June 3, 2025 8-K filing, the company (identified as CHUC by ticker) has reported two significant corporate actions: **entry into a material definitive agreement** and **completion of an acquisition or disposition of assets**. The filing occurred on May 29, 2025, and includes exhibit documents that appear to detail the terms of these transactions. Without access to the full document content, the specific nature of the agreement and asset transaction cannot be determined from this header information alone, but the dual reporting suggests a substantial business combination or asset restructuring event. Investors should review the complete 8-K document and attached exhibits to understand the financial impact, deal terms, and strategic implications for the company's future operations and shareholder value.
May 2025
13 filings
▼
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,9.01
# SEC 8-K Filing Summary
Based on this May 23, 2025 8-K filing (CIK 1938046), the company has disclosed **material corporate transactions** including:
**Key Events:**
- **Entry into a Material Definitive Agreement** (Item 1.01) - A significant new contract or deal was executed
- **Termination of a Material Definitive Agreement** (Item 1.02) - An existing material agreement was ended
- **Completion of Acquisition or Disposition of Assets** (Item 2.01) - The company completed a transaction involving asset purchase/sale or acquisition
**Investor Implications:**
This filing indicates substantial strategic changes to the company's business structure. The simultaneous termination of one agreement and execution of another, coupled with asset transaction completion, suggests a potential pivot in business operations, partnership restructuring, or acquisition activity. Investors should review the detailed exhibits (EX-10.1, 10.2, 10.3) to understand the financial impact, terms, and strategic rationale of these transactions. The materiality designation means these events could significantly affect shareholder value and future earnings.
SLE
NASDAQ
▲ SUPER 8-K
Super League Enterprise, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this May 22, 2025 8-K filing by SLG (CIK: 1621672), the company reported material events occurring on May 19, 2025, including the entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing contains a purchase agreement (Exhibit 2.1) and supplementary disclosures (Exhibit 99.1), suggesting the company completed a significant M&A transaction. While the specific details of the deal terms, financial impact, and strategic rationale require reviewing the full 8-K document and exhibits, investors should evaluate whether this transaction strengthens the company's market position, impacts earnings, or changes capital structure. The inclusion of multiple exhibits and financial statement references indicates this is a substantial corporate action that could materially affect shareholder value.
BLMH
OTC
▲ SUPER 8-K
BLUM HOLDINGS, INC.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on May 21, 2025 by a company (CIK 1996210) covering a material event that occurred on May 15, 2025.
**Key Material Events:**
The filing reports two significant items: (1) entry into a Material Definitive Agreement and (2) completion of an acquisition or disposition of assets. A Management Service Agreement dated May 15, 2025 has been executed, with the full text included as an exhibit.
**What Changed:**
The company has entered into a new management service agreement and completed a transaction involving acquisition or disposition of assets on May 15, 2025, which was publicly announced via press release on May 21, 2025.
**Investor Implications:**
Without access to the full agreement details and press release content, the exact nature and financial impact cannot be fully assessed from this filing header alone. However, investors should review the attached Management Service Agreement (Exhibit 10.1) and press release (Exhibit 99.1) to understand the transaction's scope, financial terms, and strategic implications for the company's operations and future performance.
PTIX
OTC
▲ SUPER 8-K
Protagenic Therapeutics, Inc.\new
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this May 19, 2025 8-K filing, the company experienced multiple significant corporate events. The filing discloses the completion of an acquisition or disposition of assets (Item 2.01), entry into material definitive agreements (Item 1.01), unregistered equity issuances (Item 3.02), and modifications to security holder rights (Item 3.03). Additionally, the company made changes to its articles of incorporation/bylaws (Item 5.03) and experienced officer/director changes with new compensatory arrangements (Item 5.02).
**For investors:** This filing signals major structural changes to the company, including potential ownership shifts from the acquisition activity, new equity dilution from unregistered securities, and governance restructuring. The breadth of items disclosed (9 separate material items) suggests a transformative event—possibly a merger, significant acquisition, or recapitalization. Investors should review the detailed exhibits and transaction agreements (particularly EX-2.1) to understand the financial impact, dilution levels, and new management implications.
PULM
NASDAQ
▲ SUPER 8-K
Pulmatrix, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This Form 8-K was filed on May 15, 2025, by a company (CIK: 1574235) reporting a material event dated the same day.
**Material Event:**
The filing reports the **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has successfully closed a significant M&A transaction. The specific details of the acquired or divested assets are contained in the accompanying exhibits and disclosure documents.
**Key Implications for Investors:**
- This represents a completed transaction, meaning negotiations and conditions have been finalized and the deal has closed
- The acquisition/disposition could materially impact the company's balance sheet, revenue streams, operational structure, or market position depending on the nature and size of the transaction
- Investors should review the full 8-K filing and exhibits for transaction details, purchase price, financing structure, and management's strategic rationale for the deal
**Next Steps:**
Investors should examine Exhibit 99.1 and related documents for comprehensive details about the transaction terms, expected financial impact, and how management believes this transaction will benefit shareholders going forward.
MYSZ
NASDAQ
▲ SUPER 8-K
My Size, Inc
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on May 12, 2025 (covering events through May 9, 2025) disclosing a material transaction for CIK 1211805.
**Key Material Events:**
The filing reports three significant items: (1) **Entry into a Material Definitive Agreement** (Item 1.01), (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01), and (3) **Regulation FD Disclosure** (Item 7.01). These items indicate the company has either entered into and/or completed a major business transaction, with supporting agreements included as exhibits.
**Investor Implications:**
Without access to the actual document content (only the filing structure is visible), the specifics of the transaction—such as deal value, strategic importance, or financial impact—cannot be determined from this summary. However, the presence of both Item 1.01 and 2.01 suggests a recently completed significant acquisition or asset sale that required formal board approval and is material enough to warrant immediate public disclosure. Investors should review the full 8-K and attached exhibits (particularly EX-10.1) to understand the transaction's terms, valuation, and potential effects on earnings and strategy.
NMEX
OTC
▲ SUPER 8-K
NORTHERN MINERALS & EXPLORATION LTD.
EDGAR Items: 2.01,5.02
# SEC 8-K Filing Summary
**Company & Filing Details:** This Form 8-K was filed on May 12, 2025, by a company (CIK 1415744) covering events from April 17, 2025.
**Material Events:** The filing reports two significant corporate actions: (1) the completion of an acquisition or disposition of assets (Item 2.01), and (2) changes in the company's executive leadership, including the departure and/or appointment of officers and modifications to executive compensation arrangements (Item 5.02).
**Investor Implications:** The asset transaction and executive changes represent material corporate restructuring that could impact the company's strategic direction, operational efficiency, and financial performance. Investors should review the detailed 8-K document to understand the acquisition/disposition terms, the identity of departing/new officers, and any modifications to executive compensation that might affect shareholder value. The specific impact will depend on whether the asset transaction is accretive or dilutive and how the leadership changes position the company for future growth.
RIME
NASDAQ
▲ SUPER 8-K
Algorhythm Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# SEC 8-K Filing Summary
**Filing Date:** May 8, 2025 (Period of Report: May 2, 2025)
**Key Material Events:**
This 8-K discloses multiple significant corporate transactions: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) creation of direct financial obligations, and (4) unregistered equity sales. The filing includes substantial exhibits (three major agreements totaling over 850KB) and supporting financial documentation, indicating a complex, multi-faceted transaction.
**What This Means for Investors:**
The simultaneous disclosure of new debt obligations, equity issuance, and asset/business transactions suggests the company is restructuring its capital or financing structure, likely to fund an acquisition. Investors should carefully review the attached agreements (Exhibits 10.1-10.3) to understand the transaction terms, debt covenants, dilution from equity issuance, and the strategic rationale. The completeness of disclosure across multiple Item categories indicates material financial impact that could affect shareholder value and the company's future cash flow and balance sheet.
LSAK
NASDAQ
▲ SUPER 8-K
Lesaka Technologies, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
Based on this May 7, 2025 8-K filing, the company reported the **completion of an acquisition or disposition of assets** (Item 2.01). While the specific details of the transaction are not visible in this document index, the filing indicates a material corporate event has been finalized. The company has included comprehensive financial statements and exhibits to support the transaction disclosure. Investors should review the full 8-K document and Exhibit 99.1 for details on the deal structure, financial impact, and strategic rationale, as acquisition completions can significantly affect shareholder value, debt levels, and future earnings guidance.
LIMN
NASDAQ
▲ SUPER 8-K
Liminatus Pharma, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filed on May 6, 2025 (for period ending April 30, 2025), the company underwent **significant corporate restructuring** involving multiple material events. The filing indicates a **change in control of the registrant**, completion of an **acquisition or disposition of assets**, changes in **certifying accountants**, **director/officer changes**, and **amendments to corporate governance documents** (articles of incorporation, bylaws, code of ethics). The company also appears to have changed its shell company status and conducted an **unregistered equity issuance**.
**For investors**, this represents a transformative event that could substantially alter the company's operations, management, and ownership structure. The multiple governance changes and accounting firm transition warrant careful review of the detailed exhibits to understand deal terms, new leadership implications, and any dilution from the equity issuance. This level of simultaneous change carries both opportunity (if the restructuring is strategic) and execution risk that investors should monitor closely.
DFDV
NASDAQ
▲ SUPER 8-K
DeFi Development Corp. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing:** Form 8-K filed May 5, 2025 by a company (CIK 1805526)
**Key Material Events:**
The company completed a material asset acquisition on May 1, 2025, involving the purchase of assets from SOL. The transaction included execution of three definitive agreements: an Asset Purchase Agreement, an Intellectual Property Assignment Agreement, and an Assignment and Assumption Agreement covering contracts and obligations.
**What Changed:**
The company has acquired new assets and intellectual property while assuming certain liabilities and contracts associated with the SOL operation. Additionally, the company issued unregistered equity securities as part of the transaction consideration.
**Investor Implications:**
This acquisition represents a significant corporate development that could impact the company's growth trajectory, asset base, and operational scope. Investors should review the detailed asset purchase agreement and valuation terms to assess whether the acquisition was made at reasonable valuations and whether the acquired assets will meaningfully contribute to future earnings and shareholder value. The use of unregistered securities as consideration should also be evaluated for potential dilution effects.
GREH
OTC
▲ SUPER 8-K
Green Rain Energy Holdings Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# SEC 8-K Summary - NOW Corp (May 2, 2025)
NOW Corp filed a material 8-K on May 2, 2025, disclosing several significant corporate events effective May 1, 2025. The filing indicates the company entered into a material definitive agreement and completed an acquisition or disposition of assets, with details provided in a Purchase and Sale Agreement. Additionally, the company issued unregistered equity securities and made key management changes, including the appointment of new officers and directors and the resignation of Mark Newbauer.
**For investors:** This filing suggests NOW Corp has undergone substantial restructuring through an acquisition/asset sale and significant leadership transitions. The unregistered equity issuance may indicate dilution to existing shareholders, while the management changes suggest a shift in strategic direction. Investors should review the full Purchase and Sale Agreement and board resolutions to understand the financial impact and new leadership's strategic vision.
AHRO
OTC
▲ SUPER 8-K
Authentic Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,3.03,5.03,9.01
# SEC 8-K Filing Summary: AHRO (Filed May 2, 2025)
Aethlon Medical, Inc. (AHRO) announced a material acquisition/asset purchase and corporate restructuring on April 29, 2025. The filing includes entry into a definitive asset purchase agreement, completion of an acquisition, issuance of unregistered equity securities (Series F Preferred Stock), modifications to shareholder rights, and amendments to the company's articles of incorporation. These multiple simultaneous items indicate a significant corporate transaction that will alter the company's capital structure and potentially its ownership composition. Investors should review the detailed Asset Purchase Agreement and Certificate of Designation for Series F Preferred Stock to understand the deal terms, dilution impact, and any preferential rights granted to new investors, as the preferred stock issuance suggests potential loss of control or substantial equity dilution for existing shareholders.
April 2025
3 filings
▼
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary: GD Culture (April 30, 2025)
**Key Material Events:**
On April 28, 2025, GD Culture completed a material transaction involving a Software Purchase Agreement and unregistered equity sale. The filing indicates three significant items: entry into a definitive material agreement, completion of an asset acquisition, and issuance of unregistered equity securities.
**What Changed:**
The company acquired software assets through a structured purchase agreement dated April 28, 2025, and simultaneously issued unregistered equity securities as part of the transaction consideration. These actions represent meaningful changes to the company's asset base and capital structure.
**Investor Implications:**
Investors should review the Software Purchase Agreement details (included as Exhibit 10.1) to understand the strategic rationale, valuation metrics, and potential revenue/cost impacts. The unregistered equity issuance may have dilutive effects on existing shareholders, while the software acquisition could represent a strategic expansion or capability enhancement—though the specific nature and financial terms require examination of the complete filing documents.
ATXI
OTC
▲ SUPER 8-K
AVENUE THERAPEUTICS, INC.
EDGAR Items: 1.01,1.02,2.01,9.01
# 8-K Filing Summary
Based on this SEC 8-K filing dated April 30, 2025 (for the period ending April 24, 2025), the company reported **four material events**: entry into a material definitive agreement, termination of a material definitive agreement, completion of an acquisition or disposition of assets, and financial statements/exhibits. While the HTML provided doesn't contain the full details of these transactions, the filing indicates **significant corporate restructuring activity** involving both a new agreement and termination of an existing one, along with asset changes.
To fully assess the impact on investors, you would need to review the actual 8-K document (tm2513615d1_8k.htm) to understand the nature of the agreements, the assets involved, and the financial implications. The presence of both a new material agreement and termination suggests the company may be **pivoting its strategy or business relationships**, which could affect shareholder value depending on the terms and rationale disclosed in the full filing.
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** April 25, 2025 | **Period:** April 24, 2025
This 8-K filing indicates multiple material corporate events occurred simultaneously. The company entered into material definitive agreements, completed an acquisition or disposition of assets, conducted unregistered equity issuances, and made officer/director changes with compensatory arrangements. These combined disclosures suggest a significant business restructuring or M&A transaction.
The variety and breadth of reported items—spanning new agreements, asset transactions, equity issuances, and executive personnel changes—suggest a complex, multi-faceted corporate event rather than a routine operational matter. Investors should review the detailed exhibits and full 8-K document to understand the specific terms, financial impact, and strategic implications of these changes on the company's future performance and shareholder value.